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Objectives And Outline Of Thesis 
Objectives 
Since the thalidomide disaster the teratogenic risk of chemicals has been recog-
nized as a serious threat to human health. Regulations concerning the introduc-
tion of new chemicals have therefore been extended in order to warrant a thor-
ough evaluation of the reproductive toxic risk they might impose to humans. 
These regulations refer to the use of in vivo studies with laboratory animals, 
usually rats, rabbits and mice. However the use of these animals is costly, time-
consuming and has been challenged due to the public debate on the use of 
animals for experimental goals. For these reasons the search for in vitro alterna-
tives is intensified. One of the in vitro approaches used in teratologic research is 
the postimplantation rat embryo culture, or rat whole embryo culture. Since its 
introduction in teratologic research this model has been applied in several ways. 
It can be used as a tool to test the embryotoxic potential of chemicals. It is also 
very useful to investigate mechanisms involved in teratogenesis. To a small 
extent it has been used to test for pathogenic factors present in sera of women 
with an abnormal pregnancy outcome. 
When chemicals are tested in this culture one has to bear in mind that some 
chemicals are not embryotoxic in their native form, but only exert an embryo-
toxic action after they have been bioactivated. The organ that biotransforms the 
bulk of xenobiotics that enter the body is the liver. This organ is not present in 
the embryos used in the rat whole embryo culture and the enzymes responsible 
for the bioactivation of the chemicals are not or only to a very low extent ex-
pressed in embryonic tissues. In order to be able to test the embryotoxic poten-
tial of such chemicals the rat whole embryo culture has to be combined with an 
1 
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external biotransfomning system capable of bioactivating these chemicals. The 
development of several approaches of combining adult hepatocytes with rat 
whole embryo culture and the comparison of them, using cyclophosphamide as 
a model substance are the objectives of part I of this thesis. 
Besides the use of rat whole embryo culture as a way to investigate the embryo-
toxic potential of chemicals, rat whole embryo culture has been used as a tool in 
fundamental embryologie and teratologic research as well. In this way this in 
vitro model has been applied in part II of this thesis. The objectives of this part 
of the thesis were to investigate the embryotoxic potential of homocysteine and 
elucidate the mechanism of its embryotoxicity. The incentive leading to these 
studies was the observation that a mild hyperhomocysteinemia frequently 
occurred in mothers that gave birth to children with neural tube defects (NTDs). 
This observation indicated that the metabolism of homocysteine in these moth-
ers and possibly their children was deranged. The gestational development of 
homocysteine metabolism in the rat was therefore investigated in this thesis as 
well. 
Outline of thesis 
Almost all of the studies described in this thesis are performed with the rat whole 
embryo culture model. Part I of this thesis starts with an introductory chapter, 
shortly reviewing the history of this model and describing the methodology. In 
chapter 2 the background of our studies on the use of adult hepatocytes as an 
external bioactivating system in rat whole embryo culture is clarified. Special 
attention is given to the metabolism and teratogenicity of cyclophosphamide, 
that was used as a model substance. Chapter 3 compares two different ap-
proaches: the method to culture adult hepatocytes suspended in the medium in 
which the embryos are cultured as well - i.e. the co-culture model - and the 
sequential culture model in which embryos are cultured in media in which 
hepatocytes had been incubated in the presence of a prodysmorphogen. Fur-
thermore the co-culture model was applied to the drug sodium valproate, an 
anticonvulsant known to increase the risk for spina bifida. It was noted that the 
sensitivity of the sequential culture model as observed by us differed from that 
described by others. Therefore in Chapter 4 we evaluated the effects of gender 
and Aroclor 1254 pretreatment of the rats providing the hepatocytes on the 
embryotoxicity and mutagenicity of cyclophosphamide. Chapter 5 is an exten-
sion of the study described in the previous chapter and describes the levels of 
three main metabolites of cyclophosphamide found in the hepatocytes media. In 
Chapter 6 the results and conclusions of the studies of part I are summarized. 
In Part II several studies are presented concerning a derangement of homocyste-
ine metabolism and its possible relation to the aetiology of NTDs. In Chapter 7 
the morphogenesis of the neural tube is described. It is indicated multiple pro-
2 
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cesses are involved in neurulation, which shows multiple targets exists for terato-
gens. Special emphasis is given to folate metabolism and its relation to NTDs. 
Finally in this chapter the incentive that prompted us to study the embryo-
toxicity of homocysteine is clarified. In Chapter 8 the embryotoxicity of L-homo-
cysteine in gestational day 10 rat embryos is described. The specificity of the 
embryotoxic effects of L-homocysteine is demonstrated by comparison with the 
toxicity of the enantiomere and derivatives of L-homocysteine. Additionally the 
toxic effect of L-homocysteine to pre-implantation mouse embryos is demon-
strated. In Chapter 9 further details of the embryotoxicity of L-homocysteine to 
gestational day 10 rat embryos are given and the attenuating effects of vitamin 
Bl2, Cu(II)S04, L-serine, 5-methyltetrahydrofolate and L-methionine are de-
scribed and discussed. Furthermore this chapter is concerned with the mecha-
nism of L-homocysteine embryotoxicity, giving tentative evidence that inhibition 
of transmethylation reactions by reduction of the ratio of S-adenosylmethionine 
(SAM) to S-adenosylhomocysteine (SAH), due to elevated L-homocysteine 
concentrations, is the cause for L-homocysteine embryotoxicity in vitro. Finally, 
in this chapter the results of experiments with gestational day 9.5 rat embryos 
are given. These experiments showed that L-homocysteine and L-methionine, 
but not folinic acid could prevent neural tube defects in these rat embryos, when 
they were cultured in human serum. In Chapter 10 the gestational development 
of homocysteine metabolism in the rat is investigated. In Chapter 11 the results 
and conclusions of Part II are summarized. Additionally in this chapter our 
results and work from other investigators on the mechanisms of folic acid-pre-
ventable NTDs are put in perspective and an attempt is made to place present 
knowledge in an unifying theory. Finally the implications of this theory for the 
primary prevention of NTDs are discussed. 
3 
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PARTI 
THE USE OF ADULT HEPATOCYTES 
AS AN EXTERNAL BIOACTIVATING SYSTEM 
IN WHOLE EMBRYO CULTURE 
5/Part I 
6/Part I 
Introduction 
The culture of postimplantation mammalian embryos 
During the postimplantation phase of mammalian embryonic development the 
main cell lineages diversify and the organ systems are formed. The inaccessibil-
ity of the embryos during this period of development in the mother's uterus 
makes it very difficult to study the processes of development in utero. The devel-
opment of methods to culture these embryos in vitro has brought about great 
advancements in both fundamental embryology and in teratology. The method 
of culturing postimplantation mammalian embryos is often referred to as mam-
malian whole embryo culture or, depending on the species used, rat or mouse 
whole embryo culture. 
Methodology 
The first attempts to culture mammalian embryos during the postimplantation 
period were made by Nicholas and Rudnick (1934) in the USA and Jolly and 
Lieure (1938) in France. Although their results were poor by present standards, 
they provided a valuable starting point for the development of improved tech-
niques, which was accomplished mostly by the work of New and co-workers 
(New, 1966; 1978). By the methods they developed it was possible to culture 
rat embryos from egg cylinder stage (gestational day 8) till the 63 somites stage 
(gestational day 14.5). However, the embryos explanted at the earliest stages do 
not develop up to the 63 somites stage in vitro. Embryos to be cultured at late 
stages have also to be explanted at a later stage (Fig. 2.1). The period dunng 
which embryos are commonly cultured in teratologic research is from gestational 
7/Part I 
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Figure 2.1 Development in culture obtainable from ratembryos explanted at different stages 
of organogenesis The length of each black area indicates the extent of differentia-
tion in culture. The increasing hight of the black areas from left to right symbolizes the 
growth in size of the embryos (not drawn to scale). Reprinted from D.A.T New in: Copp and 
Cockroft (1990), by permission of Oxford University Press. © 1990 IRL Press at Oxford 
University Press. 
day 9.5 (head fold stage) till gestational day 11.5 (appearance of the hind limb 
buds). During this period development of the embryos in vitro is morphologi-
cally not different from embryos developed in utero (New, 1978). The species 
used for whole embryo culture are usually rat and mouse. Experiments with 
other species (opossum, New et al., 1977; hamster, Givelber and DiPaolo, 
1968; guinea-pig, Jolly and Lieure, 1938; rabbit, Daniel, 1971 and Glenister, 
1971; pig, Trujana and Wrathall, 1985) gave poor results. However more re-
cently fair to good results have been reported on the culture of hamster (Ebron-
McCoy et al., 1988) and rabbit embryos (Ninomiya et al, 1993). There are 
several reasons why rodent embryos are more suitable for whole embryo cul-
ture. An important factor contributing to the suitability of rodent embryos for 
whole embryo culture is the presence of an inverted yolksac. As a result of this 
embryo lies inside its yolk sac. After removal of the Reichert's membrane and 
the parietal yolk sac, the same layers as in the human conceptus remain, al-
though the layers are still inverted (Garbis-Berkvens and Peters, 1989; Jollie, 
1990). In rodents the yolk sac is well developed and is even in vivo up till the 
8/Part I 
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twelfth gestational day the main organ exchanging nutrients and gasses between 
the embryo and the maternal compartment. 
The basic features of the methods developed by New et al. (1978) are removal 
of the Reichert's membrane after explantation, but leaving the ectoplacental 
cone intact, placing the embryos in rotating bottles, using homologous serum as 
culture medium, and gassing (either continuously or intermittently) with a gas 
mixture containing varying oxygen concentrations depending on the stage of 
development (increasing from 5 to 95%). Numerous variations on all aspects of 
this basic methodology have been made by many authors, which makes com-
parison of results sometimes difficult. The details of the methods used in this 
thesis are given in the various chapters of this thesis under the heading materials 
and methods. A comprehensive description of all facets of whole embryo culture 
can be found in Copp and Cockroft (1990). Although homologous serum is the 
most optimal medium for development of the embryos in vitro, the use of hu-
man serum may be advantageous when embryotoxic factors in human blood 
are investigated. Rat embryos explanted at gestational day 10 (4-8 somites) 
develop well in human serum, however development of rat embryos in human 
serum at earlier stages appears to be variable (New, 1990; Priscott 1983; Chatot 
et al., 1980; Steele, 1985; chapter 9 of this thesis). Addition of a few percent rat 
serum appears to improve development of these embryos (Anwar and Beck, 
1988). Also the addition of 3 mg/ml glucose to the serum appears to be a neces-
sity for the use of human serum as a culture medium. 
Embryonic development and its assessment 
It has been proposed to name those substances that elicit any toxic effect on the 
conceptus, including structural or functional abnormalities, embryotoxic. Terato-
genicity on the other hand should be regarded as a special case of embryo-
toxicity. Substances that cause specific structural or functional abnormalities, 
usually apparent at birth, within a dose range where there is no generalized 
toxicity are called teratogenic (Sullivan et al, 1993). This terminology has been 
adopted in this thesis as well1. During the optimal period of rat whole embryo 
culture, i.e. from gestational day 9.5 till gestational day 11.5, many organ sys-
tems develop rapidly (Brown and Fabro, 1981; Langenfeld et al., 1988). This 
makes it feasible to the investigator not only to observe embryotoxicity in vitro, 
but to discriminate between general embryotoxicity and teratogenicity in the 
culture system. Although structural abnormalities are never apparent at birth in 
this model (the conceptuses will never be bom), specific changes in the develop-
ment of certain parts of the conceptus as a result of a teratogenic insult, 
Where necessary previously published papers that have been included in this thesis have 
been modified according to this terminology 
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A 1 
A 2 
A 3 
B1 
B2 
ВЭ 
B4 
C l 
C 2 
C 3 
D1 
D2 
D3 
E1 
E2 
ЕЭ 
E4 
E5 
E6 
E7 
Fl 
F2 
G 1 
H1 
H 2 
He1 
He2 
H e 3 
He4 
Л 
K1 
M 1 
N 1 
N 2 
P1 
Fai 
Q 1 
Q 2 
si 
S2 
S3 
S4 
VOIlcsac circulation 
AlIdntOIS 
Flexion 
Hedrt 
Cduddl neurdl tube 
Rhombencephalon 
Mesencephalon 
Prosencephalon 
Other hedd region 
O t i c primordium 
Opt ic primordium 
Branchial bars 
Maxillary processes 
Mandibular processes 
Other facial region 
Forelimb buds 
Somites 
O t h 1 Others 
0 t h 2 
O t h 3 
0 t h 4 
O t h 5 
Othé 
defective 
small yollcsac vessels 
small or avascular 
not fused with chorion 
large 
small or avascular allantois 
Fused abnormally 
incomplete 
absent 
inverted tail (positioned at wrong side of head) 
delayed cardiac tube formation 
wide pericardial sac, filled with fluid 
other abnormalities (specify) 
Open posterior neuropore (dt a sta9e where it should be 
irregular dorsal midline 
aplasia 
lanky 
locally wider 
anterior-posterior fusion 
curving more extreme 
open rhombencephalon 
large or transparent rhombencephalon 
open mesencephalon 
open prosencephalon 
small prosencephalon 
irregular suture line 
abnormal craniofacial appearance 
haemorrhages 
edema 
deformed 
deformed 
one pair or more missing 
Idrge 
small 
unapproached 
(specify) 
small 
missing 
small 
irregular 
fused 
amorphogenesis 
edema 
haemorrhages 
general growth retardation 
embryonic death 
cell death 
other abnormalities (specify) 
closed) 
Table 2.2 Checklist of dysmorphogenic features. 'As compared to the normal situation. 
2Visible as opaque regions or spots at places where these are normally not present. 
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without an effect on other parts of the conceptus, may be regarded as an expres­
sion of the teratogenic potential of a substance (Schmid and Cicurel, 1986). 
To assess embryonic development during culture and to quantify the extent to 
which it is impaired, several scoring systems have been developed, of which the 
one developed by Brown and Fabro (1981) for the evaluation of rat embryo 
culture is the most elaborate. In an adapted form this scoring system is used in 
this thesis as well (Table 2.1). Adding up all scores in this system for each em­
bryo results in the Total Morphological Score (TMS), which is an accurate and 
sensitive measure for the embryonic development that occurred during culture. 
However teratogenic effects affecting only one or two of the separate scores may 
be masked in this overall measure. One might be tempted to statistically test for 
differences between control and experimental embryos for each separate mor­
phological parameter. However the very large number of comparisons made in 
such a way makes this precarious. 
Besides the use of the morphological scoring system all abnormal features of the 
embryos were recorded as well. For this purpose a check list was used (Table 
2.2). Often such abnormal features are called malformations. However it has 
been argued that abnormalities visible at gestational day 11 or 11.5 do not 
necessarily have to result in malformations apparent at birth. Therefore these 
abnormalities should rather be called dysmorphogenic features instead of mal­
formations (Brown et α/., 1990). This terminology has been adopted in this 
thesis. 
Finally three growth-related parameters were measured as well, namely head 
length, crown-rump length and yolksac diameter. 
Prodysmorphogens in whole embryo culture 
The principal usage of whole embryo culture is to test the teratogenic or 
embryotoxic potential of compounds. A major difference with in vivo testing is 
the exclusion of the influence of maternal factors. This gives the investigator the 
ability to examine the direct effects of the compound tested. An important 
maternal factor having the potential of affecting the embryotoxic effect of a 
compound is the maternal metabolism of the xenobiotic, usually called biotrans­
formation. When this biotransformation leads to the formation of metabolites 
that do elicit toxic effects, this process is often named bioactivation. Many sub­
stances do not cause any embryotoxic or teratogenic effects in their parent form, 
but first have to be bioactivated (Juchau, 1989). Similarly compounds do often 
not show mutagenic or carcinogenic properties unless they have been bio­
activated. Such compounds are referred to as promutagens or procarcinogens. It 
has therefore been proposed to name compounds that have to be bioactivated 
before they elicit embryotoxic or teratogenic effects proteratogens (Oglesby et 
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al., 1986). However, referring to the terminology adopted above, teratogenicity 
comprises only a part of the embryotoxic spectrum. Morphologic abnormalities 
observed after exposure of embryos to embryotoxic substances are called dys-
morphogenic features. In conjunction with this terminology, substances that 
elicit these abnormalities should therefore be named dysmorphogens. From this 
it follows that substances that need to be bioactivated before they elicit dysmor-
phogenic features should be called prodysmorphogens. 
If whole embryo culture is used without taking into account the possible effects 
of biotransformation for (pre-)screening of compounds, the exclusion of mater-
nal biotransformation might be judged as a disadvantage. However biotransfor-
mation of xenobiotics is quite often different in laboratory animals from biotrans-
formation in humans. Therefore, bearing in mind that compounds are usually 
tested to investigate their potential harmfulness for humans, the results obtained 
with in vivo testing in laboratory animals may rather be misleading instead of 
predicting when it are the metabolites that cause the harmful effects. Testing the 
parent compound and species-specific metabolites separately in whole embryo 
culture may therefore provide a much better insight in the embryotoxic potential 
of substances. 
External bioactwating systems 
The metabolites possibly involved in the embryotoxicity of a compound are 
often unknown or these metabolites are unavailable. It is therefore necessary to 
develop other approaches to investigate the role of maternal metabolism in the 
embryotoxicity of compounds. Basically there are two ways to introduce species-
specific metabolites in the whole embryo culture system when they are not 
directly at hand. One is to administer the parent compound to an animal and 
draw the blood from it in which the metabolites formed by the animal are pres-
ent. Subsequently the serum may be used to culture the embryos in. This may 
be especially interesting when not the blood from an animal is used but human 
blood from for example a patient who has taken a drug. In such a case human 
metabolites of the drug can be tested in whole embryo culture, as first was 
demonstrated by Chatot et al. (1980). A drawback of this approach is the loss of 
instable metabolites which may occur as a result of the necessity to heat-inacti-
vate the serum and the occurrence of extended time periods between the mo-
ment of administration of the drug, the drawing of the blood and the moment of 
testing in the embryo culture. 
An alternative way to introduce species-specific metabolites in the whole embryo 
culture system is by adding an external bioactivating system to the culture. The 
first to use this approach were Fantel et al. (1979) and Sanyal et al. (1979), who 
showed that the in vitro embryotoxicity of cyclophosphamide could be greatly 
increased by adding a rat hepatic microsomal fraction to the embryo culture. 
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The presence of reconstituted microsomes and the necessary cofactors is toler-
ated by the embryos in culture (Kitchin et al, 1981a,b) However there is con-
cern about artifacts such as prolonged exposure of differentiating tissues to 
stable denvatives that are not detoxified in reconstituted systems and the persis-
tence of entirely unphysiological reaction products (Welsch, 1992) Also the 
spectrum of reactions catalyzed by microsomes m vitro is limited Inactivation of 
toxic reaction products may occur in living animals or intact liver cells but be 
absent in reconstituted microsomal fractions Furthermore toxic products may be 
retained in the hepatocytes and never reach the embryo m uwo The shortcom-
ings of the use of microsomes have prompted Oglesby et al (1986) to develop a 
co-culture system of intact hepatocytes and rat embryos In the model they 
developed, hepatocytes of phénobarbital pre-treated and untreated rats, rabbits 
and hamsters were used They showed that the embryotoxicity of cyclophospha-
mide could be modified to different degrees depending on the pre-treatment 
and the species from which the hepatocytes onginated Instead of co-cultunng 
hepatocytes and rat embryos by cultivating the embryos on top of a monolayer 
of hepatocytes, co-cultivation is also possible by suspending the hepatocytes in 
the serum in which the embryos are floating, as was shown by Piersma et al 
(1991) A somewhat different approach of combining intact hepatocytes and rat 
embryos was undertaken by Bechter et al (1989) In the model they developed 
cyclophosphamide was added to a monolayer culture of rat hepatocytes Me-
dium samples from this culture were taken at vanous intervals and used for the 
culture of postimplantation rat embryos to assess the embryotoxicity of the 
metabolites formed Since the hepatocytes and the embryos are not cultured 
together, but sequentially, this model is referred to as the sequential culture 
model An advantage of the sequential culture model over the co-culture models 
is that some aspects of the pharmacokinetics can be taken into account as well, 
since the appearance and disappearance of embryotoxic metabolites can be 
monitored in this model 
Further evaluation of the sequential culture model onginally descnbed by 
Bechter et al (1989) and the co-culture model descnbed by Piersma et al (1991) 
is the main objective of this part of this thesis The results of these investigations 
will be presented in the next three chapters 
Cyc lophosphamide 
Cyclophosphamide (Fig 2 2) has now been used for over three decades as an 
anti-neoplastic and immunosuppressive drug A well-known charactenstic of 
this drug is that it first must be bioactivated before it is therapeutically effective 
The necessity for bioactivation is not only true for its therapeutic action but also 
the toxic properties of cyclophosphamide only become apparent after bio-
activation For this reason cyclophosphamide has been used extensively in 
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toxicologie studies as a model substance to demonstrate the presence of bio-
transforming capacity of tissues, cells or cell-free extracts used in in vitro models. 
In this way cyclophosphamide has also been applied in our studies. Since 
model-dependent differences in metabolism of cyclophosphamide were part of 
the subject of our studies and the goal was the application of bioactivating 
systems in whole embryo culture, both the metabolism and the teratogenicity of 
cyclophosphamide will be shortly described below. 
C I C H C H NH C H Fig· 2.2 Structural formula of cyclophosphamide 
2 2 \ / 2 \ 
N - P - 0 CH2 
CICHjCH,/ 4 o он/ 
Metabolism 
The metabolism of cyclophosphamide as described here is schematically repre­
sented in Fig. 5.2. The first step of its bioactivation is a hydroxylation at the ring 
C-4 position, which yields 4-hydroxycyclophosphamide. This reaction is per­
formed by NADPH-dependent mono-oxygenases (Sladek, 1988). There is 
evidence this reaction may also be catalyzed by peroxidases, however the con­
tribution of these enzymes to the formation of 4-hydroxycyclophosphamide in 
hepatic tissues is neglectable due to the abundance of mono-oxygenases in 
these tissues (Kanekal and Kehrer, 1993). The mono-oxygenases catalyzing the 
oxidation of cyclophosphamide to 4-hydroxycyclophosphamide are enzymes 
belonging to the cytochrome P450 family. In untreated rats the principal forms 
of cytochrome P450 responsible for this activation are CYP2C6 and the male-
specific CYP2C11. However when rats are phénobarbital pretreated CYP2B1 is 
the main catalyst (Clarke and Waxman, 1989). 
Once cyclophosphamide is bioactivated to the 4-hydroxy form it can tauto-
merize to an open ring structure, that is aldophosphamide. Aldophosphamide is 
unstable in an aqueous solution and will spontaneously degrade to phosphor-
amide mustard by ß-elimination of acrolein. These two reaction products are 
believed to be responsible for most toxic effects caused by cyclophosphamide. 
Subsequently phosphoramide mustard will degrade spontaneously to another 
mustard compound, namely nomitrogen mustard (Jardine et al., 1978). 
Above the metabolic steps necessary for cyclophosphamide activation are sum-
marized. However besides activation other metabolic steps are possible as well, 
notably those that lead to detoxification. Detoxification of cyclophosphamide 
may occur in two different ways. One is by oxidôtive reactions that render less 
or non-toxic metabolites, and the other is conjugation with glutathione (GSH). 
Both the main forms of 'activated' cyclophosphamide - 4-hydroxycyclo-
phosphamide and aldophosphamide - are prone to oxidative detoxif¡cations. 
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The first can be oxidized to 4-ketocyclophosphamide, probably by an aldehyde 
oxidase (Hohorst et ai., 1971), and the second to carboxyphosphamide, a 
reaction that is catalyzed aspecifically by numerous aldehyde dehydrogenases 
(Domeyer and Sladek, 1980; Lindahl, 1992). Conjugation with GSH may occur 
spontaneously or mediated by specific enzymes, named glutathione-S-transfer-
ases (GSTs). GSH conjugation of the native cyclophosphamide molecule occurs 
only enzymatically at a neutral pH by displacement of the chloride atoms, 
whereas phosphoramide mustard may react both spontaneously and by media-
tion of GSTs through an aziridinium intermediate (Colvin et al., 1993). Acrolein 
may react also with GSH which results in the formation of glutathionyl-
propionaldehyde. The latter reaction is reversible and acrolein may also sponta-
neously react with other thiol compounds (Ohno and Ormstadt, 1985). 
Above the role of GSH and GSTs in the detoxification of cyclophosphamide 
and its metabolites is explained. However, the role of GSH and GSTs in the 
biotransformation of cyclophosphamide has a more ambivalent nature. Besides 
in detoxification they also have a function in the stabilisation of 'activated' cyclo-
phosphamide. As explained above 'activated' cyclophosphamide, once it is 
formed, spontaneously degrades to phosphoramide and acrolein. However, as 
already pointed out by Draeger et al. (1976) and Peter et al. (1976), substitution 
of the 4-hydroxy group with a thiol compound will result in a thiol conjugate of 
medium stability in an aqueous solution. The most abundant thiol present in 
hepatocytes is GSH. GSH reacts either with the dehydrated form of 4-hydroxy-
cyclophosphamide - 4-iminocyclophosphamide - or 4-glutathionylcyclophosph-
amide is formed via a hemithioacetal intermediate (Pallante et al., 1986; Lee et 
ai, 1991). Since this conjugate is of medium stability in an aqueous solution it 
will spontaneously deconjugate after a while. In this way 'activated' cyclophos-
phamide is formed once again. This process has therefore also been referred to 
as 'delayed toxication' (Hohorst et al., 1976). The hydrophilic properties and 
relative stability of this conjugate make it likely that it has an important role in 
the redistribution of 'activated' cyclophosphamide (Fenselau et ai, 1982; Dirven, 
1994). 
Teratogenicity 
The teratogenicity of cyclophosphamide is well investigated in laboratory ani-
mals, mostly rats, mice and rabbits. The most predominant congenital malfor-
mations induced are malformations of the central nervous system and skeletal 
deformities. In monkeys (Macaca mullata) similar results were obtained (Mirkes, 
1985). Experience on the teratogenicity of cyclophosphamide in man is ob-
tained with cancer patients on therapy. Multiple congenital malformations have 
been described frequently. However in most cases chemotherapy was combined 
with irradiation therapy and in one case a multiagent chemotherapy was used. It 
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is therefore difficult to draw conclusions from these observations (Mirkes, 1985; 
Ostensen, 1992). A case of transplacental secondary cancer in a twin exposed in 
utero has been reported as well (Zemlickis et al., 1993). 
The mechanism of teratogenicity of cyclophosphamide has been studied inten-
sively. In the beginning it was thought that - contrary to the mutagenic and 
antineoplastic action of cyclophosphamide - the teratogenicity of cyclophospha-
mide was caused rather by the parent compound than by metabolites thereof 
(Gibson and Becker, 1968). However as Fantel et al. (1979) and Sanyal et al. 
(1979) demonstrated, the in vitro embryotoxicity of cyclophosphamide could be 
greatly increased by adding a reconstituted microsomal enzyme system to the 
culture. Subsequent studies in which metabolites were added to the embryo 
culture or where conceptuses were injected inrra-amniotically in vivo, showed 
that phosphoramide mustard and acrolein were the proximate teratogens 
(Mirkes et al., 1985; Juchau, 1989; Welsh, 1992). 
Although the congenital malformations induced by acrolein and phosphoramide 
mustard are very much alike, the mechanisms seem to differ. Whereas the 
proteins of the yolk sac seem to be the prime target of acrolein, phosphoramide 
mustard seems to react primarily with the embryonic DNA (Welsh, 1992). The 
interaction of phosphoramide mustard with embryonic DNA has been given the 
most attention and a number of facts have been established on this matter. 
Adducts of guanine and breakdown products of phosphoramide mustard have 
been identified in organogenesis-stage rat embryos after exposure in vitro 
(Mirkes et al., 1992). Exposure of rat embryos to 'activated' cyclophosphamide 
induces both single strand DNA breaks and DNA cross-linking (Little and Mirkes, 
1987). Phosphoramide mustard induces dose-dependently a perturbation of the 
cell cycle, with a decrease in the percentage of cells in Gl/Go, a delay in S-
phase, and an increase in the percentage of cells in G2/M (Little and Mirkes, 
1992). Recently Chen et al. (1994) demonstrated that a teratogenic dose of 
phosphoramide mustard caused DNA fragmentation and increased expression 
of sulphated glycoprotein-2, suggesting apoptosis is involved in mediating the 
teratogenicity of phosphoramide mustard. 
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Introduction 
The whole embryo culture (WEC) of rodent embryo's as developed by New 
(1978) has been used now for over ten years to study the embryotoxicity of 
substances either as a safety evaluation test (Schmid and Cicurel, 1986) or to 
study mechanisms of teratogenesis (Freeman and Steele, 1986). Since several 
substances require bioactivation in order to produce embryotoxic effects, it is a 
major drawback of the WEC that the biotransforming capacity of the embryos is 
very limited (Wilson, 1978). Therefore several approaches have been used to 
introduce an active adult hepatic biotransforming system to the WEC. Micro-
somal fractions (Kitchin et al. 1981a; 1981b; Fantel et al., 1979) or liver homo-
genates contain only part of the metabolic activity, which results in different 
metabolic patterns when compared with intact hepatocytes (Oglesby et al., 
1986). Several methods have been developed to combine the WEC with a 
culture of intact hepatocytes (Brown and Kram, 1982; Oglesby et al, 1986; 
Bechter et al., 1989; Piersma et al., 1991). In these reports cyclophosphamide 
has proven to be a useful prodysmorphogen in order to show the efficacy of the 
model under investigation. In our study we therefore used cyclophosphamide to 
compare co-culture and sequential culture of maternal hepatocytes and post-
implantation rat embryos in human serum. 
Valproic acid, an anti-epileptic drug, is associated with an increased risk of 
See note on p. 9 
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developing spina bifida (as high as 1-2%) (Lammer et al, 1987, Anonymous, 
1988) The parent substance is rapidly metabolized (Nau, 1986, Binkerd et al, 
1988, Rettenmeier et al, 1986) and metabolites differ widely in teratogenic 
potence (Nau and Loscher, 1986) We therefore used the co-culture system to 
investigate wether there was a potentiating effect of the metabolic system when 
sodium valproate was added 
Materials and m e t h o d s 
Serum preparation 
Blood was taken from adult volunteers (male and female) between 20 and 50 years of 
age The blood was defibnnized during donation by shaking with glass pearls in a glass 
bottle The defibnnized blood was centrifuged immediately and the serum was heat-
ìnactivated The glucose concentration was raised by 4 mM After testing each individual 
serum for compatibility with WEC, the serum of two to four individuals was pooled and 
stored at -20 °C 
Embryo culture 
Random-bred Wistar rats were housed in pairs or with three together in cages and were 
allowed to eat (standard food, Hope farms) and drink (tap water) ad libitum Lights were 
on from 12 00 a m till 12 00 ρ m On day 0 females (11 26 weeks old, 200 300 g), 
willing to mate, were brought together with males (1 1) from 9 00 a m till 12 00 a m 
Embryos were explanted between 1 30 ρ m and 3 30 ρ m on day 10 Only embryos 
between four and eight somites and without any abnormalities were used for WEC The 
embryos were cultured for 24 hours in a 25 ml glass bottle containing 2 ml medium at 
37 5 °C and rotated at 30 rpm The culture bottles were previously gassed with a gas 
mixture of 02, N2 and C02 (5 90 5) After 2 and 18 hours of culture the bottles were 
gassed with 02, N2 and C02 (20 75 5) 
Hepatocyte isolation and co-culture of hepatocytes and embryos 
Hepatocytes were isolated from 10 days' pregnant rats by the perfusion method This 
method and the co-culture system have been described previously (Piersma et al, 1991), 
except for the perfusion buffers being Hank's balanced salt solution instead of Ham's FIO 
and the co-culture medium being human serum instead of rat serum Sodium valproate 
or cyclophosphamide was added to the medium in 0 1 ml Hank's balanced salt solution 
Sequential culture of hepatocytes and embryos 
Hepatocytes, isolated as indicated above, were suspended in supplemented Williams' 
medium E (Bechter et al, 1989) with 10% foetal calf serum (FCS) at a concentration of 
вхІО тІ Cells were seeded on rat-tail collagen coated petn dishes (10 cm a, Nunc), 10 
ml/plate and incubated at 37 °C with 5% C02 in air and with 100% humidity After 4 
hours the medium was replaced by supplemented Williams' medium E without FCS, with 
or without 1 mM cyclophosphamide After 0, 1, 2, 4, 8 and 16 hours plates were taken, 
the medium underwent sterile filtration, and aliquots were frozen in fluid N2 and stored 
at -80°C For embryo culture 0 8 ml of the hepatocyte culture medium was added to 1 2 
ml human serum and embryos were cultured as indicated above 
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Morphological endpoints 
During the culture the embryos were monitored inside the incubation chamber for 
turning, neural tube closure, heart rate and yolksac circulation This was done after 2 
and 18 hours of culture and at the end of the culture After culture the embryos were 
scored as described by Brown and Fabro (1981), resulting in a total morphological score 
(TMS) Yolksac diameter (YSD), crown-rump length (CRL), head length (HL) and 
increase in number of somites (Δ somites) were also measured All dysmorphogemc 
features were recorded 
Statistical analysis 
The least square means of the morphological parameters of each group were estimated 
by analysis of covanance, taking the number somites at the start of the culture as 
covanant Least square means were compared using Students t-test Differences were 
regarded as statistically significant at P<0 05 
Resul ts 
Co-culture of hepatocytes and embryos cyclophosphamide 
In the presence of hepatocytes and 100 μΜ cyclophosphamide or more Δ 
somites was significantly smaller compared with controls (0 μΜ cyclophospha­
mide) (Fig 3 le) Also the number of dysmorphogemc features/conceptus was 
significantly increased under these conditions (Fig 3 If) TMS and HL were 
significantly decreased at a concentration of 330 μΜ cyclophosphamide or more 
(Fig 3 la,c) CRL was also significantly decreased at this concentration, but was 
not at ImM cyclophosphamide (Fig 3 lb) YSD was not changed at any 
concentration tested 
In the absence of hepatocytes at the highest concentration of cyclophosphamide 
(3 3 mM), TMS decreased significantly (Fig 3 la) and the number of dysmor­
phogemc features/conceptus increased significantly (Fig 3 If) Other morpho­
logical parameters didn't differ significantly at any concentration of cyclophos­
phamide tested compared with controls (0 μΜ cyclophosphamide) 
Dysmorphogemc features appeanng in a dose-dependent way as a result of 
incubation of the embryos and hepatocytes with cyclophosphamide were 
abnormal craniofacial appearance, dysmorphogenesis of the caudal part of the 
neural tube and cell death 
Co-culture of hepatocytes and embryos sodium valproate 
The presence of hepatocytes did not grossly affect the embryotoxicity of sodium 
valproate (Fig 3 2) Most morphological parameters were significantly de­
creased at 3 mM sodium valproate (Fig 3 2a e) The number of dys­
morphogemc features/conceptus was significantly increased at 2 mM sodium 
valproate (Fig 3 2f) Absence of malformations at low concentrations sodium 
valproate (0 3 and 1 mM) in the presence of hepatocytes is notable, however, 
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dysmorphogenic features did occur at these concentrations when hepatocytes 
were absent. This difference was only statistically significant at 0.3 mM sodium 
valproate. However, as mentioned before, a comparison of the embryos 
cultured without hepatocytes with 0.3 mM sodium valproate and there controls 
(0 mM sodium valproate) showed no significant increase of dysmorphogenic 
features/conceptus. At further analysis of the types of dysmorphogenic features, 
dose-dependent impairment of yolksac circulation, irregular suture line of the 
neural tube, delay in limb bud formation, irregular somites and cell death were 
seen. At 3 mM sodium valproate many more dysmorphogenic features could be 
seen, such as malformed optic and otic vesicles, open cranial neural tubes, 
incomplete (or absence of) turning and growth retardation. 
Sequential culture of hepatocytes and embryos: cyclophosphamide. 
Fig. 3.3 shows that after 4 hours of incubation of the hepatocytes in the pres-
ence of 1 mM cyclophosphamide, enough embryotoxic metabolites have been 
formed to impair the normal growth of the embryos. TMS and CRL are signifi-
cantly decreased from this time onward (Fig. 3.3a,b). The number of dysmor-
phogenic features/conceptus has also significantly increased at that time (Fig. 
3.3f). HL and YSD are not affected to a significant degree (Fig. 3.3c.d). The 
types of dysmorphogenic features are the same as those seen in the co-culture 
system with cyclophosphamide. 
Discussion 
The results obtained with the co-culture system when cyclophosphamide was 
tested are in accordance with those described earlier (Piersma et al., 1991). 
Hepatocytes are active, embryos grow well in the presence of hepatocytes, and 
bioactivation of cyclophosphamide occurs when hepatocytes are co-cultured 
with the embryos. This demonstrates that the use of human serum is compatible 
with the co-culture system. 
Inconsistency of CRL as a morphological parameter when cyclophosphamide or 
sodium valproate are tested in the co-culture system must be explained by the 
low number of surviving embryos at high concentrations of test substance added 
and the interference of these substances with the turning of the embryos that did 
survive. YSD seems to be an insensitive parameter. We therefore plead in favour 
of the use of more elaborate parameters such as the TMS originally described by 
Brown and Fabro (1981). 
The absence of dysmorphogenic features in the presence of hepatocytes and 
low concentrations of sodium valproate (whereas dysmorphogenic features did 
occur when hepatocytes were absent) suggests some detoxifying effect on the 
part of the hepatocytes. The fact that no potentiating effect by the hepatocytes 
could be observed, means that either potent embryotoxic metabolites are not 
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formed in quantities large enough to cause any increase in embryotoxicity, or 
that the formation of embryotoxic metabolites is equalled by the disappearance 
of sodium valproate, which is embryotoxic itself. 
Our results demonstrate that it is possible to bioactivate cyclophosphamide and, 
thereby, elicit its embryotoxic potencies by culturing hepatocytes and embryos 
sequentially. In contrast to an earlier report (Bechter et al., 1989), we could not 
detect a significant embryotoxic effect within 4 hours of incubation of the 
hepatocytes. This difference may be explained by the fact that we used non-
induced maternal hepatocytes, whereas Bechter and coworkers used Aroclor 
1254-induced male hepatocytes. This also explains why we needed much 
higher concentrations of cyclophosphamide and that embryotoxic compounds 
are still present in the hepatocytes medium after 16 hours; this, too, is in contrast 
with Bechter's results, who used only 60 μΜ cyclophosphamide and found a 
maximum embryotoxicity after 5 hours. It is therefore clear that the sequential 
culture system we used is less sensitive than the one described by Bechter, but it 
also demonstrates that under the more physiological circumstances of our 
system bioactivation of cyclophosphamide and embryotoxicity do still occur. 
When we compare the results of the co-culture system and the sequential culture 
system, it is obvious that the sequential culture system is as sensitive or slightly 
less sensitive than the co-culture system. (0.33 mM cyclophosphamide in the 
sequential culture system showed some embryotoxicity after 16 hours of 
incubation of the hepatocytes; results not shown). It therefore seems that the loss 
of some of the bioactivating capacity during the attaching period of the hepato­
cytes and the loss of instable metabolites are not of great importance under 
these circumstances. Compared with the co-culture system, the sequential 
culture system has two major advantages: (i) One hepatocyte isolation and 
incubation provides sufficient medium for all embryo cultures of an experiment, 
whereas in the co-culture system, hepatocytes must be isolated for each embryo 
culture, (ii) Taking medium from the hepatocyte culture at different times gives 
an impression of the time-dependent formation of embryotoxic metabolites and 
detoxification of embryotoxic compounds. 
In conclusion, we believe that both the co-culture system and the sequential 
culture system can be useful in eliciting the embryotoxicity of metabolites 
formed from suspected prodysmorphogens. However the sequential culture 
system seems to be the more practical approach. 
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Abstract The sequential culture of rat hepatocytes and postimplantation rat embryos 
has been proposed as a model for the in vitro testing of prodysmorphogens. Comparing 
this model with a model in which embryos and hepatocytes are cultured simultaneously a 
striking difference in sensitivity was noted. To address the question whether this differ-
ence could be explained by different sex and/or Aroclor 1254 pretreatment of the rats 
providing the hepatocytes, an experiment was designed with four groups: male Aroclor 
1254 pretreated (MA), male untreated, pregnant female Aroclor 1254 pretreated (PA) and 
pregnant female untreated rats. Hepatocytes were incubated in the presence of cyclo-
phosphamide and rat embryos were cultured in the media derived from the hepatocyte 
culture (i.e. the sequential culture model) Additionally, the cyclophosphamide concentra-
tions of the media were analysed and subsequently the media were tested in a bacterial 
mutagenicity test {Salmonella typhimunum TA 1535). With a cyclophosphamide concen-
tration of 300 μΜ, MA produced maximum embryotoxicity and mutagenicity after 4 hours 
of hepatocytes incubation. All other groups showed no or only a slight increase in 
embryotoxicity and mutagenicity for all hepatocyte incubations. MA was also quickest to 
eliminate cyclophosphamide from the medium These results indicate that despite a strong 
increase in total cytochrome P450 in both sexes as a result of Aroclor 1254 pretreatment, 
and in the absence of a significant difference in total cytochrome P450 between MA and 
PA, Aroclor 1254 pretreatment has a much more pronounced effect in male rats than in 
pregnant female rats with regard to the production of embryotoxic and mutagenic metabo­
lites of cyclophosphamide. 
Introduction 
Some substances require bioactivation before they can exert their embryotoxic 
See note on p. 9 
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activity It is therefore a major drawback of isolated whole embryos in culture 
that their biorransforming capacity is limited In order to facilitate biotransforma­
tion in whole embryos in culture, several approaches have been used Besides 
addition of hepatic microsomal fractions (Fantel et al, 1979, Kitchm et al, 
1981a,b) intact hepatocytes have also been used, both m co-culture (Oglesby et 
al, 1986, Piersma et al, 1991, VanAerts et al, 1992) and in sequential culture 
(Bechter et al, 1989, VanAerts et al, 1992) with rodent embryos In the sequen­
tial culture model hepatocytes are incubated with the substance under investiga­
tion, whereafter the medium containing metabolites is mixed with serum and 
rodent embryos are cultured in it 
When we compared our results, obtained with the sequential culture model, 
using cyclophosphamide as prodysmorphogen (VanAerts et al, 1992), with the 
results obtained by Bechter et al (1989), we noted a striking difference in sensi­
tivity This difference could not simply be explained by the fact that Bechter and 
coworkers had pretreated their (male) rats with Aroclor 1254, since pretreatment 
with Aroclor 1254 of our (pregnant female) rats did not show a potentiating 
effect on the bioactivation of cyclophosphamide (L A G J M VanAerts, unpub­
lished results, 1991) We therefore designed an expenment in which both sex 
and pretreatment with Aroclor 1254 of the rats providing the hepatocytes were 
varied, in order to investigate the role of both factors in their capacity to influ­
ence the bioactivation of cyclophosphamide 
Materials and m e t h o d s 
Hepatocyte culture 
Male random bred Cpb WU (Wistar) rats (8-10 wk old, 220-280 g) were housed in 
groups and were allowed access to food (MRH-TM pellets, Hope farms В V , Woerden, 
The Netherlands) and water [acidified tap water (0 025% HCl)] ad lib A 12-hr 
light/dark cycle was used (light from 6 0 0 a m to 6 00 p m ) Female rats (22 29 wk old, 
240-315 g) were treated as indicated in the section whole embryo culture (WEC) Three 
male and three pregnant female rats were injected ip with 100 mg Aroclor 1254/kg body 
weight (Alltech, Deerfield) in olive oil, six and three days prior to hepatocyte isolation 
Three male and three pregnant female rats that were not injected with Aroclor 1254, 
served as controls Hepatocytes were isolated by the perfusion method as described 
previously (Piersma et al, 1991), except that for the perfusion Hank's balanced salt 
solution was used instead of Ham's FIO Maternal hepatocytes were isolated on day 10 
of gestation The viability of the hepatocytes isolated, as assayed with trypan blue exclu­
sion, was 88±3% Hepatocytes were suspended in supplemented William's medium E 
(Row Laboratories, Irvine, Scotland) (Bechter eí al, 1989) with 10% fetal calf serum 
(FCS) (Flow Laboratories, Irvine, Scotland) at a concentration of 8 x l 0 5 cells/ml Cells 
were seeded on rat-tail collagen (Boehnnger, Mannheim, Germany) coated pern dishes 
(10 cm 0) (Nunc, Roskilde, Denmark), 10 ml/plate and incubated at 37 °C with 5% C02 
in air and with 100% humidity After 4 hr the medium was replaced by supplemented 
Williams' medium E without FCS, to which cyclophosphamide (Endoxan, punty>97%, 
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ASTA-Pharma, Bielefeld, Germany) was added (0, 10, 30, 100, 300 and 1000 μΜ) 
After 0, 1, 2, 4, 8 and 18 hr plates were taken (one for each concentration), the medium 
was sterile filtered (0 2 μπ\, Schleicher & Schuell, Dassel, Germany) and aliquots were 
frozen m fluid N2 and stored at -80 °C 
Whole embryo culture 
Human serum used in WEC was prepared as follows Blood was taken from adult 
volunteers (male and female) between 20 and 50 yr of age The blood was defibnnized 
during donation by shaking with glass pearls in a glass bottle The defibnnized blood was 
centrifuged immediately, the serum was heat-inactivated (30 min, 56 °C) and D-glucose 
was added (720 mg/1) After testing each individual serum for compatibility with WEC, 
the serum of two to five individuals was pooled and stored at -20 DC Female random 
bred CpbWU (Wistar) rats (11-26 wk old, 200-300 g) were housed in pairs or three 
together in cages and were allowed access to food (MRH TM pellets, Hope Farms В V , 
Woerden) and water (tap water) ad lib A 12 hr light/dark cycle was used (lights from 
12 00 a m to 12 00 ρ m ) On day 0, females willing to mate were brought together with 
males (11) from 9 00 α m to 12 00 α m Embryos were explanted between 1 30 ρ m 
and 3 30 ρ m on day 10 Only embryos with four to eight somites were used for the 
culture The embryos were cultured separately for 24 hr in 25 ml glass bottles containing 
2 ml medium at 37 5 °C and rotated at 30 rpm The culture medium consisted of 1 2 ml 
human serum and 0 8 ml supplemented Williams' medium E in which hepatocytes had 
been cultured The culture bottles were gassed with a mixture of 02, N2 and C02 
(5 90 5) After 2 and 18 hr of culture the bottles were gassed with a mixture of 02, N2 
and C02 (20 75 5) After cultunng, the morphology of the embryos was evaluated as 
described by Brown and Fabro (1981) All dysmorphogenic features were recorded 
Total cytochrome P450 content 
Frozen-thawed hepatocytes were dissolved in 0 1 M phosphate buffer (pH 7 4) contain­
ing 2 3 % glycerol and 0 1% Tnton-X-100 The suspension was sonicated twice for 15 sec 
and hepatocyte cytochrome P450 was assayed by its carbon monoxide difference 
spectrum after reduction with sodium dithionite according to the procedure of Omura 
and Sato (1964) Protein content was assayed with Coomassie Brilliant Blue G (Sigma, 
St Louis, MO, USA) according to Bradford (1965) All samples were analysed in tripli­
cate 
Analysis of cyclophosphamide concentrations 
Cyclophosphamide concentrations in the hepatocyte media were analysed with gas 
chromatography according to the method descnbed for cyclophosphamide analysis of air 
samples, wipe samples and gloves by Sessink et al (1992) After identification of cyclo­
phosphamide and isophosphamide (internal standard, Holoxan, punty>97%, ASTA-
Pharma, Bielefeld, Germany) peaks by mass spectrometry (Sessink et al, 1992) routine 
analyses were performed with the same gas chromatographic method, but with a thermo 
ion-specific detector instead All samples were analysed in duplicate 
Mutagenicity assay 
For testing the mutagenicity of the hepatocyte media after incubation with cyclophospha­
mide, 0 4 ml of the sterile samples were added per plate and assayed with the Salmo-
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Fig 4 1 Total cytochrome P450 content of 
rat hepatocytes as determined by its 
carbon monoxide difference spectrum (nmol/ 
mg cellular protein) Sex and Aroclor 1254 
pretreatment as indicated Bars and error bars 
represent mean and SEM, respectively 
calculations were performed with SAS statistical 
410 computer 
nella typhunurium strain TA1535, ac­
cording to Maron and Ames (1983) All 
samples were assayed in triplicate 
Statistical and other calculations 
Differences between groups were tested 
with Student's t-test The Bonferroni 
correction was used to correct for multi­
ple comparisons with a nominal о of 
0 05, differences were regarded as sta­
tistically significant at P<0 05/fc where к 
is the number of comparisons made 
The least square means of total mor­
phological scores (TMS) and the num­
ber of dysmorphogenic fea-
tures/conceptus were estimated by anal­
ysis of covanance, taking the number of 
somite pairs at the beginning of culture 
as covenant Pseudo-first-order rate 
constants of cyclophosphamide elimina­
tion from the hepatocyte media were 
calculated by a linear regression model 
in which the natural logarithm of the 
ratio of the cyclophosphamide concen­
tration and the initial cyclophosphamide 
concentration was a function of the 
incubation time elapsed 
( l n ( [ c y c l o p h o s p h a m i d e ] / 
[cyclophosphamide]mitìal) = к' time ) All 
software ν 6 06 on a Digital VAX 6000-
Results 
Total P450 content 
Total cytochrome P450 content after Aroclor 1254 pretreatment was increased 
3 8-fold and 6 6-fold in male and female rats, respectively As a result of this the 
difference in total cytochrome P450 content between the sexes was greatly 
reduced after Aroclor 1254 pretreatment and it was no longer statistically signif­
icant (Fig 4 1) 
Cyclophosphamide elimination 
Hepatocytes isolated from Aroclor 1254 pretreated males eliminated cyclophos­
phamide from the medium approximately four times more rapidly than 
hepatocytes isolated from untreated males or Aroclor 1254 pretreated or un-
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Sex 
Male 
Male 
Female 
Female 
Aroclor 1254 
+ 
-
+ 
-
/f'ts-1) 
38 4(1 2)x10"6* 
104(1 2)x 1 0 6 
9 5 (0 6) χ 10 6 
7 5 (2 8) χ 10 s 
treated females (Table 4.1, Fig. 
4.2) There was no significant 
difference in cyclophosphamide 
elimination between the three 
latter groups. 
Embryotoxicity and mutage­
nicity 
When hepatocytes isolated from 
Aroclor 1254 pretreated male rats 
were cultured in the presence of 
300 μΜ cyclophosphamide, 
within 1 hr, sufficient embryotoxic 
metabolites were produced to 
Table 4.1 Pseudo-first-order rate constants (k') for 
cyclophosphamide elimination from 
media in which hepatocytes were incubated in 
monolayer culture Sex and pretreatment with Aro­
clor 1254 of rats that provided the hepatocytes as 
indicated Each value was calculated on the basis of
 r e c
j
u c e
 the TMS and increase the 
data from three different incubations with five dif­
ferent concentrations of cyclophosphamide (ΙΟ­
Ι 000 μΜ) 'Values shown are means and SEM * = 
P < 0 0001 in Students (-test when compared with 
each of the other values 
number of dysmorphogenic fea­
tures of conceptuses in a statisti­
cally significant way. Maximum 
embryotoxicity occurred after 4 
hr. Thereafter embryotoxicity di­
minished (Fig. 4.3d). When hepatocytes were isolated from untreated male rats 
or from untreated or Aroclor 1254 pretreated female rats and were incubated in 
the presence of 300 μΜ cyclophosph-amide, only a small increase of 
embryotoxicity during the hepatocyte culture could be observed when embryos 
were cultured in these hepatocyte conditioned media. A statistically significant 
difference was only observed for the increase in the number of dysmorphogenic 
features in conceptuses cultured with the medium conditioned by untreated 
female rat hepatocytes (Fig. 4.3a-c). When hepatocytes were cultured in the 
presence of 1000 μΜ cyclophosphamide, embryotoxicity, as expressed by a 
reduced TMS and an increase of the number of dysmorphogenic features, could 
be observed in all experimental groups. The difference between groups under 
these circumstances was that the hepatocytes isolated from Aroclor 1254 
pretreated males produced the embryotoxic metabolites more quickly than did 
the hepatocytes isolated from other rats. Because of the larger quantity of cyclo­
phosphamide added to the medium, no diminishing of embryotoxicity could be 
observed (results not shown) 
Similar patterns could be observed when media were assayed for mutagenicity. 
After incubation in the presence of 300 μΜ cyclophosphamide, hepatocytes 
isolated from untreated female rats produced no statistically significant level of 
mutagenic metabolites, as assayed with the Salmonella mutagenicity test. 
Hepatocytes isolated from Aroclor 1254 pretreated females or untreated males 
produced sufficient mutagenic metabolites to evoke a significant increase in 
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Fig. 4.2 Cyclophosphamide concentration against time curves for media in which 
hepatocytes were incubated in monolayer culture. Hepatocytes were 
derived from untreated pregnant female (a), Aroclor 1254 pretreatedpregnant female 
(b), untreated male (c) and Aroclor 1254 pretreated male rats (d). Values shown are 
means s SEM. Each point consists of duplicate measurements of three samples from 
three different incubations. 
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Fig. 4.3 Embryotoxicity of media in which hepatocytes were incubated in monolayer 
culture in the presence of 300 μΜ cyclophosphamide. Hepatocytes were derived 
from untreated pregnant female (a), Aroclor 1254 pretreated pregnant female (b), untreated 
male (c) and Aroclor 1254 pretreated male rats (d). Embryotoxicity is expressed as TMS (left 
axis, ) and number of dysmorphogenic features per embryo (right axis, — - ) . Values shown 
are least square means ± SEM for nine embryos cultured in media from three different 
hepatocyte incubations. * = P<0.008 in Student's£-test when compared with samples from 
incubation lime = 0. 
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Fig. 4.4 Mutagenicity of media in which hepatocytes were incubated in monolayer culture 
in the presence of 300 μΜ cyclophosphamide ( ) or no cyclophosphamide (----). 
Hepatocytes were derived from untreated pregnant female (a), Aroclor 1254 pretreated 
pregnant female (b), untreated male (c) and Aroclor 1254 pretreated male rats (d). Values 
shown are means ± SEM of revenants per plate for triplicate assays in the Salmonella mutage­
nicity test of media from three different hepatocyte incubations. * = P<0.01 in Student'si-
test when compared with samples from incubation time = 0 . 
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bactenal mutants only after 18 hr of hepatocyte culture Hepatocytes isolated 
from Aroclor 1254 pretreated males bioactivated cyclophosphamide quickly 
enough to increase the mutagenicity of the medium within 2 hr in a statistically 
significant way In the latter group, the number of revertants was highest after 4 
hr of hepatocyte culture However, since media m which hepatocytes from 
Aroclor 1254 pretreated males were cultured without cyclophosphamide also 
showed a significant increase in mutagenicity after 4 hr, this peak might be 
biased for some unknown reason (Fig 4 4) 
Discussion 
Our results show that the bioactivation of cyclophosphamide can be greatly 
enhanced in male rats after Aroclor 1254 pretreatment, while this P450-enzyme 
inducer has only little effect on the bioactivation of cyclophosphamide in preg-
nant female rats A similar sex difference in the inductive capacity of Aroclor 
1254 on the bioactivation of a xenobiotic has been reported by Juchau et al 
(1985), who showed that the production of hydroxylated metabolites of 2-
acetylaminofluorene was much more enhanced by Aroclor 1254 in male livers 
than in maternal livers When rat embryos were cultured in the presence of 2-
acetylaminofluorene, crude microsomal fraction (S9) prepared from Aroclor 
1254 pretreated male livers elicited many malformations in the embryos, 
whereas addition of S9 prepared from Aroclor 1254 pretreated maternal livers 
had no embryotoxic effect at all Cytochrome P450 iso-enzymes CYP1A1 (for 
terminology see Nebert et al, 1991), participating in the hydroxylation of 2-
acetylaminofluorene, and CYP2B1, the main P450 iso-enzyme bioactivating 
cyclophosphamide after phénobarbital induction (Clarke and Waxman, 1989, 
Giachelh and Omiecinski, 1985), are known to be induced by Aroclor 1254 
(Ryan et al, 1978) The distnbution of these iso-enzymes is not sex specific, 
although there are sex differences in the levels of expression (Waxman et al, 
1985, Clarke and Waxman, 1989) The observed sex differences in inductive 
capacity of Aroclor 1254 remain therefore partly unexplained One factor that 
might have contributed to the observed effects, is the difference in age between 
the male rats and the pregnant female rats used Indeed it has been reported 
that the phénobarbital responsiveness of CYP2B1 mRNA expression is highest 
at the 46th day of post-natal development of the rat and is decreased to 40% of 
the peak level at the 65th day Whether there is a further decrease of CYP2B1 
inducibility thereafter is not known 
Another element that might have attributed to the observed results is pregnancy 
It is known that the cytochrome P450 content of rat maternal liver decreases 
during pregnancy (Brown et al, 1986, Nakajima et al, 1992) Indeed it has 
been shown that two iso-enzymes, involved in cyclophosphamide bioactivation, 
namely CYP2C6 and CYP2B1 (Clarke and Waxman, 1989), are present at a 
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somewhat lower level in pregnant female rats on day 10 of gestation than in 
non-pregnant female rats (Nakajima et al, 1992) Whether these slightly lower 
levels of expression dunng pregnancy render these iso-enzymes much less 
susceptible to Aroclor 1254 induction is not known 
An interesting feature of the sequential culture model, as applied here, is the 
possibility to follow the appearance and disappearance of embryotoxic metabo­
lites time-dependently Our results show that embryotoxic and mutagenic me­
tabolites appear simultaneously when Aroclor 1254 pretreated male rat 
hepatocytes are incubated in the presence of 300 μΜ cyclophosphamide After 
4 hr of incubation the embryotoxicity of the medium decreases significantly, 
while the mutagenicity of the medium remains high This might be explained as 
follows first cyclophosphamide is bioactivated cytochrome P450-dependently to 
4-hydroxycyclophosphamide The tautomer of 4-hydroxycyclophosphamide, 
aldophosphamide, degrades spontaneously in aqueous solution, which results in 
the formation of acrolein and phosphoramide mustard (Slott and Hales, 1988) 
Acrolein is very embryotoxic, but not mutagenic (Ellenberger and Mohn, 1977, 
Hales, 1982) and is detoxified by a reaction with glutathione (Ohno and 
Ormstad, 1985) This reaction is probably enhanced, since glutathione transfer­
ases are also induced by Aroclor 1254 Phosphoramide mustard, on the other 
hand, is both a mutagen and a dysmorphogen If phosphoramide mustard is 
more persistent in the medium, this could explain the differential detoxification 
rates as observed for the mutagenicity and the embryotoxicity of the hepatocyte 
media 
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Abstract In a previous paper (VanAerts ef a/., Toxicology in Vitro 1993, 7, 769-775) we 
have shown that the embryotoxicity of cyclophosphamide was greatly enhanced when 
cyclophosphamide had been added to a primary hepatocyte culture derived from Aroclor 
1254-pretreated male rats (MA) and the medium from this culture was added to a post-
implantation rat embryo culture. However, when medium from hepatocytes that had been 
derived from untreated male rats (Mc), untreated pregnant rats (Pc) or Aroclor 1254-
pretreated pregnant rats (PA) was used embryotoxicity was low. We now present data on 
the concentrations of 4-ketocyclophosphamide, carboxyphosphamide and nornitrogen 
mustard in the primary hepatocyte culture media. 4-Ketocyclophosphamide was absent in 
media from Pc or PA and present in low concentrations in media from Mc and MA. 
Carboxyphosphamide and nornitrogen mustard were present in all media, but their con-
centrations were several times higher in medium from MA than in media from other sour-
ces. This indicates that Aroclor 1254 pretreatment enhances cyclophosphamide metabo-
lism much more in male rats than in pregnant rats It is suggested that both a greater 
inducibility of CYP2B1 and augmented stabilization of 4-hydroxycyclophosphamide by 
glutathione conjugation may be processes that contribute to the observed differences in 
metabolite concentrations. 
Introduction 
The culture of post-implantation rodent embryos has become a well-established 
tool for investigating the embryotoxicity of chemical substances. However, many 
substances need bioactivation before they exert any embryotoxic effects. There-
fore this model has been extended by introducing external biotransforming 
systems. One of the approaches used for this purpose is the sequential culture 
model (Bechter et ai, 1989, VanAerts et ai, 1993b). In this model a prodys-
morphogen is added to a primary rat hepatocyte culture. The medium derived 
from this culture is used for the culture of post-implantation rat embryos to 
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assess the embryotoxicity of the metabolites formed. In order to enhance the 
biorransforming capacity of the hepatocytes used, rats are often pretreated with 
Aroclor 1254, a commercial mixture of polychlonnated biphenyls. Routinely 
male rats are used for this purpose. However, using pregnant rats would be a 
more physiological approach to investigate the embryotoxicity of prodys-
morphogens. We designed an expenment in which hepatocytes were denved 
from four different sources: untreated male rats (Mc), Aroclor 1254-pretreated 
male rats (MA), untreated pregnant rats (PC) and Aroclor 1254-pretreated preg­
nant rats (PA) (VanAerts et al., 1993b). It was shown that the embryotoxicity 
was much greater when medium from cyclophosphamide-exposed MA hepato-
cyte cultures was used than when media from hepatocytes from other sources 
were tested. Lack of enhancement of cyclophosphamide teratogenicity by 
Aroclor 1254 pretreatment was also reported by Welsch (1985), who used mice 
and assessed teratogenicity in uiuo. This author even found a diminished terato­
genicity of cyclophosphamide after Aroclor 1254 pretreatment. 
We now extend our studies by presenting data on the levels of carboxy-
phosphamide, 4-ketocyclophosphamide and nomitrogen mustard found in the 
media in which hepatocytes had been incubated with cyclophosphamide for 
different time intervals. The media that have been analysed, are the same as 
those that have been used for cyclophosphamide analysis, rat embryo culture 
and mutagenicity testing for which the data have been published in a previous 
paper (VanAerts et al. 1993b). 
Materials and m e t h o d s 
Chemicals 
Cyclophosphamide, trophosphamide, carboxyphosphamide and 4-ketocyclo-
phosphamide were gifts from Asta-Medica (Frankfurt am Main, Germany) Nomitrogen 
mustard was purchased from Aldnch Chemical Co (Milwaukee, Wl, USA) Benzene-
sulfonylchlonde was obtained from Janssen Chimica (Beerse, Belgium) Ν,Ν-dimethyl-
formamide dimethyl acetal was purchased from Chrompack (Middelburg, The Nether­
lands) All other chemicals were of the highest purity obtainable 
Experimental design 
A detailed description of the experimental design is given in VanAerts et al (1993b) 
Briefly, hepatocytes were isolated from MC, MA, PC and PA by a perfusion method and 
incubated in the presence of 300 μΜ cyclophosphamide in a monolayer culture ( 8 x l 0 6 
cells/10 ml dish) In each group three rats were used Media samples were taken at 
different time intervals (0, 1, 2, 4, 8 and 18 hr) These media were used for embryo 
culture, mutagenicity testing and analyses of cyclophosphamide and its metabolites 
carboxyphosphamide, 4-ketocyclophosphamide and nomitrogen mustard 
Metabolite analyses 
All media samples (three per group at each time interval) were analyzed in duplicate 
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Analyses of metabolites were adapted from the methods developed by Sessmk et al (in 
press) Briefly, for measurement of carboxyphosphamide and 4-ketocyclophosphamide 
samples were diluted with water and Tris buffer (pH 8 0) Excess of cyclophosphamide 
was removed by diethylether extraction to avoid interference during the analysis The 
ether layers were discarded and 6 M HCl was added The mixture was extracted with 
ethylacetate. The ethylacetate layers were dried under nitrogen at 40°C The residue was 
dissolved in toluene, containing Ν,Ν-dimethylformamide dimethyl acetal, and denvatized 
at 115° С After denvatization the samples were dried under nitrogen at 50° С The 
residues were dissolved in toluene, containing 1 дд trophosphamide (internal standard) 
The derivatives were analysed by gas chromatography with nitrogen phosphorus detec­
tion 
For measurement of nomitrogen mustard the samples were diluted with water and Tris 
buffer (pH 8 0) Diethylether containing benzenesulphonylchlonde was added and the 
samples were shaken for 90 min The ether layers were removed and dried under nitro­
gen at 30°C Finally, the residue was dissolved in toluene The nomitrogen derivative 
was analysed by gas chromatography with mass spectrometric detection 
Statistical analysis 
Rates of metabolite production were calculated by linear regression analysis Differences 
in metabolite levels or rates of metabolite production were tested with Student's t-test 
Since six comparisons were made in each test a difference was only regarded statistically 
significant at P < 0 01. When metabolite levels were below the detection limit, 0 was used 
as a value for the calculations 
Results 
The concentrations of carboxyphosphamide, 4-ketocyclophosphamide and 
nomitrogen mustard present in the media after incubation with hepatocytes are 
depicted in Fig 5.1. 4-KetocycIophosphamide was not detected in media from 
PC or PA. However, 4-ketocyclophosphamide was formed at a rate of 
0 30±0.15 nmol/hr-106 cells (mean ± standard deviation) by Mc and this rate 
increased significantly to 1.7±0.4 nmol/hr-106 cells when the male rats had 
been Aroclor 1254 pretreated Carboxyphosphamide was detected in the media 
from all experimental groups. In Pc the rate of carboxyphosphamide formation 
was 1.5±0.3 nrnol/hrlO6 cells. This rate was not significantly increased in PA 
(2 6±1.6 nmol/hr-106 cells). In MC the rate of carboxyphosphamide formation 
was between those observed in Pc and in PA (2 2±1.1 nmol/hr-106 cells). This 
rate increased significantly to 6.6±0 7 nmol/hr-106 cells when male rats were 
pretreated with Aroclor 1254. Nomitrogen mustard was also detected in media 
from all experimental groups. In PC the rate of nomitrogen mustard formation 
was 0.20±0 04 nmol/hr-106 cells This rate was not significantly increased in PA 
(0 50 ± 0 23 nmol/hr-106 cells) In Mc the rate of nomitrogen mustard formation 
was between those observed in PC and PA (0.35±0 04 nmol/hr-106 cells) This 
rate increased to 1 9±0.8 nmol/hr-106 cells when male rats were pretreated with 
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Aroclor 1254. However because of the larger variation of nomitrogen mustard 
concentrations in this group and non-linearity of the concentration against time 
curve, this increase did not reach a statistical level of significance 
(0.01<P<0.05). On the other hand in hepatocytes derived from untreated rats 
the nomitrogen formation was significantly higher in those from males than in 
those from pregnant females. The much higher levels of metabolites in media 
from MA is therefore partly due to the slightly higher basic rate of formation of 
metabolites by male-derived hepatocytes than in hepatocytes derived from 
pregnant females. The major cause of the much higher levels of metabolites, 
however, is a larger effect of Aroclor 1254 pretreatment on male hepatocytes. 
Discussion 
Carboxyphosphamide and 4-ketocyclophosphamide are stable non-toxic oxida-
tive metabolites of aldophosphamide and 4-hydroxycyclophosphamide, respec-
tively. They are formed by NAD(P)-linked cytosolic aldehyde dehydrogenases 
(ALDHs) (Cox et al., 1976; Domeyer and Sladek, 1980) and probably an alde-
hyde oxidase (Hohorst et al., 1971), respectively (Fig. 5.2). Our results confirm 
that 4-ketocyclophosphamide is only a minor metabolite formed by rat hepato-
cytes (Sladek, 1988). We could not detect 4-ketocyclophosphamide in the 
media from PC or PA. 
Treatment with Aroclor 1254 increased the formation of carboxyphosphamide. 
Theoretically this could be due to induction of ALDHs (Lindahl, 1992; Deitrich 
et al., 1978). However, the relative abundance of ALDHs in liver tissue and the 
low Km of some of them for the oxidation of aldophosphamide makes it less 
likely that even in an uninduced state the aldophosphamide oxidation capacity 
of hepatic ALDHs is limiting (Manthey et al., 1990). Therefore higher levels of 
carboxyphosphamide are most probably not the result of induction of subse-
quent metabolism of aldophosphamide, but rather reflect higher steady state 
levels of aldophosphamide. 
Phosphoramide mustard is formed spontaneously from aldophosphamide by ß-
elimination of acrolein (Sladek, 1988). In an aqueous solution, however, 
phosphoramide mustard will spontaneously degrade to nomitrogen mustard 
(Jardine et ai., 1978). Therefore nomitrogen mustard levels measured in the 
media will reflect the levels of activated cyclophosphamide, (i.e. 4-hydroxy-
cyclophosphamide and its tautomere aldophosphamide), as well. 
Higher levels of activated cyclophosphamide may be the result of a higher rate 
of formation or of a greater persistence of activated cyclophosphamide in the 
medium. The formation of activated cyclophosphamide in hepatocytes is pri-
marily mediated by P450 isozymes (Sladek, 1988; Clarke and Waxman, 1989; 
Kanekal and Kehrer, 1993). After Aroclor 1254 treatment, CYP2B1 is the princi-
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Fig. 5.2 Schematic representation of the biotransformation of cyclophosphamide 
* Cyclophosphamide and phosphoramide mustard have been shown to be 
metabolized to their mono- and diglutalhionylconjugates by glutathione-S-transferase (GST) 
by direct displacement of the chloride atoms and through azindinium intermediates, respec-
tively, as represented in the inset § Transport forms of activated cyclophosphamide are 
within the dashed frame 1 These metabolites may also react spontaneously with other 
sulfhydryl compounds to form their respective mercapto derivatives ALDH = aldehyde 
dehydrogenase ALDO = aldehyde oxidase P450 = cytochrome P450 mono-oxygenase GSH 
= glutathione 
41 / Part I 
Chapter 5 
pal mono-oxygenase hydroxylating cyclophosphamide (Borlakoglu et al, 1993, 
Parkinson et al, 1983a,b, Ryan et al, 1979), However, to our knowledge a sex 
difference m CYP2B1 ìnducibility has never been reported 
Prolonged persistence of activated cyclophosphamide m the medium may have 
been caused by glutathione conjugation of 4-hydroxycydophosphamide 
(Pallante et al, 1986, Lee, 1991, Fenselau et al, 1982) The conjugate, 4-
glutathionylcyclophosphamide, is of moderate stability in an aqueous solution 
(Draeger et al, 1976, Peter et al, 1976) When it deconjugates, activated cyclo-
phosphamide is formed once again and this process has therefore been referred 
to as 'delayed toxication' (Hohorst et al, 1976) Total GST activity, using 1-
chloro-2,4-dinitrobenzene as a substrate, is about 1 5-fold higher in male rats 
than in female rats and GST activity can be induced by classical inducers, like 3-
methylcholantrene, phénobarbital and Aroclor 1254 (Kaplowitz et al, 1975, 
Coecke et al, 1990, Borlakoglu et al, 1993) Gender-specific inducibility of 
GST subclasses has been reported for 3-methyIcholantrene and phénobarbital, 
but not for Aroclor 1254 (Igarashi et al, 1987) 
Gender may not have been the only factor causing the observed differences in 
our expenments The pregnant state of the females may have contributed as 
well It is known that pregnancy Veduces P450 levels (Feuer, 1979, Neale and 
Parke, 1973) It has also been shown that the inducibihty of ethylmorphine N-
demethylase by phénobarbital, is reduced two-fold dunng pregnancy in rats 
(Guenthner and Mannenng, 1977) However, CYP2B1 mRNA levels in preg-
nant rats were increased 40-fold after Aroclor 1254 treatment (Borlakoglu et al, 
1993) 
Thus, further research will be needed to determine if reduced inducibihty of 
CYP2B1 by Aroclor 1254 treatment m pregnant rats, in companson with male 
rats, or increased GST activity in Aroclor 1254 pretreated male rats may have 
caused the large difference in the formation of embryotoxic metabolites of 
cyclophosphamide as it was observed in our sequential model Furthermore a 
possible effect of pregnancy on these processes will have to be investigated as 
well 
Our observations make it clear that the choice of the external bioactivating 
system used in the sequential culture model has a major influence on the out-
come of the expenments when this model is used to study prodysmorphogens 
Acknowledgements We gratefully acknowledge the assistance by Ρ van den Broek 
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The capacity of postimplantation rat embryos to metabolize xenobiotics is lim-
ited. Therefore if the role of biotransformation in teratogenesis is investigated or 
when one wants to use whole embryo culture as a pre-screening tool and does 
not want to exclude the possible effects of metabolites, the postimplantation rat 
embryo culture model has to be extended with an external bioactivating system. 
We therefore set out to combine the culture of rat embryos with the culture of 
intact rat hepatocytes. This work was started at the National Institute of Public 
Health and Environment in the Netherlands in collaboration with Piersma and 
co-workers (VanAerts et al., 1989; Piersma et al., 1991). In this original ap-
proach the hepatocytes were cultured in suspension in the serum in which the 
embryos were cultured as well. This model was designated as the co-culture 
model. It was shown that cyclophosphamide, which was used as a model com-
pound, elicited embryotoxicity at a concentration of 30 ^g/ml in the presence of 
hepatocytes, whereas in the absence of hepatocytes no embryotoxicity was 
observed up to a concentration of 1000 ¿¿g/ml. 
Another approach to the combination of the culture of hepatocytes and the 
culture of rat embryos was made by Bechter et al (1989). They first cultured the 
hepatocytes in a monolayer culture. From this culture media samples were taken 
at various time intervals. These media were combined with serum, in which the 
embryos were cultured. This model was designated as the sequential culture 
model. 
In chapter 3 a comparison between the co-culture model and the sequential 
culture model was made. The sensitivity of both models was comparable. How-
ever, both models have their advantages and disadvantages. In the co-culture 
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model the hepatocytes and the embryos are cultured simultaneously Instable 
metabolites are therefore able to elicit embryotoxic effects, since they have direct 
access to the embryos, once they are released by the hepatocytes However, in 
the sequential culture model the media in which the hepatocytes are incubated 
are stored and added later on to the embryo culture Therefore some loss of 
instable metabolites may occur in this system On the other hand in the co-
culture model only an endpoint measurement is made That is, the sum of the 
effects of the formation of toxic metabolites and the subsequent detoxification of 
them is observed, since the hepatocytes are present throughout the incubation 
period However, in the sequential culture model it is possible to observe the 
temporal effects of bioactivation and detoxification, since medium samples of 
the hepatocytes culture are taken at different time intervals The most pragmatic 
approach is probably to start out with the co-culture model to get a general 
impression of the effect of metabolism of a certain compound, whereas the 
sequential culture model can be applied to get a more detailed view of the 
bioactivation and detoxification processes Another practical advantage of the 
sequential culture model is, that only a few hepatocytes isolations and incuba-
tions have to be performed in order to gather sufficient medium for all embryo 
cultures, whereas in the co-culture model for each embryo culture hepatocytes 
have to be isolated as well 
It was noted that the sensitivity of the sequential culture model as observed by 
us was at least ten times lower than the sensitivity of this model as reported by 
Bechter et al (1989) A likely cause for this discrepancy was the nature of the 
hepatocytes used Bechter had used hepatocytes from Aroclor 1254 pretreated 
male rats, whereas we used hepatocytes from untreated pregnant females To 
investigate whether the observed differences in sensitivity were caused by the 
Aroclor 1254 pretreatment of the rats, or were caused by the sex difference, we 
designed an experiment in which both factors were vaned (chapter 4 and 5) It 
was found that neither gender nor Aroclor 1254 pretreatment alone were suffi-
cient to explain the differences between Bechter's and our results Instead it was 
found that only in male rats the biotransformation of cyclophosphamide was 
greatly enhanced by Aroclor 1254 pretreatment The principal cytochrome P450 
mono-oxygenase responsible for cyclophosphamide activation after Aroclor 
1254 pretreatment is CYP2B1 (Borlakoglu et al, 1993, Parkinson et al, 1983a, 
1983b, Ryan et al, 1979) However, gender-specificity for the induction of this 
cytochrome has never been reported We speculated that instead of an in-
creased formation an increased persistency of 'activated' cyclophosphamide 
may have occurred as a result of differences in the activity of GST's, which may 
have lead to differences in the degree in which 4-glutathionylcyclophosphamide 
was formed Nevertheless on the basis of the results presented in this thesis no 
firm conclusion can be drawn as to whether the increased biotransformation of 
cyclophosphamide by male hepatocytes after Aroclor 1254 pretreatment is 
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caused by increased formation of 'activated' cyclophosphamide due to a gender-
specific difference in the rate of induction of CYP2B1 or that the differences in 
embryotoxicity reflected differences in the extent to which 'activated' cyclophos-
phamide was stabilised by 4-glutathionylcyclophosphamide formation. To 
answer this question further research will have to be conducted. Furthermore in 
our experiments pregnant females were used. The relatively small effect of 
Aroclor 1254 pretreatment in pregnant rats on the biotransformation of cyclo-
phosphamide may be caused by gender-specific properties of the rats as well as 
by the pregnant state these rats were in. Future investigators should recognize 
both of these possibilities and design their experiments in such a way that differ-
ences in their observations can be delineated to either of these factors. 
The studies presented in this thesis show that it is possible to combine the cul-
ture of hepatocytes with culture of rat embryos, both by co-culturing them in 
one bottle as well as by a sequential culture model. Our studies also clearly 
demonstrate that the choice of the source of the hepatocytes may have a major 
influence on the outcome of the experiments and should therefore carefully be 
considered. 
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Neurulation 
According to Adelmann (1966) the earliest significant contributions to the 
embryological study of neurulation - the formation of the neural tube - were 
made by Malpighi (1672). Despite the simple structure of microscopes in the 
early days he clearly saw and described the neural walls in the chicken embryo. 
Nevertheless Malpighi did not discover the true meaning of them, being the very 
anlagen of the central nervous system. Instead he interpreted them as walls 
'guarding' the space between them within which the cerebral vesicles were 
formed by a 'plastic spirit' (Malpighi, 1697). Even one and a half century later a 
famous embryologist as Von Baer (1828) maintained Malpighi's interpretation 
that the cerebral vesicles were deposited within the lumen of the neural walls. It 
were Rusconi (1826) and Reichert (1840; 1842) who first appreciated the full 
significance of the neural walls . 
Today neurulation is considered to occur in two phases: primary and secondary 
neurulation (Fig. 7.1). At the time the neural walls are visible primary neurula-
tion has already proceeded half the way as it actually starts with the formation of 
the neural plate. Formation of the neural plate is initiated as early as the primi-
tive streak stage. In the rat this is at gestational day 8.5, in humans approxi-
mately in the first half of week 3. During the primitive streak stage ectodermal 
cells of the epiblast migrate ventrally and laterally through the primitive streak to 
form the mesodermal layer, displace the hypoblasts endoderm into the extra-
embryonic endoderm and form the definitive embryonic endoderm. This pro-
cess is often referred to as gastrulation. Little is known of the process of neural 
induction - i.e. the formation of the neural plate - in mammals. However based 
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Figure 7.1 Formation of the neural tube in humans. The neural folds (A) begin to fuse (B) 
at about 22 days. At 24 and 26 daysthe rostral and caudal neuropores close (C). 
In D and E a slight pit indicates the position of the former caudal neuropore, beyond which 
the neural tube is formed by secondary neurulation (shaded). In G a solid cord has formed 
beneath the surface ectoderm. More rostrally (F) a lumen has appeared in the cord and is 
continuous with that formed during primary neurulation (arrow). Reprinted from O'Rahilly 
and Müller (1992) by permission of John-Wiley-Liss Inc. © 1992 John Wiley &_ Sons Inc. 
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on presumed parallels with amphibian embryos, it is generally believed that the 
neural plate is formed by induction of dorsal ectodermal cells of the epiblast by 
the underlying mesodermal and possibly endodermal cells, as well as by the 
notochord (Moms-Kay et al, 1994, Schoenwolf, 1994) The earliest neural plate 
consists only of tissue that will develop into the forebrain, midbrain and the most 
rostral part of the hindbrain The subsequent broadening and lengthening of the 
neural plate occurs in the rat between gestational day 8 5 and gestational day 
9 5 and in humans between gestational day 16 and gestational day 19 Broad-
ening of the neural plate is due to a change of epithelial structure from pseudo-
stratified to cuboidal, the cell number remaining constant Cell division contnb-
utes only to the lengthening of the neural tube During this phase the neural 
groove appears and the neural plate gets the appearance of two neural folds 
which onginally have a convex shape -1 e the lateral edges are bent ventrally 
At gestational day 9 5 in the rat - approximately gestational day 20 in humans -
the lateral edges of the neural folds start to elevate Many processes contribute 
to the elevation and bending of the neural folds The following bnef descnption 
is mainly based on studies on neurulation in the chicken (Schoenwolf, 1994), 
but most of the processes descnbed are applicable to mammals as well (Moms-
Kay et ai, 1994, O'Rahilly and Muller, 1992, Stanisstreet, 1987) An important 
event is the change of cell shape of the neuroepithelial cells The lateral neuro-
epithelial cells increase in hight as they get a high columnar, spindle-shaped 
configuration and the neuroepithelial cells at the median hinge-point decrease in 
hight as they get a low columnar wedge shaped configuration The change and 
maintenance of cell shape and curvature of the neural folds is achieved by the 
action of microfilaments and microtubules Also apicobasal flattening and inter-
calation of surface ectodermal cells contribute to the bending of the neural folds 
Another extnnsic force -1 e lying outside the neural tissue - is the expansion of 
the extracellular matrix of the underlying mesenchyme, which provides m this 
way a mechanical force pushing the neural tissue dorsally and medially This 
extracellular matnx could also have a regulatory influence on cell behaviour 
thereby affecting other events important for neurulation Intercalation of neuro-
epithelial cells in the transverse plane assists the narrowing and concomitant 
extension of the neural tube, whereas new cells that are deposited in the longi-
tudinal direction contribute to the elongation of the neural tube As a result of 
the elevation and bending of the neural folds the apices of the neural folds 
finally appose along the dorsal midline where the neural tube starts to close by 
adherence and fusion of the apices For this the formation of an adhesive glyco-
conjugate coat on the cell surface is needed Also protrusive activity of the cells 
in the neural fold transition zone is involved At gestational day 10 3 in the rat 
(gestational day 22 in humans) fusion starts at the cervical region at the level of 
somite 1-3 From this point fusion proceeds rostrally and caudally Previously 
this fusion initiation point was considered to be the only one and fusion was 
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Fig. 7.2 Schematic drawing illustrating the 
multi-closure model vs the single-
closure model (also referred to as the 'zipper 
model') of primary neurulation in mammals 
After Golden and Chernoff ( 1993) Repri nted 
from Golden and Chernoff (1993), by permis-
sion of John-Wiley-Inc © 1993 John Wiley & 
Sons Inc. 
thought to proceed until the most rostral part - the rostral neuropore - and the 
most caudal part - the caudal neuropore - was reached. However Golden and 
Chernoff (1983; 1993) showed in three mouse strains that there were at least 
four different closure initiation sites, the first being the cervical one just men-
tioned. Closure II takes place at the prosencephalic-mesencephalic border and 
also proceeds bidirectional. Closure III is unidirectional, beginning adjacent to 
the stomodeum and proceeding caudally to meet closure II. Finally closure IV 
takes place over the rhombencephalon where it meets closure II to complete 
rostral neural tube closure (Fig. 7.2). Also Sakai (1989) observes multiple clo-
sure sites in the mouse, however concludes differences may exist between 
different strains. Rostral neural tube closure is complete at gestational day 10.8 
in the rat and at gestational day 24 in humans. Golden and Chernoff (1993) 
reviewed the literature and found tentative evidence that multi-closure of neural 
tube formation occurs also in the hamster, the rat, the rabbit, the pig and in 
humans. O'Rahilly and Müller (1994) recognize that there is at least a second 
rostral closure initiation site in the human, which is equivalent to closure II as 
proposed by Golden and Chernoff (1993). Van Allen et al. (1993) studied the 
spatial distribution of neural tube defects in humans and concluded that a multi-
closure model as proposed by Golden and Chernoff (1993) provided the best 
explanation for their observations. They even suggested that the most caudal 
neural tube defects might be related to the failure of a fifth closure event at the 
level of L2 to S2. Neural tube closure is not homogenous at all sites. Especially 
the rhombencephalic closure (closure IV) is unlike the others as it does not occur 
by fusion of the neural folds, but rather by elongation of a membrane which 
eventually covers the rhombencephalon. 
With the closure of the caudal neuropore (gestational day 11.2 in the rat, gesta-
tional day 26 in humans) primary neurulation has completed and secondary 
neurulation can start. Caudally of the previous caudal neuropore the tail bud 
(caudal eminence) has formed. It comprises of undifferentiated mesenchymal 
cells and represents the remains of the primitive streak (Griffith et al., 1992). 
This seemingly homogenous tissue gives rise to various tissues including the 
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hind tail gut, somites and their derivatives and neural crest cells. During second-
ary neurulation peripheral cells of the medullary cord arrange radially and 
differentiate from a mesenchymal to an epithelial form (the neural cord). The 
lumen of the primary neural tube proceeds caudally into the neural cord, thus 
giving rise to the secondary neural tube. In humans the process of secondary 
neurulation is complete at the sixth week of gestation. At the end of the embry-
onic period the neural cord still reaches till the end of the vertebral column, but 
during the fetal period it regresses to sacral and then lumbar levels. 
Neural tube defects 
Neural tube defects (NTDs) are some of the most distressing congenital mal-
formations that occur when the process of neural tube closure, which takes place 
in humans in the fourth week post conception, fails. The most common forms of 
NTDs are spina bifida and anencephaly. Their prevalence at birth varies be-
tween countries and socioeconomic and ethnic groups. In Finland the preva-
lence frequency is only 1 in 2500. In Mexico it is 1 in every 300 births. Even 
higher rates have been reported in the past, i.e. 12 per 1000 births in the coal-
mining valleys of South-Wales. On average the prevalence frequency is 1 in 500 
(International Clearinghouse, 1991; Elwood and Elwood, 1980; Carter, 1974; 
Laurence et al., 1967). In the Netherlands the prevalence of NTDs is 1 in 700 
(EUROCAT Working Group, 1991). In these figures the affected embryos and 
foetuses that are spontaneously aborted are usually not included. Of the foe-
tuses that are spontaneously aborted the frequency of NTDs has been estimated 
to be ten-fold higher as compared to in term births (Creasy and Alberman, 
1976; Byrne and Warburton, 1986). Shiota (1993) estimated the prenatal 
mortality rate of NTD-affected embryos to be 98.4%, and most (93%) of the 
embryos do not survive the embryonic period proper. Thus the prevalence of 
NTDs at the end of the neurulation is ten to fifty times as high as observed at 
birth. 
Based on their aetiology and appearance NTDs can be subdivided in two 
groups: the so-called 'open' and the 'closed' NTDs. In open NTDs the defect has 
arisen due to non-closure of the neural tube. Also rupture of the neural tube 
after a transient closure has been suggested as a rare cause for open NTDs 
(Hook, 1992). The subsequent development of surrounding tissues will be 
disturbed, which will result in exposure of the neural tissue at the surface. The 
most severe type of open NTDs is craniorachischisis in which both the cranial 
and the spinal part of the neural tube did not close. When either the cranial or 
the spinal part of the neural tube are involved, the defects are named anenceph-
aly and myeloschisis, respectively. Anencephaly, the lack of substantial parts of 
the brain, is generally believed to result from deterioration of exencephalic brain 
tissue that was present in the embryonic period. Thus exencephaly as observed 
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in laboratory animals is the equivalent of anencephaly in humans In the case of 
myeloschisis (also called spina bifida aperta) fluid may accumulate in the sub-
arachnoid space ventral to the neural tissue, thereby pushing the neural tissue 
dorsally The resulting cystic appearance of this NTD is called myelomeningo-
cele (meningomyelocele, spina bifida cystica) Since the open NTDs are caused 
by a failure of the neural tube to close, the period human embryos are suscepti-
ble to these defects ranges from the third till the end of the fourth week post 
conception In the case of closed NTDs the neural tube did form completely It is 
possible that these malformations anse from a faulty development of the mesen-
chymal tissue in the area of the neural tube These tissues are necessary for the 
formation of the meninges (arachnoid and dura), the vertebral arches and skull 
bones Failure of the formation of these tissues may result in a protrusion of 
meninges, which is covered by skin (meningocele, spina bifida cystica) When 
this defect occurs in the cranial region, the protruding mass may contain brain 
tissue, in which case it is named an encephalomeningocele In the least severe 
cases of closed NTDs the skeletal parts (vertebral arches or skull bones) did not 
completely close, however there is no protrusion of the meninges These defects 
are called spina bifida occulta and cranium bifidum occultum Since formation 
of the vertebral arches and skull bones starts at the fifth week after conception 
and continues until the early fetal penod, this is the time window in which closed 
NTDs may be induced Albeit, ossification still has to occur later on and contin-
ues until after birth Spina bifida occulta in the sense of incomplete ossification 
of the vertebral arches is a normal appearance at birth and its persistence in the 
sacrum in 20 to 25% of the adults is considered a normal vanation without 
clinical significance This thesis is concerned with the aetiology of open NTDs 
Therefore when the term NTD is used it refers to the open types of these defects 
As stated above NTDs anse from a failure of the neurulation process From the 
previous section it is clear that many processes are involved in neurulation 
Since a disturbance of each of these processes may result in a NTD, it should be 
clear that the causes for NTDs are manyfold This is demonstrated by expen-
ments in which rodent embryos have been subjected to substances interfenng 
with processes involved m neurulation Decrease of the cellular ability to change 
its shape by inhibitors of microtubule function like colchicine and nocadazole, 
resulted in neural tube defects when mouse embryos were exposed m Ditro 
(O'Shea, 1981, Smedley and Stanisstreet, 1986) Cytochalasins, agents which 
disrupt microfilament functioning and therefore decrease the cellular ability to 
change shape, also produced NTDs in mammalian embryos (Shepard and 
Greenaway, 1977, Wiley, 1980) NTDs can also be induced experimentally by 
inhibiting neural crest cell movement, as was demonstrated by Momss and New 
(1979) when they exposed rat embryos to increased oxygen concentrations 
Disturbance of normal development of the paraxial mesenchyme may also lead 
to NTDs, e g by exposure to trypan blue (Momss-Kay and Crutch, 1982, 
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Morriss-Kay and Tuckett, 1989; Peters and Dormans, 1981). 
These examples of experimentally induced NTDs clearly demonstrate the in-
volvement of several processes in neurulation. Still, the aetiology of 'naturally' 
occurring NTDs is poorly understood (Campbell et al., 1986). Expenments as 
mentioned above reveal the processes we have to take into account. However, 
the factors that are responsible for the disturbances of processes essential to 
neurulation, are mostly unknown. They may be both genetic and environmental 
(Carter, 1969; Holmes et al., 1976). Environmental and genetic factors may also 
act together as environmental factors may either increase or decrease the fre-
quency of NTDs in the progeny given a certain genetic susceptibility. For exam-
ple woman with an increased genetic susceptibility for NTDs due to a metabolic 
disorder related to folate metabolism might be more prone to give birth to an 
NTD affected child when their folate status is low than woman without the 
metabolic disorder. The other way around, their risk for a NTD affected preg-
nancy might be reduced by folate supplementation. The concept of folic acid 
preventable NTDs, and the experimental evidence that has led to it, will be 
discussed in the next section. 
Prevention of neural tube defects by peri-conceptional folic acid 
supplementation 
A possible link between folic acid and NTDs was first reported by Hibbard and 
Smithells (1965). Subsequently both observational and intervention studies have 
been undertaken, which have been reviewed elsewhere (e.g. Steegers-
Theunissen et al., 1993; Wald, 1994; Scott et ai., 1994). Although in some 
studies dietary intake was simply divided in categories like 'good' or 'poor' and in 
many studies peri-conceptional supplementation had occurred in the form of a 
multivitamin preparation, these studies suggested a key role for folic acid. Stron-
gest evidence came from the MRC trial (MRC Vitamin Study Research Group, 
1991). This study had a factorial design in which the recurrence risk for NTDs 
was investigated in four groups. The first receiving folic acid alone (4 mg daily), 
the second receiving a multivitamin preparation without folic acid, the third 
receiving both and the fourth receiving a placebo containing neither vitamins 
nor folic acid. It was found that peri-conceptional folic acid supplementation 
resulted in a 72% reduction of the recurrence risk for NTDs. The other vitamins 
did not show a significant reduction of the recurrence risk for NTDs. Since in 
other studies in which folic acid containing multivitamin preparations were used, 
the preventive effect was on average similar to the one in the MRC trial, the 
observed preventive effect in these studies may be ascribed to folic acid as well 
(Wald, 1994; Czeizel and Dudas, 1992). 
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Folic acid deficiency and neural tube defects 
As peri-conceptional folic acid supplementation has a preventive effect on the 
risk for NTDs, the most simple explanation for this effect would be that folic acid 
supplementation relieves an existing folic acid deficiency. Of three studies inves-
tigating women with a folic acid deficiency so severe that they developed mega-
loblastic anaemia, two studies did not find that anaemic women were at higher 
risk for a NTD-affected pregnancy than healthy controls (Fraser and Watt, 1964; 
Giles, 1966; Pritchard et al., 1970). Aminopterin, an anti-folate agent, has 
repeatedly been mentioned as a NTD-inducing agent in man. However as 
pointed out by Seller (1994) a wide variety of congenital malformations was 
observed and the case reported by Thiersh (1952) was the only one in which 
with certainty a NTD occurred. Nevertheless this case is also the only one in 
which exposure to aminopterin had occurred during the neurulation period. 
Human studies investigating the folate status of mothers of NTD-affected chil-
dren as compared to mothers of normal children gave inconsistent results. 
Whereas in some studies NTD-mothers did have a lower folate status in other 
studies no significant difference in folate status was found between cases and 
controls (Scott et al., 1990). The-time of sampling (e.g. during the index preg-
nancy or thereafter and early or late in the index pregnancy) and the use of the 
more probing method of measurement of red cell folate instead of measurement 
of serum folate, which reflects much more recent folate intake, are probable 
causes for the inconsistency of the results of the human studies on folate status. 
In a recent study by Kirke et al. (1993) with a large enough number of NTD 
cases (81) and controls (247) to detect subtle differences in folate status it was 
shown that even though the folate status of the cases was in the normal range, 
the frequency of NTDs was inversely related to the serum folate and red blood 
cell folate concentrations. 
In laboratory animals the administration of anti-folates early in gestation rather 
led to increased resorption rates than to an increase of congenital malforma-
tions, and if the animals were exposed later in gestation congenital malforma-
tions varied depending on the time of exposure (Johnson and Chepenik, 1981). 
In mice a nutritional folate deficiency alone was insufficient to induce defective 
neurulation reproducibly (Heid et al., 1992). Extreme folate deficiency in golden 
hamsters resulted in early embryonic loss (Mooij et al., 1992). 
In a study using the postimplantation rat embryo culture gestational day 9.5 rat 
embryos were cultured in serum from rats with a dietary folate deficiency (Miller 
et ai, 1989). Embryos were growth retarded and had many malformations, 
particularly of axial rotation (which is essential to rodent embryos to adopt the 
characteristic fetal conformation). Although development of prosencephalon 
and mesencephalon of rat embryos cultured in the serum from folate deficient 
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rats was inferior to the development of these brain vesicles in control embryos 
no NTDs were observed. Addition of N 5-methyltetrahydrofolate (5-methylTHF) 
to the serum reduced the number of malformed embryos, however they were 
still growth retarded, as expressed by their protein content. This indicates the 
dietary induced folate deficiency caused secondary effects which had a terato-
genic action on their own that could not be overcome by increasing the folate 
supply in vitro. 
Although some studies, especially the human studies, have been unsatisfactory, 
it can be concluded NTDs are not or seldom evoked by an overt folate defi-
ciency, either due to administration of folate antagonists or due to nutritional 
deficiencies, but rather are caused by a folate-related phenomenon that is sensi-
tive to a low folate status (although in the normal range) and can be counter-
acted upon by folic acid supplementation. Possibly an overt folate deficiency 
disturbs embryonic development to such an extent, that the conceptus is lost 
long before it is bom. 
Folate related metabo l i sm 
To understand which phenomena could be sensitive to a low folate status and 
might respond to folic acid supplementation, it is neccessary to have a closer 
look at the metabolic pathways that make use of or are related to folate. 
Folate uptake and distribution 
Folate (Fig. 7.3) is an essential nutrient for mammals. Dietary intake is primarily 
in the form of protein bound 5-methylpteroylpolyglutamates. Sufficient protease 
and conjugase activity are needed to convert them to the monoglutamate form, 
which is absorbed by the epithelial cells of the intestinal villi. Folic acid as pres-
ent in food supplements is a monoglutamate form in which the pteroyl moiety is 
fully oxidized. Folic acid is absorbed by the intestinal cell as such and fully 
reduced to tetrahydrofolate (THF). In the intestinal cell the reduced folates are 
either released directly into the portal circulation, converted to 5-methylTHF or 
polyglutamated and released into the portal circulation. Since the intestinal 
reduction and methylation processes of folic acid are considered to be saturable, 
folic acid may be released unmodified into the circulation and first be metabo-
lised in the liver when this compound is given as a food supplement at high 
doses (Lucock et ai., 1994). The monoglutamate form of 5-methylTHF is the 
principal circulating form of folate and therefore also the principal form by which 
the tissues are supplied with folate (Shane and Stokstad, 1983). The liver con-
tains the main body store of folates, primarily in the polyglutamated form. 
Sarcosine synthase is the main folate binding enzyme. In other tissues folates 
can be polyglutamated as well, which has a function in the cellular retainment of 
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folate. For most of the enzymes of one-carbon metabolism that use folate deriv-
atives, the polyglutamated folates are more effective substrates than the mono-
glutamated folates, and polyglutamation offers a potential regulatory mechanism 
in one-carbon metabolism (Shane, 1989). 
The function of folate in one-carbon metabolism 
The one-carbon substituted folates (Fig. 7.3) are used for various metabolic 
steps in which a carbon atom is transferred. The carbon atom is situated at the 
N5- and/or N10-site of the pteroyl moiety. It can be present in different oxidation 
states varying from 5-methylTHF to N 5-formyltetrahydrofolate (5-formylTHF) 
and N 10-formyltetrahydrofolate (10-formylTHF). The metabolic pathways of 
one-carbon metabolism are depicted comprehensively in Fig. 7.4. More concise 
illustrations of the relation of folate metabolism and the metabolism of homo-
cysteine and methionine are Fig. 9.1 and Fig. 10.1. 
The principal source of the carbon atoms is serine, which is converted to glycine 
by serinehydroxymethyltransferase. In this reaction tetrahydrofolate is converted 
to N5,N10-methylenetetrahydrofolate. Alternative sources are fomniminoglutamic 
acid, a breakdown product in histidine catabolism and the mitochondrial glycine 
cleavage pathway and choline catabolism. The formation of 10-formylTHF from 
formate, ATP and THF is another possible way by which a carbon atom is 
attached to folate, however this pathway constitutes only a minor source of one-
carbon units in mammalian tissues. Folate dependent one-carbon metabolism is 
used for purine and thymidine synthesis, histidine catabolism, the 
interconversion of glycine and serine, choline catabolism and the synthesis of 
methionine. This shows how much folate-dependent metabolism is intertwined 
with major metabolic pathways of the cell. 
Methionine synthase and the methylation cycle 
Folate enters the cell mostly in the form of 5-methylTHF. Methionine synthase is 
the only known enzyme capable of demethylating 5-methylTHF and is therefore 
a key enzyme to the cell's folate supply. The importance of the methionine 
synthase reaction for cellular folate levels becomes even more clear given the 
notion that 5-methylTHF is a poor substrate for folylpolyglutamate synthase and 
polyglutamation is necessary for cellular retainment of folate. Methionine syn-
thase is also the enzyme by which folate metabolism is linked with the so called 
methylation cycle. The methyl group is transferred to the sulphur atom of homo-
cysteine. The product of this reaction, methionine, is activated at the expense of 
ATP to the sulphonium ion S-adenosylmethionine (SAM). SAM is the universal 
substrate for methyltransferase reactions. There are 115 known different 
methyltransferase reactions that transfer the methyl group of SAM to a wide 
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range of substrates, including proteins, RNA, DNA and lipids (Scott et al., 1994). 
Besides the methylated products, the methyltransferase reactions produce S-
adenosylhomocysteine (SAH), which is an inhibitor of methyltransferases. SAH 
should therefore be quickly degraded, which is accomplished by S-adenosyl­
homocysteine hydrolase. This hydrolysis can only occur when its products, 
homocysteine and adenosine, are sufficiently low in concentration. Adenosine is 
metabolised by adenosine deaminase. Homocysteine can either be remeth-
ylated to methionine or condensed with serine to yield cystathionine. The fate of 
homocysteine depends on the presence of the enzymes capable of metabolising 
homocysteine and on the need for SAM (see below). When homocysteine is 
remethylated the methylation cycle is complete. Homocysteine can be re-
methylated by methionine synthase or by betaine-homocysteine methyl­
transferase. The latter enzyme, however, is in most mammals only present in the 
liver and kidney. 
Regulation of the methylation cycle 
Methionine synthase is not the only link between folate metabolism and the 
methylation cycle. Regulatory feedback mechanisms are responsible for a more 
subtle intertwining of both (Finkelstein, 1990). Methyltransferase reactions 
depend on a sufficiently high SAM/SAH ratio. When SAM levels are high 
cystathionine-ß-synthase activity will be increased, which will result in increased 
breakdown of homocysteine through the transsulfuration pathway, thus leaving 
less homocysteine left to be remethylated. Also will high SAM levels inhibit 
methylenetetrahydrofolate reductase (MTHFR), thereby leading to a decrease of 
5-methylTHF. The simultaneous decrease of the levels of both substrates for 
methionine synthase will lead to a reduced formation of methionine. When SAM 
levels are high most of it will be catabolized by sarcosine synthase (glycine-N-
methyltransferase) (Balaghi et α/., 1993). This enzyme is inhibited by 5-
methylTHF. The lowering of 5-methylTHF by high SAM levels will reduce this 
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inhibition, by which the breakdown of SAM will be stimulated Reversely, when 
SAM levels are low, the degree of transsulfuration will be reduced, the inhibition 
of MTHFR will be abolished, the formation of 5-methylTHF will be increased 
and sarcosine synthase will be inhibited Increased SAH levels will decrease the 
inhibitory effect of SAM on MTHFR and stimulate the activity of cystathionine-
ß-synthase, thereby warranting an increased metabolism of homocysteine 
Adult and embryonic folate metabolism 
One-carbon metabolism as described above is mainly based on studies in liver 
tissues of adult rats and pigs Although most pathways are universal in mam-
mals, considerable differences exist between adult tissues and fetal tissues For 
example cystathionine-ß-synthase activity is not present in rat embryonic tissue 
during neurulation (chapter 10 of this thesis) Methionine adenosyl transferase 
exists as three isozymes The low affinity type, apparently used for methionine 
catabolism when methionine concentrations are high, is only present in adult 
liver (Honkawa et al, 1993) Also differences in folate enzymes exist between 
embryonic and adult tissues These differences tend to favor one-carbon flow 
towards punne and pynmidine synthesis at the expense of methionine synthesis 
in embryos (Shane, 1989) 
Folate related metabo l i c disorders and neural tube defects 
Yates et al (1987) first proposed a disordered folate metabolism as a basis for 
genetic predisposition to neural tube defects Their proposition was based on 
their discovery NTD-mothers not only had lower red cell folate levels as com-
pared to controls, but also a difference existed between subjects and controls in 
the relationship between red cell folate and dietary folate intake In other words 
the cases - or a substantial portion of the cases - made a poorer use of the 
dietary folate supply as compared to the controls The hypothesis that this could 
be due to decreased activity of intestinal γ-carboxypeptidase - an enzyme that 
breaks down the polyglutamated folates to their absorbable monoglutamated 
forms - was investigated by Bower et al (1993) Their results did not support 
this hypothesis, but rather indicated distnbution or metabolism of folic acid or its 
metabolites was impaired Results of another study of limited scale (Lucock et 
al, 1994) also suggested that NTD-mothers had a biochemical lesion some­
where in the multi-enzyme pathway leading from folic acid to 5-methylTHF 
Other studies suggest low vitamin Bl2 plasma levels or a disordered transport or 
metabolism of vitamin Bl2 are associated with an increased nsk for NTDs 
(Schorah et al, 1980, Gardiki-Kouidou and Seller, 1988, Magnus et al, 1991, 
Economides et al, 1992, Kirke et al, 1993) A recent study by Kirke et al 
(1993) showed an inverse relationship between both folate and Bl2 status and 
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the risk for a NTD-pregnancy Moreover, they showed there was a significant 
correlation between plasma Bl2 and red cell folate in cases, but not in controls 
Vitamin Bl2 in the form of methylcobalamin is the prosthetic group of methio-
nine synthase Since 5-methylTHF is the main circulating form of folate and 
methionine synthase is the only known enzyme capable of demethylating 5-
methylTHF, this enzyme is the key enzyme to the cell's folate supply Reduced 
activity of this enzyme would therefore be expected to result in a lower cellular 
folate level Kirke et al (1993) therefore suggested cases possessed an abnormal 
methionine synthase that is responsive to plasma vitamin Bl2 over a range 
where the normal enzyme would be fully functional and active However they 
did not exclude the possibility of a metabolic defect up- or downstream of me-
thionine synthase, expressing itself through different rates of substrate flux 
through this enzyme between cases and controls Also a study by Schorah et al 
(1993) pointed in the direction of a reduced activity of methionine synthase in 
placental cytotrophoblasts from NTD affected pregnancies 
Thus there is accumulating evidence both mildly impaired folate metabolism 
leading to reduced availability of 5-methylTHF and mildly impaired vitamin Bl2 
metabolism possibly in combination with a low folate or vitamin Bl2 status are 
involved in the aetiology of folic acid-preventable NTDs The common denomi-
nator of such defects is a reduced substrate flux through the enzyme methionine 
synthase A reduced substrate flux through methionine synthas will lead to 
increased homocysteine levels and reduced methionine formation The investi-
gation of the possibility that increased homocysteine levels are responsible for 
the increased nsk for NTDs is the main objective of this thesis The concept of 
homocysteine toxicity will be shortly reviewed in the next section 
Homocysteine toxicity 
In 1962 Carson and Neill reported homocystinuna as a pathological condition in 
humans Mudd et al (1964) first showed a lack of cystathionine-ß-synthase 
activity in liver tissue of such a patient Due to the lack or diminished activity of 
this enzyme metabolism of homocysteine is decreased In untreated patients 
plasma homocysteine concentrations may reach levels of 0 2 mM, whereas in 
normal subjects total homocysteine concentrations in plasma are approximately 
10 μΜ (Ueland et al, 1992) The main clinical manifestations are ectopic lenses, 
mental retardation, osteoporosis, dohchostenomelia and thromboembolism The 
latter of these symptoms is the major cause of morbidity in these patients. This 
complication is related to changes in vascular walls and perhaps enhanced 
clotting Since not only cystathionine-ß-synthase deficient patients show these 
vascular changes, but also homocystinunc patients due to a MTHFR deficiency 
or a disorder in cobalamin metabolism, who have high plasma homocysteine 
levels as well, but no hypermethionaemia, it has been hypothesized that the 
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elevated plasma and tissue homocysteine concentrations are the cause for the 
vascular pathology as observed in these patients (Mudd et al., 1989). 
Besides classic homocystinuria, which is the homozygous form of the autosomal 
recessively inherited cystathionine-ß-synthase deficiency, a slight increase in 
blood homocysteine levels, often designated as mild hyperhomocysteinemia, is 
a risk factor for premature vascular disease as well (Boers et ai, 1985; Clarke et 
al., 1991). An often used method to identify such individuals is the oral methio-
nine loading test. In this test post-loading plasma homocysteine levels are mea-
sured. Plasma homocysteine concentrations more than two standard deviations 
above the mean of a control population is regarded as positive with regard to a 
disturbance in methionine metabolism. Heterozygosity for cystathionine-ß-
synthase deficiency as a possible cause for the observed mild hyperhomo-
cysteinaemia can only be concluded after measuring cystathionine-ß-synthase 
activity in a cell culture derived from the subject, e.g. a fibroblast culture. The 
increased blood homocysteine levels may also be caused by a low folate or 
vitamin Вб or Bl2 status or disordered folate or vitamin Bl2 metabolism. 
Similarly Steegers-Theunissen et al. (1991) reported that NTD mothers fre­
quently showed a derangement of methionine metabolism as diagnosed by the 
methionine loading test. Cystathionine-ß-synthase deficiency was not found in 
these women, nor were the vitamin levels of these women out of the normal 
range (Steegers-Theunissen et al., 1994). This suggested these women had a 
disorder in folate or vitamin Bl2 metabolism which led to increased homocyste-
ine levels. As has been discussed above folic acid supplementation can prevent 
NTDs. Folic acid therapy is also an established way to correct homocysteine 
levels in hyperhomocysteinaemic patients (Refsum and Ueland, 1990). It was 
therefore hypothesized that the increased maternal or embryonic homocysteine 
concentrations could be an aetiologic factor in the induction of folic acid-pre-
ventable NTDs and that the mechanism of folic acid-mediated prevention of 
NTDs could be based on a correction of a mild hyperhomocysteinaemic state. In 
the studies presented in the next three chapters this hypothesis is investigated. 
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Abstract Recently a derangement of homocysteine metabolism has been suggested 
as a possible risk factor for neural tube defects and recurrent spontaneous abortion. To 
investigate a possible role of homocysteine in the aetiology of neural tube defects we 
tested the in vitro embryotoxicity of L-homocysteine by culturing day 10 post coitum post-
implantation ratembryos in whole embryo culture (WEC) for 24 hours and day 2 posi 
coitum pre-implantation mouse embryos for 48 hours. With an area under curve (AUC) of 
6.3 mM-hr L-homocysteine significantly reduced the percentage of mouse embryos that 
developed into blastocysts. In rat WEC an AUC for L-homocysteine of 3.6 mM-hr reduced 
the mitotic index of the neural epithelium of the rhombencephalon and the cell density of 
the mesenchyme adjacent to it, while at an AUC of 7.2 mM-hr L-homocysteine reduced the 
total morphological score (TMS) and the number of dysmorphogenic features per concep-
tus was increased. Dysmorphogenic features most often seen were transparent rhom-
bencephalon, no or delayed forelimb bud formation, dysmorphogenesis of the somites and 
blister formation dorso-laterally of the place of forelimb bud formation. The embryotoxicity 
of L-homocysteine was stereospecific since D-homocysteine caused no embryotoxic 
effects. Also the oxidation product L-homocystine (AUC, 72 mM-hr) and the metabolite L-
methionine (AUC, 144 mM-hr) were not embryotoxic. Both stereoisomers of 
homocysteinethiolactone were embryotoxic at an AUC of 72 mM-hr. The results are 
discussed in relation to the metabolism of homocysteine and methionine and their possi-
ble role in the neurulation process. 
Introduction 
Recently a derangement of homocysteine metabolism has been suggested as a 
possible risk factor for neural tube defects (NTDs) and recurrent spontaneous 
abortion (Steegers-Theunissen et al, 1991; 1992). The underlying mechanism is 
See note on page 9 
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L-homocystine 
not clear, but the fact that patients show abnormally high blood levels of homo­
cysteine after oral methionine loading indicates that homocysteine disposal is at 
risk. Hyperhomocysteinaemia is an established risk factor for premature vascular 
disease (Boers et ai, 1985; Clarke et ai, 1991). Pathological accumulation of 
homocysteine in tissues and blood of cystathionine-ß-synthase deficient patients 
is generally considered to initiate the vascular occlusive diseases from which 
these patients suffer (Mudd et ai, 1989). Besides inherited metabolic disorders 
like cystathionine-ß-synthase deficiency and disorders in conversion and han-
dling of cobalamin species, vitamin Bl2 deficiency and folate deficiency may 
also lead to accumulation of L-homocysteine (Mudd et al., 1989; Refsum and 
Ueland, 1990). Intriguing in this respect is that these deficiencies also have been 
associated with the occurrence and recurrence of NTDs (Smithells et ai, 1980, 
1983; Shorah et ai, 1980; Laurence et ai, 1981; Gardiki-Kouidou and Seller, 
1988; MRC Vitamin Study Research Group, 1991). Therefore we were promp-
ted to test the embryotoxicity of L-homocysteine and related compounds (Fig. 
8.1) in order to investigate the possible role of L-homocysteine in the aetiology 
of NTDs. 
Whole embryo culture (WEC) has been used to investigate embryotoxic effects 
of deficiencies as well as excess of amino acids (Denno and Sadler, 1990; 
Hamers et ai, 1989; Cockroft, 1988; Coelho et ai, 1989). Therefore we used 
WEC to test the embryotoxicity of L-homocysteine during neurulation. We also 
used pre-implantation mouse embryo culture to test the embryotoxicity of L-
homocysteine during early embryonic development. 
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Materials and methods 
Chemicals 
Homocysteinethiolactones and amino acids were purchased from Sigma (St. Louis, MO, 
USA). Hormones were purchased from Organon (Oss, The Netherlands). 
WEC medium preparation 
Blood was taken from adult volunteers (male and female) between 20 and 50 yr of age. 
The blood was defibrinized during donation by shaking with glass pearls in a glass bottle. 
The defibrinized blood was centrifuged immediately, the serum was heat-inactivated (30 
min, 56 °C) and D-glucose was added (720 mg/I). After testing each individual serum for 
compatibility with WEC, the serum of two to five individuals was pooled and stored at 
-20 °C. The WEC medium consisted of 75% serum and 25% Tyrodes salt solution. All 
substances added to the medium were dissolved in Tyrodes salt solution Homocysteine 
was freshly prepared from homocysteinethiolactone by alkaline hydrolysis (5 min, 37 °C, 
5NNaOH). 
Thiol concentrations 
Homocysteine concentrations were assayed by measurement of the thiol concentrations 
with 5,5'-dithiobis(2-nitrobenzoic acid) (Ellman, 1959). 
Whole embryo culture 
Method Random bred Cpb.WU (Wistar) rats were housed two or three to a cage and 
were allowed to eat (MRH-TM pellets, Hope Farms B.V., Woerden, The Netherlands) 
and drink (tap water) ad lib.. Lights were on from 12.00 until 00.00 hr. On day 0 fe­
males (11-26 wk old, 200-300 g), ready to mate, were housed together with males, one 
to one, from 9.00-12.00 hr. Embryos were explanted between 13.30 and 15.30 hr on 
day 10. Only embryos with 4-8 somites and without any abnormalities were used for 
WEC. The embryos were cultured for 24 hr in a 25 ml glass bottle containing 2 ml 
medium at 37.5 °C and rotated at 30 rpm. The culture bottles were gassed with a 
mixture of 5% 02, 90% N2 and 5% C02. After 2 and 18 hr of culture the bottles were 
gassed with a mixture of 20% 02, 75% N2 and 5% C02. 
Morphological and histological endpoints. After culturing, the morphology of the em­
bryos was evaluated as described by Brown and Fabro (1981). All dysmorphogenic 
features were recorded. Four embryos from each group were examined histologically. 
The embryos were fixed in Bourn's fluid, dehydrated with ethanol and chloroform and 
embedded in paraffin. The head and rump were treated separately as described by 
Langenfeld et al. (1988). 4 μτη slices were taken at 20 д т intervals and stained with 
haematoxylin and eosine. Besides general histological evaluation the mitotic indices of 
the neural epithelium of the rhombencephalon and the cell densities in 2500 μιτι2 areas 
of the mesenchyme adjacent to both sides of the rhombencephalon ventrally of the otic 
primordia were measured in three consecutive slices. 
Pre-implantation mouse embryo culture 
Random bred female Cpb:SE (Swiss) mice were housed in cages (5-20 animals in each 
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cage) and could eat (MRH-TM pellets, Hope Farms B.V.) and drink (tap water) ad lib.. 
Males were housed separately. Lights were on from 06.00 until 18.00 hr. To provoke a 
superovulation females were injected i p. with Humegon followed 48 hr later with Preg-
nyl (10 U in 0 1 ml 0.9% NaCl of each). Females were housed, one to one, with males 
and were checked for the presence of a vaginal plug the next morning. Two days post 
coitum embryos were flushed from the oviducts, checked for normal morphology and 
cultured for two days in human tubal fluid-like (HTF) medium (Quinn et al., 1985) 
containing 0 5% bovine serum albumine in an atmosphere containing 5% C02 with 
100% humidity at 37 °C After culturing the percentage of embryos that developed into 
blastocysts was determined. 
Statistical analysis 
Differences between groups were tested with Student's t-test with Bonferroni correction. 
With a nominal α of 0.05, differences were regarded as statistically significant at P< 
0.05/fc where к is the number of comparisons made Least square means of TMS and 
number of dysmorphogentc features per conceptus were estimated by analysis of co-
variance, taking the number of somite pairs at the beginning of culture as covariant All 
calculations were performed with SAS statistical software v. 6.06 on a Digital VAX 
6000-410 computer. 
Results 
Homocysteine oxidation 
During culturing of the embryos, homocysteine oxidized spontaneously to its 
disulfide homocystine. The pseudo-first-order rate constants of homocysteine 
oxidation were 7 0 x l 0 6 s"1 in WEC and 3.2x10 "6 s _1 in HTF medium. These 
rate constants correspond to half-life values of 2.8 hr in WEC and 60 hr in HTF 
medium. As a result of this oxidation homocysteine disappears from the me­
dium. We therefore considered it more appropriate to use the AUC as a mea­
sure of exposure. 
Post-implantation rat embryo culture (WEC) 
Morphology. In WEC, L-homocysteine was embryotoxic at an AUC of 7.2 
mM-hr as was demonstrated by a decreased TMS and an increase in the number 
of dysmorphogenic features per conceptus (Table 8.1). Dysmorphogenic fea­
tures most often seen were enlarged and transparent rhombencephalon, no or 
delayed formation of forelimb buds, irregular and reduced number of somites 
and blisters - sometimes filled with blood - dorso-laterally near the place of 
forelimb bud formation (Fig. 8.2). 
Histology. With L-homocysteine at an AUC of 7.2 mM-hr many histological 
abnormalities were observed, especially in the rump part. The neural tube was 
deformed and much smaller and extensive necrotic foci and many apoptotic 
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AUC 
(mMhr) 
0 
1.1 
3.6 
7.2 
10.8 
Initial 
concn 
(mM) 
0 
0.27 
0.9 
1.8 
2.7 
TMSf 
41 8 (0 7) 
43.5 (0.7) 
42 3 (0 7) 
37 1 (0.7)** 
30.3 (0.7)** 
Dysmor-
phogenlc fea-
turesf 
0 4 (0 4) 
0 1 (0.4) 
0 6 (0 4) 
5 0 (0.4)" 
7 0 (0.4)" 
Mitotic 
index§ 
4 1 (0 5) 
3.7 (0.4) 
2 9 (0.2)* 
2.6 (0.2)* 
n.d. 
Cell 
densltyfl 
12 9(0.1) 
12 0(0 7) 
10 3(0.8)" 
9.0 (0 5 ) " 
nd. 
Table 8.1. Embryotoxicity of L-homocysteine in post-implantation rat embryo culture. Values 
are least square means and, in parentheses SEM Those marked with 
asterisks differed significantly (Students (-test) from the corresponding control values: *P< 
0 05 " P < 0 005. 
t Total morphological score (n= 13) 
t No of dysmorphogenic features per conceptus (n= 13). 
§ Mitotic indices of neural epithelium of rhombencephalon (n=4) . 
H Cell densities of mesenchyme adjacent to rhombencephalon (cells/2500 μτη2, n = 4). 
π d = not detectable 
bodies were present throughout the embryos (Fig. 8.3). Although at an AUC of 
3.6 mM-hr L-homocysteine no gross histological changes were apparent, both 
the mitotic indices of the neural epithelium of the rhombencephalon and the cell 
densities of the mesenchyme adjacent to it were reduced significantly (Table 
8.1). 
Specificity of L-homocysteine embryotoxicity. When the embryotoxicity of L-
homocysteine was compared with that of related compounds it was shown that 
homocysteine embryotoxicity was stereospecific: whereas L-homocysteine was 
very toxic (AUC 10.8 mM-hr) D-homocysteine caused no embryotoxic effects at 
all (Table 8.2). Also the oxidation product L-homocystine (72 mM-hr) and L-
methionine (AUC 144 mM-hr) were not embryotoxic. However the condensed 
forms of both stereoisomers of homocysteine - D- and L-homocysteine-
thiolactone - were embryotoxic at an AUC of 72 mM-hr (Table 8.2). The thiolac-
tones induced the same abnormalities as L-homocysteine. However at the 
concentrations used the formation of large blisters near the region of forelimb 
bud formation was more pronounced and more often seen after exposure to the 
thiolactones (Fig. 8.2). 
Pre-implantation mouse embryo culture 
L-Homocysteine was also toxic for pre-implantation mouse embryos. At an AUC 
of 6.3 mM-hr (corresponding with an initial concentration of 170 μΜ) the num-
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AUC l n l t i a l
 T „ e . Dysmorphogenic C o m p o u n d
 (mM hr) c,o n™ ™ S t features* 
(mm) 
Control 
L-homocy steine 
D-homocysteine 
L-homocysteinethiolactone 
D-homocysteinethiolactone 
L-homocystine 
L-methionine 
-
10.8 
10.8 
72 
72 
72 
144 
-
2.7 
2.7 
3 
3 
3 
6 
44 5 (0 8) 
35 6 (0 8)* 
43 3 (0 8) 
29 8 (0 8)* 
32 6 (0 8)* 
42 7 (0 7) 
43 6 (0 8) 
0 4 (0 6) 
7 9 (0 6)* 
0 4 (0 6) 
12 3(0 6)* 
10 7(0 6)* 
0 6(0 5) 
0 1 (0 6) 
Table 8.2. Embryotoxicity of L-homocysteine and structural analogues in post-implantation 
rat embryo culture Values are least square means and, in parentheses, SEM 
Values marked with an asterisk differed significantly (Sludentst-test) from the corresponding 
control value · Ρ < 0 007 
t Total morphological score (n= 12) 
t No of dysmorphogenic features per conceptus (n= 12) 
ber of embryos that developed into blastocysts was reduced approximately four­
fold (Table 8.3). 
Discussion 
Our experiments clearly demonstrate that L-homocysteine is embryotoxic in 
vitro. Since its enantiomer D-homocysteine, its oxidized form L-homocystine and 
its metabolite L-methionine are not embryotoxic, it is evident that homocysteine 
embryotoxicity is not caused only by the thiol or amino acid moiety of L-homo­
cysteine, but requires the intact molecule in a stereospecific manner. 
Table 8.3. Embryotoxicity of L-
homocysteine in pre-
ìmplantation mouse embryos Values 
are means and, in parentheses SD 
Values marked with asterisks differed 
significantly (Students i-test) from 
the corresponding control values 
••P<0 001 
AUC 
(mM-hr) 
0 
0.63 
1.9 
6.3 
19 
Initial concn 
(mM) 
0 
0.017 
0.051 
0.17 
0.51 
N 
64 
38 
36 
37 
25 
% 
blastocysts 
67(12) 
76 (23) 
66(15) 
18(13)" 
0** 
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i 0 
Fig. 8.2. Rat embryos cultured in vitro from day 10 of gestation for 24 hr (x23). (a) Con-
trol, (b) L-Homocysteine AUC = 7.2 mMhr. (c) L-homocysteine AUC = 10.8 
mM-hr. (d) D-Homocysteinethiolactone AUC = 72 mMhr, showing large blister 
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d . І&ІЧЬ. 
Fig. 8.3. HE-stained slides of rat embryos culturedm vitro for 24 hours (x68). (a), (b), (c): 
Transversal section through rhombencephalon and otic primordia. (d), (e), (f) 
Transversal section through rump part showing heart and neural tube, (a), (d): 
Control, (b), (e): L-Homocysteine AUC = 7.2 mMhr. (c), (f): L-Homocysteine 
AUC =10.8 mMhr. 
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A surprising result was the observation that the stereospecificity of L-homocyste­
ine embryotoxicity is not matched by a stereospecific embryotoxicity of 
homocysteinethiolactone. This result may be interpreted as a difference in 
transport mechanism. While L-homocysteine is dependent on a stereospecific 
carrier to enter the cell, the thiolactones may - because of their reduced polarity 
- simply enter the cell by diffusion. 
The initial concentrations of L-homocysteine used in WEC are much higher than 
those found in the sera of controls and of women showing a positive result in 
the methionine loading test (Steegers-Theunissen et ai, 1991). There are several 
explanations of why these high concentrations of L-homocysteine were needed 
to cause embryotoxicity. First, L-homocysteine when added to the medium 
disappears rapidly because of its spontaneous oxidation to L-homocystine, 
which is not embryotoxic (Table 8.2). The apparent difference in sensitivity to L-
homocysteine embryotoxicity between pre-implantation mouse embryos and 
post-implantation rat embryos can be explained by a difference in the rate of L-
homocysteine oxidation. Secondly, it might be difficult to increase the intracellu­
lar homocysteine concentration by increasing the medium concentration. Indeed 
it has been hypothesized that cells possess an efficient export mechanism for L-
homocysteine to ensure low intracellular L-homocysteine concentrations which 
may be essential to some vital cellular functions (Svardal et al., 1986). 
The lower mitotic indices of the rhombencephalon and cell densities of the 
mesenchyme adjacent to it indicate that at an AUC of 3.6 mM*hr L-homocyste­
ine inhibits cell proliferation. No NTDs were observed in the embryos cultured in 
our experiments. This may be explained by the stage of development of the 
embryos. When 9.5-day-old rat embryos were cultured in cow serum, which is 
methionine deficient, they failed to close their neural tube. However the neces­
sity for methionine supplementation exists only during the first 18 hr of culture 
(Coelho et ai, 1989). When Matsuda and Yasutomi (1992) added 0.8 μ,Μ 5-
azacytidine to a culture of rat embryos (9.5 days of gestation) incomplete closure 
of the cephalic neural tube was observed. Maximum sensitivity occurred be­
tween 6 and 12 hours of culture. Thus it is plausible that the best period to 
induce NTDs in rat embryos is before day 10 of gestation. In our experiments 
the embryos were explanted at 10 days of gestation. 
From our results it is not clear what mechanism is responsible for the observed 
toxic effects of L-homocysteine. Since D-homocysteine is not embryotoxic it is 
not very likely that embryotoxicity is induced simply by a high concentration of 
oxidizable free thiols in the medium. The hypothesis therefore that the mecha­
nism is similar to that proposed for homocysteine toxicity to endothelial cells, 
where copper-catalysed oxidation of homocysteine leads to hydrogen peroxide 
formation (Starkebaum and Harlan, 1986) is rather improbable. When we view 
our results alongside those of Coelho and co-workers (Coelho and Klein, 1990: 
Coelho et al, 1989) and Matsuda and Yasutomi (1992) we suggest the follow-
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ing mechanism. Both methionine deficiency and excess of homocysteine may 
lead to a decrease of the ratio of S-adenosylmethionine (SAM) to S-adenosyl-
homocysteine (SAH) (Finkelstein, 1990). A reduced SAM/SAH ratio will inhibit 
numerous transmethylation reactions in which SAM is the methylgroup donor. 
One of the transmethylation reactions is involved in the methylation of amino 
acid residues in actin and myosin fibrils. A reduced methylation index of these 
amino acid residues in neural tube proteins was observed by Coelho and Klein 
(1990) when embryos were cultured in methionine-deficient cow serum. An-
other transmethylation product is 5-methylcytosine. This methylated nucleotide 
occurs in very specific places on the DNA and methylation of these sites may 
play a role in the regulation of the expression of tissue specific genes (Cedar, 
1988). Matsuda and Yasutomi (1992) showed that hypomethylation of DNA 
occurred in embryos that failed to close their neural tube after exposure to 5-
azacytidine. 
The in vitro embryotoxicity of L-homocysteine that we have demonstrated in the 
present work is in accordance with previous reports that a deranged homocyste-
ine metabolism could possibly be an aetiological factor in NTDs or recurrent 
spontaneous abortion (Steegers-Theunissen et al., 1991; 1992). However, 
considering the concentrations of L-homocysteine used in our experiments and 
the levels of maternal plasma L-homocysteine it is not very probable that it is the 
maternal homocysteine that causes the problems for the embryo. Further inves-
tigations will be needed to elucidate the role of homocysteine and methionine 
metabolism in the aetiology of NTDs. 
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Abstract Mild hyperhomocysteinemia is frequently observed in mothers who gave birth 
to a child with a neural tube defect (NTD). In a previous study we showed L-homocysteine 
was embryotoxic to gestational day 10 rat embryos in culture, however no NTDs were 
observed. We therefore investigated the effect of L-homocysteine on the development of 
neural plate stage (gestational day 9.5) rat embryos. Other objectives of this study were 
investigation into whether the embryotoxicity of L-homocysteine could be attenuated by 
compounds related to its metabolism and clarification of the mechanism of L-homocyste­
ine embryotoxicity. In gestational day 9.5 rat embryos L-homocysteine was not toxic at 1 
and 2 mM concentrations. Rather at these concentrations it promoted development of the 
rat embryos in serum that without supplementation caused neural tube defects in the 
embryos. L-Methionine had the same preventive effect at even lower concentrations, but 
folinic acid (1 mM) did not improve embryonic development. /V5-Methyltetrahydrofolate (5-
methylTHF) (100 μΜ), L-serine (6 mM) and L-methionine (6 and 12 mM) attenuated the 
embryotoxicity of L-homocysteine (6 mM) in gestational day 10 rat embryos. Vitamin B12 
(10 μΜ) completely abolished the embryotoxicity of L-homocysteine, which was shown to 
be mediated by catalysis of the spontaneous oxidation of L-homocysteine to the less toxic 
L-homocystine. In gestational day 11 rat embryos both L- and D-homocysteine were readily 
taken up when added to the culture (3 mM) and increased embryonic S-adenosyl-
homocysteine (SAH) levels 14 and 3-fold, respectively. This difference was shown to be 
caused by the stereospecific preference of SAH hydrolase. We propose the basis for L-
homocysteine embryotoxicity is an inhibition of transmethylation reactions by increased 
embryonic SAH levels. 
Introduction 
Several findings point to the crucial role of a disturbed homocysteine/methionine 
metabolism in the aetiology of NTDs. First, peri-conceptional folate supplemen­
tation reduces both the NTD first occurrence and recurrence risk significantly 
(Czeizel and Dudas, 1992; MRC Vitamin Research Group, 1991). Folate defi­
ciency or a disturbed folate metabolism, leading to a reduced availability of 5-
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methyltetrahydrofolate (5-methylTHF), will result in decreased homocysteine 
remethylation, and therefore increases homocysteine levels and decreases 
methionine levels (Mudd et al, 1989) (Fig. 9.1). Second, there is growing evi-
dence that, next to folate, vitamin Bl2 may play a role in the aetiology of NTDs 
as well (Schorah et al., 1980; Gardiki-Kouidou and Seller, 1988; Magnus et al., 
1991; Economides et al, 1992; Kirke et ai, 1993). Methionine synthase, the 
enzyme remethylating L-homocysteine to L-methionine is a vitamin Bl2-depend-
ent enzyme. The studies by Schorah et al. (1993) pointed in the direction of a 
reduced activity of methionine synthase in placental cytotrophoblasts from NTD-
affected pregnancies. Third, in mothers who gave birth to a child with NTD, 
homocysteine blood levels were on average higher as compared to controls, 
both before and after an oral methionine loading test, indicating a defective 
homocysteine/methionine metabolism (Steegers-Theunissen, 1993). In women 
in whom the oral methionine loading test was abnormal no deficiency of the 
homocysteine metabolizing enzyme cystathionine-ß-synthase could be found. 
(Steegers-Theunissen et ai, 1994) It is therefore more likely that the remeth-
ylation of homocysteine to methionine is reduced. L-methionine deficiency has 
been shown to induce NTD in cultured rat embryos (Coelho et al, 1989; 
Coelho and Klein, 1990) and methionine supplementation has been shown to 
promote remediation of axial defects in the mouse (Essien 1992; Essien and 
ATP 
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NADPH 
glycine 
protein synthesis polyamine synthesis 
î ï 
Î 
NADP< 
5,10-methylene-THF<v 
NADPH \ 
FADH^ ' -yV 
FAD*^ y » \ 
NADP·«-^  5-CH,-THF 
serine methionine 
1 THF« 
J 
homocysteine. SAH 
methyl 
acceptor 
methylated 
product 
adenosine 
Fig. 9.1 Simplified metabolic scheme illustrating homocysteine/methionine metabolism and 
its relation to folate metabolism and transmethylation as far as it is discussed in 
this paper SAM, S-adenosylmethionine, SAH, S-adenosylhomocysteine, THF, 
tetrahydrofolate 
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Wannberg, 1993a,b) and the attenuation of valproate toxicity in the rat (Nosel 
and Klein 1993) Finally, in a previous study we have shown, that L-homocyste-
ïne is embryotoxic to gestational day 10 rat embryos in vitro (VanAerts et al, 
1993a) 
In this paper we present several expenments concerning the effects of L-homo-
cysteine and compounds related to its metabolism on embryonic development 
and homocysteine metabolism, using the post-implantation rat embryo culture 
Since no NTDs were observed when gestational day 10 rat embryos were cul-
tured in the presence of toxic levels of L-homocysteine (VanAerts et al, 1993a) 
we cultured neural plate stage (gestational day 9 5) rat embryos in the presence 
of L-homocysteine, L-homocystine, L-methionine and folinic acid To investigate 
whether L-homocysteine embryotoxicity could be attenuated by stimulation of 
its metabolism we added 5-methylTHF, L-senne, vitamin Bl2 and L-methionine 
to the culture of gestational day 10 rat embryos We added catalase and 
Cu(II)S04 to test whether a H2O2 mediated mechanism was involved in L-
homocysteine embryotoxicity To examine if a disturbance of 
homocysteine/methionine metabolism by elevated L-homocysteine concen-
trations caused the embryotoxicity, we investigated the effect of 3 mM L- and D-
homocysteine and their thiolactones on the levels of S-adenosylmethionine 
(SAM), S-adenosylhomocysteine (SAH), methionine and homocysteine in 
gestational day 11 rat embryos Finally the enzyme kinetics of SAH hydrolase 
were studied 
Materials and m e t h o d s 
Whole embryo culture 
To investigate the effects of elevated L-homocysteine, L-homocystine, L-methionine and 
folinic acid concentrations on morphological development of conceptuses at an earlier 
stage of development, conceptuses were explanted at 9 5 days of gestation (early to late 
neural plate stage, [Fujinaga and Baden, 1991]) Reichert's membrane was removed by 
the traditional method, 1 e leaving the ectoplacental cone intact Conceptuses were 
cultured, two in a bottle, for 48 hr in 2 ml medium Medium consisted of 71% human 
serum (preparation according to VanAerts et al, [1993a]), 10% rat serum (preparation 
according to Piersma et al [1991]) and 19% Tyrode's buffer In this experiment we 
added rat serum, since human serum, compatible with embryonic development of 
gestational day 10 rat conceptuses, did not support embryonic development of gesta-
tional day 9 5 conceptuses Penicillin G, sodium salt, (6 дд/ті), streptomycinesulfate 
(0 66 mg/ml), D-glucose (final concentration 3 mg/ml) and test substances were dissolved 
in Tyrode's buffer before addition Test substances were added after preparation of the 
embryos The culture bottles were gassed initially and after 4 hr of culture with 5% 02, 
90% N2 and 5% CO2 After 20 and 28 hr the bottles were regassed, with the oxygen 
concentration increased to 20% at the expense of nitrogen After 44 hr, the oxygen 
concentration was increased to 40% Housing of the animals and the conditions of 
culture were descnbed previously (VanAerts et al, 1993a) Total morphological score 
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(TMS) was assessed by the method of Brown and Fabro (1981) and all dysmorphogenic 
features were recorded 
To test the modulation of L-homocysteine embryotoxicity by L-methionme, 5-methyl-
THF, L-senne, vitamin Bl2, Cu(II)S04 and catalase, gestational day 10 rat conceptuses 
(four to eight pairs of somites) from random-bred Cpb WU Wistar rats were cultured for 
24 hr, one in each bottle The medium consisted of 75% human serum and 25% sterile 
filtered Tyrode's buffer, in which all substances added were dissolved Human serum was 
preferred above rat serum, to reduce the number of animals used Each individual serum 
was tested in the gestational day 10 embryo culture for compatibility with embryonic 
development and those sera supporting embryonic development were pooled (four to six 
individual sera per pool) Within each experiment only one pool was used After addition 
of the test substances the media were pre-incubated for 1 5 to 3 5 hr before embryos 
were added The time of pre-incubation was equally spread among the experimental 
groups The conceptuses were evaluated in the same way as gestational day 9 5 concep­
tuses 
Gestational day 11 or gestational day 115 conceptuses were used for the experiments in 
which embryonal homocysteine, methionine, SAM and SAH concentrations were investi­
gated Older embryos were used for this experiment because physiological levels of 
homocysteine and SAH are very low and the small biomass of gestational day 9 5 or 
gestational day 10 embryos would have required the use of very large numbers of 
embryos After preparation of the gestational day 11 conceptuses the test substances 
were added and the conceptuses were cultured, two or three in a bottle, for 2 hr in 2 ml 
medium, which consisted of 75% human serum and 25% Tyrode's buffer and were 
gassed with 40% 02, 55% N2 and 5% C02 We used a shorter incubation period to 
prevent complete oxidation of homocysteine to its disulfide After culture conceptuses 
were washed three times in ice-cold Hank's buffered salt solution (HBSS) To measure 
the levels of methionine, SAM, SAH and total homocysteine in embryos proper the 
embryonic membranes (yolk sac and amnion) were removed and the embryos proper 
were washed once again in HBSS After washing the material was frozen in liquid 
nitrogen and stored at -80 °C To compare in υιυο and in vitro levels of metabolites, 
gestational day 115 rat conceptuses were either immediately frozen after explantation 
and removal of decidual tissue, Reichert's membrane and - in the case of measurement 
of metabolites in embryos proper - yolk sac and amnion, or were cultured for 2 hr as 
described for gestational day 11 embryos 
Homocysteine oxidation 
The rate of homocysteine oxidation was assayed under the conditions of gestational day 
10 embryo culture (oxygen concentration 5%) and was assessed by measuring the free 
thiol concentration according to Ellman (1959) The data obtained in this way were fitted 
to a curve with the general expression 
[homocysteine]-,- = [homocysteine]0· e' k T1, 
in which ic' is the pseudo-first order rate constant of oxidation and Τ the time elapsed 
S-adenosy/homocysfeme hydrolase assay 
SAH hydrolase was assayed in homogenate of gestational day 115 embryos proper that 
had been frozen in liquid nitrogen immediately after preparation and were stored at -80 
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°C Tissues were sonicated in an ice-cold 22 5 mM potassium phosphate buffer (pH 7 0) 
containing 1 mM Na2EDTA2H20, 20 μΜ erythro-9[2-hydroxy-3-nonyl]adenine 
(EHNA), 0 164% Triton X-100 and 1 1 mM dithiothreitol (DTT) DTT was added just 
before use The assay was performed in the same buffer at 37 °C for 20 min The 
enzyme activity was measured in the synthetic direction When L-homocysteine was the 
substrate the enzyme was assayed in quadruplicate at 11 different concentrations in the 
range from 0-800 μΜ When D-homocysteine was the substrate the enzyme was assayed 
in quadruplicate at seven different concentrations in the range from 0-8 mM Adenosine 
was added in equimolar amounts to L- or D-homocysteine The total volume was 200 μΐ 
and it contained the homogenate of Ve embryo After incubation protein was precipitated 
with 12 μΐ 8 M perchloric acid After 10 min on ice the mixture was centrifuged in an 
Eppendorf centrifuge for 5 mm (13,000 g, 4 °C) and 25 μΐ 4 M K2HP04 was added to 
the supernatant After another 10 min on ice the precipitate was removed by centnfuga-
tion and the supernatant was frozen in liquid nitrogen Samples were stored at -80 °C 
until further analysis SAH was measured by high-performance liquid chromatography 
(HPLC) and spectrophotometnc detection according to DeAbreu et al (1982) To 
calculate enzyme kinetic parameters, the data were converted to a Lineweaver-Burk plot 
Measuremeni of metabolites 
For measurement of homocysteine, methionine, SAM and SAH embryos proper and 
whole conceptuses were thawed, placed on ice, pooled in three series of either 5 whole 
conceptuses or 9 embryos proper in 300 μΐ potassium phosphate buffer (pH 6 0) and 
homogenized by sonication 
Homocysteine concentrations were measured with HPLC and fluorometnc detection 
according to Fiskerstrand et al (1993) in 70 μΐ of the homogenate The detection limit 
was 35 pmol Both inter- and intra-assay CV were < 5 % 
For determination of methionine the homogenates (50 μΐ) were deproteinized by adding 
an equal volume of ice-cold sulphosalicylic acid (25% w/v) and were placed on ice After 
10 mm the samples were centrifuged for 10 min at 3,500 g The supernatant was filtrated 
through a 0 45 μπι filter Methionine concentrations were measured with an automated 
amino acid analyzer (Pharmacia LKB Alpha-Plus) A 140 μΐ sample was injected on an 
cation-exchanged column (24 cm, internal diameter 4 6 mm, particle size 6 μιτι) After 
post-column denvatization with O-phtaldialdehyde, the eluent was monitored fluoro-
metrically The detection limit was 15 pmol Both inter- and intra-assay CV were < 5 % 
For measurement of SAM and SAH concentrations protein of the homogenates was 
precipitated by addition of 15 μΐ ice-cold 50% trichloroacetic acid (TCA) to 150 μΐ 
homogenate After 10 min on ice the samples were centrifuged for 2 min at 13,000 g 
The supematants were collected and washed three times with two volumes of peroxide-
free diethylether to remove TCA The samples were flushed with nitrogen, while on ice, 
and diluted with aquadest to an end volume of 200 μΐ SAM and SAH were separated 
and quantitated by means of HPLC and spectrophotometnc detection according to 
Molloyefa/ (1990) 
Chemicals 
Homocysteine was prepared freshly by dissolving homocysteinethiolactone in 200 μΐ 5 N 
sodium hydroxide and incubation during five minutes at 37 °C The solution was neu-
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tralized by adding 400 μΐ concentrated ( χ 18 3) Tyrode's buffer (pH 7 6) without sodium-
chlonde and 400 μΐ 2 5 N HCl and was diluted with 6 3 ml water, which resulted in final 
concentrations identical to those in Tyrode's buffer This stock solution was further 
diluted with Tyrode's buffer to the desired concentrations of homocysteine 
Homocysteinethiolactones, L-homocystine, L-methiomne, L-senne, 5-methylTHF, folinic 
acid, SAM, SAH and catalase (2,800 ΙΕ/mg, prepared from bovine liver) were purchased 
from Sigma (St Louis, MO), vitamin Bl2b (OH Bl2) was obtained from Fluka Chemie 
(Buchs, Germany), adenosine came from USB (Cleveland, OH), Penicillin G, sodium 
salt was obtained from Gist/Brocades (Delft, The Netherlands), streptomycinesulfate 
from Biochemie (Vienna, Austria), D-glucose from Merck (Darmstadt, Germany), EHNA 
frpm Burroughs Welcome (Research Triangle Park, NC), and Triton X-100 from Serva 
Feinbiochemica (Heidelberg, Germany) 
Statistical analysis 
In the experiments using gestational day 10 conceptuses least square means of TMS and 
number of dysmorphogenic features/conceptus were calculated by analysis of co-
variance, taking the number of somite pairs at the beginning of culture as covanant 
Least square means were compared by Student's t-test with Bonferroni correction With 
a nominal α of 0 05, differences were regarded as statistically significant at P<0 05/ie 
where к is the number of comparisons made Since in the experiments with gestational 
day 9 5 embryos, more than one embryo per bottle was cultured, analysis of covanance 
could not be applied and analysis of variance was used instead Frequencies of specific 
dysmorphogenic features were tested with Pearson's chi-square test Unexpected distn-
bution of frequencies was regarded as statistically significant at P<0 01 If 50% or more 
of the cells had expected counts of less than five, the test was regarded not valid Stu­
dent's t-test with Cochran's approximation was used to test differences in the levels of 
metabolites measured Correlations between metabolite levels were tested by calculating 
Pearson's correlation coefficient in a linear regression model 
Resul ts 
Prevention of neural tube defects by L-homocysteine, L-homocystme and 
L-methionine m gestational day 9 5 rat embryos 
Rather large amounts of L-homocysteine had to be added to the culture of 
gestational day 10 rat embryos to elicit embryo toxicity and no NTDs were 
observed Gestational day 9 5 rat embryos are generally considered to be more 
sensitive and the neurulation process is still at the neural plate stage We there­
fore cultured gestational day 9 5 embryos in the presence of L-homocysteine, L-
homocystine, L-methionine and folinic acid Despite addition of rat serum to the 
human serum control embryos developed poorly The dysmorphogenic features 
in controls were open prosencephalon, open mesencephalon, open rhomben­
cephalon, haemorrhages in the head region and deformed optic pnmordia 
However addition of L-homocysteine (1 or 2 mM), L-homocystine (2 mM) or L-
methionine ( 1 mM) resulted in well developed embryos after 48 hr of culture 
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Control 
L-homocysteine 
L-homocystine 
L-methionlne 
Folinic acid 
300 μΜ 
1mM 
2mM 
4mM 
2mM 
30 μΜ 
100 μΜ 
300 μΜ 
1 mM 
1 т М 
Nt 
29 
12 
12 
11 
7 
12 
13 
11 
11 
13 
12 
Dead 
2 
7 
TMS* 
37 5±0 8 
38 3±1 2 
46.9±1 2* 
46 8±1 3* 
44 1±1 2* 
40 4±1 2 
44 7±1 3* 
43 4±1 3* 
45 8±1 2* 
39 8±1 2 
Dysmorphogenic 
features!! 
4 4±0 4 
3 8±0 6 
0 2±0 6* 
0 2±0 6* 
0 8±0 6* 
3 0±0 6 
1 5±0 6* 
1 3±0 6* 
0 3±0 6* 
3 9±0 6* 
Table 9.1 Effect of L-methionine, L-homocysteine, L-homocystine, and folinic acid on the 
culture of gestational day 9 5 rat embryos Values shown are least square 
means±SEM 
tNo of embryos 
tTotal morphological score 
UNo of dysmorphogenic features/conceptus 
Lower concentrations of L-homocysteine did not improve embryonic develop­
ment, but TMS increased significantly and number of dysmorphogenic fea­
tures/conceptus decreased significantly when 100 or 300 μΜ L-methionine was 
added. Addition of 4 mM L-homocysteine to the culture killed all gestational day 
9.5 embryos during culture. The addition of the folate derivative folinic acid did 
not improve embryonic development (Table 9.1). 
Embryotoxicity of L-homocysteine and its attenuation by 5-methylTHF, 
L-serine and vitamin Bl2 in gestational day 10 rat embryos. 
The addition of 4 or 6 mM L-homocysteine to the culture of gestational day 10 
rat conceptuses resulted in high frequencies of dysmorphogenic features (Table 
9.2) and a reduced TMS (Tables 9.3, 9.4 and 9.7) 
To test whether the embryotoxicity of L-homocysteine could be attenuated by 
stimulation of its metabolism 5-methylTHF, L-serine and vitamin Bl2 were 
added to the culture. The addition of either 100 μΜ 5-methylTHF or 6 mM L-
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Yolksac circulation 
Allantois 
Flexion 
Heart 
Caudal neural tube 
Rhombencephalon 
Mesencephalon 
Prosencephalon 
Optic primordium 
Branchial bars 
Maxillary process 
Defective 
Smallt yolksac vessels 
Not fused with chorion 
Smallt or avascular 
Incomplete 
Absent 
Controls 
(n=B1) 
KD 
KD 
20 (25) 
2(2) 
2(2) 
0(0) 
Inverted tail (positioned at wrong side of head) 10(12) 
Delayed cardiac tube formation 
Widet pericardial sac, filled with fluid 
Irregular dorsal midline 
Aplasia 
Kinky 
Curving more extreme 
Open 
Larget or transparent 
Open 
Open 
Smallt 
Deformed 
One pair or more missing 
Smallf 
Mandibular processesUnapproachedt 
Other head 
Forelimb buds 
Somites 
Others 
Irregular wavy suture line of neural folds 
Abnormal craniofacial appearance 
Haemorrhagic areas 
Smallt 
Missing 
Smallt 
Irregular 
Amorphogenesls 
Edema 
Haemorrhages 
General growth retardation 
Embryonic death 
Cell death* 
2(2) 
0(0) 
0(0) 
0(0) 
1(1) 
0(0) 
KD 
0(0) 
0(0) 
0(0) 
0(0) 
1(1) 
0(0) 
2(2) 
0(0) 
2(2) 
2(2) 
2(2) 
0(0) 
2(2) 
0(0) 
0(0) 
2(2) 
KD 
5(6) 
4(5) 
0(0) 
2(2) 
L-Homocysteine 
4mM 
(n=29) 
8(28) 
2(7) 
9(31) 
0(0) 
9(31) 
1(3) 
3(10) 
0(0) 
0(0) 
3(10) 
2(7) 
6(21) 
2(7) 
1(3) 
1(3) 
2(7) 
2(7) 
1(3) 
2(7) 
0(0) 
4(14) 
1(3) 
0(0) 
1(3) 
5(17) 
3(10) 
16 (55) 
0(0) 
6(21) 
6(21) 
15(52) 
8(28) 
12 (42) 
1(3) 
23 (79) 
6mM 
(n=56) 
15(27)* 
11 (20)* 
17(31) 
6(11) 
14 (25)* 
0(0) 
10(18) 
4(7) 
4(7) 
1(2) 
9 (16)* 
24 (43)* 
7(13) 
0(0) 
17 (30)* 
0(0) 
0(0) 
15(27)* 
18(32)* 
7(13) 
27 (48)* 
0(0) 
0(0) 
1(2) 
5(9) 
5(9) 
47 (84)* 
1(2) 
34(61)* 
32 (57)* 
35 (63)* 
16(29)* 
35 (63)* 
1(2) 
53 (95)* 
Table 9.2 Dysmorphogenic features of gestational day 10 conceptuses cultured with L-homo-
cysteine. Cumulative data from 10 separate experiments Values shown are no of 
conceptuses Percentages are in parentheses *P<0 01 in Chi-square test TAs compared to the 
normal situation tVisible as opaque regions or spots at places where these normally are not 
present. 
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Dysmorphogenic 
features^ 
Control 
6 m M L-homocysteine 
6 roM L-homocysteine + 100 μΜ 5-methylTHF 
6 mM L-homocysteine + 6 mM L-serine 
6 mM L-homocysteine + 10 μΜ Bi2 
6 mM L-homocysteine + 100 μΜ 5-methylTHF 
+ 6 mM L-serine 
6 mM L-homocysteine + 100 μΜ 5-methylTHF 
+ 10 μΜ B12 
6 mM L-homocysteine + 6 mM L-serine + 10 μΜ 
6 mM L-homocysteine + 100 μΜ 5-methylTHF 
+ 6 mM L-serine + 10 μΜ Bi2 
Table 9.3 Attenuation of L-homocysteine embryotoxicity in gestational day 10 rat embryos 
by 5-methylTHF, L-senne and vitamin Bl2 Values shown are least square means 
±SEM. 
tNo. of embryos 
tTotal morphological score 
INo. of dysmorphogenic features/conceptus 
* P < 0 00625 in Student's t-test when compared with embryos exposed to L-homocysteine 
alone. 
P < 0 00625 in Student's t-test when compared with controls 
serine attenuated the embryotoxicity of L-homocysteine. The TMS increased (P-
values 0.0013 and 0.0065, respectively) and the dysmorphogenic features/ 
conceptus decreased (P-values 0.02 and 0.08, respectively) relatively to those 
embryos that were exposed to L-homocysteine alone. More striking was the 
effect of the addition of vitamin Bl2. Both morphological parameters of the 
embryos grown in the presence vitamin Bl2 were no longer different from con­
trols (Table 9.3, Fig. 9.2). 
Homocysteine oxidation and attenuation of L-homocysteine embryo­
toxicity in gestational day 10 rat embryos by vitamin Bl2, Cu(II)S04 but 
not by catalase. 
Since vitamin Bl2 can act as an transition metal ion in the catalysis of L-homo-
18 
12 
11 
10 
11 
42.8±0 7* 
32.2±1 5§ 
36.5±1 4*§ 
35 9 1 5§ 
42 2±0 8* 
0 4±0.2* 
10 2±0.2§ 
7 4±1 4 § 
8.0±1.4§ 
2 1±0 8* 
11 42 2±0 6* 1.4±0 55 
B12 11 43.2±0 8* 0 7±0 3§ 
12 43 3±0.6* 0 5±0 2* 
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Fig. 9.2. Attenuation of L-homocysteine toxicity in gestational day 10 rat embryosiH vitro 
by 5-methylTHF, L-serine and vitamin Bi2. Embryos were treated as follows.a: 
Control, b : 6 mM L-homocysteine, c: 6 mM L-homocysteine + 6 mM L-serine, d: 6 mM L-
homocysteine + 1 0 0 μΜ 5-methylTHF,e: 6 mM L-homocysteine + 1 0 μΜ vitamin Bl2 and f: 
6 mM L-homo-cysteine + 6 mM L-serine + 100 μΜ 5-methylTHF + 10 μΜ vitamin B12. Bar 
indicates 1 mm. 
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cysteine to L-homocystine, we investigated if the observed effect of vitamin Bl2 
could be matched by the addition of another transition metal ion, Cu2+. Both 
vitamin Bl2 and Cu(II)S04 increased the rate of homocysteine oxidation in the 
medium under whole embryo culture conditions (Fig. 9.3). The pseudo-first-
order rate constant of homocysteine oxidation without further additions was 
7.67xl0~5 sec1, whereas these rate constants increased, when 10 μΜ vitamin 
Bl2 or 10 μΜ Cu(II)S04 were added, to 1.77xl0~4 sec"1 and 9.78x10 "5 sec "\ 
respectively. The half-lives of homocysteine in the medium corresponding to 
these rates of oxidation were 150, 65 and 118 min, respectively. Addition of 
Cu(II)S04, like vitamin Bl2, allowed normal embryonic development, as as­
sessed by the TMS and the number of dysmorphogenic features/conceptus 
(Table 9.4). H2O2 is proposed as a mediator in the toxicity of L-homocysteine to 
endothelial cells (Starkebaum and Harlan, 1986). To investigate if such a mech­
anism is applicable to L-homocysteine embryotoxicity, catalase was added to the 
culture as well. It was found that catalase had no significant attenuating effect on 
L-homocysteine embryotoxicity (Table 9.4). 
Levels of homocysteine, methionine, S-adenosylmethionine and S-
adenosylhomocysteine in gestational day 11 and gestational day 11.5 rat 
embryos. 
An alternative hypothesis for the mechanism of L-homocysteine embryotoxicity 
could be an imbalance in homocysteine/methionine metabolism caused by 
elevated embryonic homocysteine concentrations. To investigate this hypothe­
sis, we first compared physiological 
metabolite levels in gestational day 
11.5 rat conceptuses immediately 
frozen after explantation [in υ'ωο) 
and conceptuses cultured for 2 hr (in 
vitro). It was found that culturing the 
conceptuses did not change methio­
nine, SAH and homocysteine con­
centrations significantly. However 
SAM increased twofold (Table 9.5). 
Homocysteine and methionine con­
tent of whole conceptuses were five-
to tenfold of those found in the em­
bryos proper, whereas SAM and 
SAH content of whole conceptuses 
were only twice that found in em­
bryos proper. Since the volume of 
the whole conceptus is roughly ten 
100 200 300 
Minutes 
Fig. 9.3. Oxidation of homocysteine under 
gestational day 10 embryo culture 
conditions (oxygen concentration 5%) о о, 
homocysteine without further additions, Δ-—Δ, 
homo-cysteine in the presence of 10 μΜ vita­
min Bl2 and G D, homocysteine in the 
presence of 10 μΜ Cu(II)S04 RSH, free thiol 
concentration 
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м+ ТМЧ+ Dysmorphogenic 
Nt TMS* features^ 
Control 
β mM L-homocystelne 
6 mM L-homocysteine + 10 μΜ Βΐ2 
6 mM L-homocysteine + Cu(ll)S04 
6 mM L-homocysteine + catalase (500 IU/ml) 
Table 9.4 Effect of vitamin Bi2, Cu(II)S04, and catalase onL-homocysteine embryotoxicity 
in gestational day IO rat embryos Values shown are least square means ±SEM 
t N o of embryos 
tTotal morphological score 
UNo of dysmorphogenic features/conceptus 
* P < 0 0125 in Student's (-test when compared with embryos exposed to L-homocvsteine 
alone 
P < 0 0125 in Student's (-test when compared with controls 
7 
7 
7 
8 
6 
42 B±0 3* 
33 1±0 6§ 
42 6±0 5* 
42 6±0 2* 
37 0±0 5s 
0 5±0 1* 
9 4±0 3 § 
1 2±0 1* 
1 4±0 2* 
8 8±0 7 § 
Homocysteine 
Methionine 
S-adenosylmethionine 
S-adenosylhomocysteine 
In vivo 
Embryo 
proper 
0 054±0 016 
2 3±0 48 
0 27±0 051 
0 013±0 001 
Embryo + 
yolksac 
0 35±0 061 
17±0 51 
0 54±0 046 
0 048±0 012 
In vitro 
Embryo 
proper 
0 052±0 018 
3 1±0 77 
0 59±0 13 
0 013±0 001 
Embryo + 
yolksac 
0 50±0 26 
19±2 3 
1 2±016* 
0 024±0 004 
Table 9 5 Levels of methionine, homocysteine, S-adenosylmethionine, and S-adenosyl-
homocysteine in gestational day 11 5 rat embryos/и vivo and after 2 hr of culture 
(nmol/embryo) Values shown are means based on three different pools of 9 embryos or5 
embryos + yolksac ± SEM *P<0 05 in Student's i-test when compared to m vivo embryos 
times that of the embryo proper, this indicates that homocysteine and methio­
nine are present intracellularly and in extraembryonic fluids at comparable 
concentrations, whereas SAM and SAH seem to be largely confined to the 
cellular compartment. 
The addition of 3 mM L-homocysteine or D-homocysteine to the culture of 
gestational day 11 embryos increased the homocysteine content of the embryos 
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proper 180- and 133-fold, respec­
tively (Fig. 9.4). L-homocysteine in­
creased embryonic methionine 1.9-
fold and SAH 14-fold. D-homocyste-
ine increased the methionine levels 
1.5-fold and SAH only 3-fold. The 
homocysteinethiolactones increased 
embryonic homocysteine, methio­
nine and SAH levels even more, and 
again stereospecific differences were 
observed. The SAM/SAH ratio, an 
important determinant for the rate of 
transmethylation reactions, was 42 
in controls. Exposure to 3 mM L-ho­
mocysteine reduced it to 3.6. After 
D-homocysteine exposure it was 11. 
L- and D-homocysteinethiolactone 
reduced it to 2.1 and 5.3, respec­
tively. 
Stereospecificity of S-adenosyl-
homocysteine hydrolase 
When fitted in a linear regression 
model embryonic SAH levels and 
embryonic homocysteine levels cor­
related well, both after D- and L-ho­
mocysteine exposure, however the 
regression coefficients differed 
markedly. D-homocysteine resulted 
in a regression coefficient (± SEM) 
of 0.0044±0.0004 (Pearson corre­
lation coefficient 0.996, p=0.06, n=3). L-homocysteine resulted in a regression 
coefficient of 0.012±0.003 (Pearson correlation coefficient 0.83, p=0.006, 
η=9). This suggests that the stereospecific embryotoxicity of homocysteine 
might be caused by a difference in the rate of conversion of homocysteine to 
SAH by SAH hydrolase. We therefore assayed this enzyme in the synthetic 
direction with both D- and L-homocysteine as a substrate (Table 9.6). The Km of 
the enzyme for L-homocysteine is 79 times as low as the Km for D-homocysteine, 
demonstrating a clear stereospecific preference of the enzyme. The Km for L-
homocysteine in embryo homogenate found by us is the same as the one re­
ported for the purified rat liver enzyme (Kajander and Raina, 1981). Substrate 
inhibition as reported by Duerre and coworkers (Walker and Duerre, 1975; 
Fig. 9.4 Levels of homocysteine, methio­
nine, S-adenosylhomocysteine and 
S-adenosylmethionine in gestational day 11 
rat embryos after 2 hr of culture in (A) 75% 
human serum and 2 5 % Tyrode's buffer or the 
same medium to which (B) 3 mM L-homocys-
teine, (C) 3 mM D-homocysteine, (D) 3 mM 
L-homocysteinethiolactone or (E) 3 mM D-
homocysteinethiolactone had been added. Val­
ues shown are means ± SEM of three pools of 
nine embryos proper for each group. * = 
P<0.05 when compared with controls (group 
A) in Student's i-test. 
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Substrate 
Kmt 
(μΜ) 
Vmaict 
(nmol»mlrr1· 
embryo1) 
L-Homocysteinet 62 5 05 
D-Homocysteine^ 4 9*103 3 3 
Table 9.6 Stereospecificity of S-
a d e n o s y l h o m o c y s t e i n e 
hydrolase. Enzymatic activity assayed for 
the synthesis of S-adenosylhomocysteine 
tCalculated after conversion of the data to 
a Lineweaver-Burk plot. tValues shown are 
based on quadruplicate measurement at 11 
different concentrations TValues shown 
are based on quadruplicate measurement 
at seven different concentrations 
Hoffman et al., 1979) was only observed with D-homocysteine at the highest 
concentration (8 mM). 
Attenuation of L-homocysteine embryotoxicity in gestational day 10 rat 
embryos by L-methionine. 
Since embryotoxicity of L-homocysteine is possibly caused by a reduction of the 
SAM/SAH ratio we examined if this embryotoxicity could be attenuated by 
addition of L-methionine. The addition of high doses of L-methionine (6 and 12 
mM) improved the morphology slightly, as compared to the embryos exposed to 
L-homocysteine alone (P-values for TMS were 0.11 and 0.07, respectively, and 
those for the number of dysmorphogenic features/conceptus were 0.07 and 
0.06, respectively) (Table 9.7). 
Nt TMS+. Dysmorphogenic features^ 
Control 
6 mM L-homocysteine 
5 mM L-homocysteine + 1.5 mM L-methjonine 
6 mM L-homocysteine + 3 mM L-methionine 
6 mM L-homocysteine + 6 mM L-methionine 
6 mM L-homocysteine + 12 mM L-methionine 
Table 9.7 Attenuation of L-homocysteine embryotoxicity in gestational day 10 rat embryos 
by L-methionine Values shown are least square means ±SEM. 
t N o of embryos 
tTotal morphological score 
UNo. of dysmorphogenic features/conceptus. 
* P < 0 01 in Student's f-test when compared with controls 
12 
12 
12 
12 
12 
12 
45.0±0.8 
34.7±1 2* 
34.2±1.2* 
33.4 1 9* 
37 0±1 0* 
37 3±1 1* 
0.1±0.1 
10 0±0 9* 
10 3±1 0* 
11 4±1 2* 
7 5±0 9* 
7 4±1 2* 
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Discussion 
Gestational day 9.5 rat embryos developed very well when 1 or 2 mM L-homo­
cysteine was added to the culture, whereas these embryos had an open prosen­
cephalon, an open mesencephalon, an open rhombencephalon, haemorrhages 
in the head region and deformed optic primordia when L-homocysteine was 
omitted. These dysmorphogenic features can all be related to the failure of one 
process, namely closure of the anterior neural tube. This is the first demonstra­
tion that L-homocysteine promotes embryonic development of rat embryos in 
vitro when it is added to serum that without supplementation does not support 
normal embryonic development. L-methionine had the same beneficial effect on 
gestational day 9.5 rat embryos at even lower concentrations. This finding is in 
line with reports from other laboratories (Coelho et al., 1989; Coelho and Klein, 
1990; Ferrari et al, 1993; Flynn et al., 1987). Coelho and Klein (1990) could 
not replace methionine by homocysteine to prevent NTDs when gestational day 
9.5 rat embryos were cultured in cow serum, but they used only 185 μΜ. In the 
gestational day 9.5 embryo culture we tested L-homocystine only at a 2 mM 
concentration. At this concentration it was just as effective as 1 or 2 mM L-ho­
mocysteine in preventing NTDs. This suggests that it may be reduced intra-
cellularly to L-homocysteine. However uptake of the oxidized from will be lim­
ited, or its intracellular reduction may be incomplete, since an equimolar a-
mount of homocysteinyl moieties in their reduced form (4 mM L-homocysteine) 
killed all embryos. 
The beneficial effect of L-homocysteine in the culture of gestational day 9.5 rat 
embryos can be explained in two ways. First, L-homocysteine will be converted 
to L-methionine and thus supply the embryo with the amino acid that is proba­
bly limiting in embryonic development. Second, conversion of L-homocysteine 
to L-methionine will concomitantly demethylate 5-methylTHF, thus liberating 
THF for other essential functions such as purine and thymidine synthesis. Our 
observations that methionine is about 10 times as effective in promoting devel­
opment of gestational day 9.5 rat embryos as compared to L-homocysteine and 
that folinic acid did not promote development both favour the first explanation. 
It is not clear which processes are disturbed by methionine deficiency. Methio­
nine is used for protein synthesis and it is converted to SAM. SAM is the univer­
sal methyl group donor in transmethylation reactions, and both reduced DNA 
methylation (Matsuda and Yasutomi, 1992; Li et al., 1992) and reduced protein 
methylation (Coelho and Klein, 1990) have been suggested as teratogenic 
mechanisms. SAM is also a precursor in polyamine synthesis and reduced 
synthesis of these bioamines may deteriorate embryonic development as well. 
Finally when SAM levels are reduced the negative feedback on the reduction of 
N 5 , N 10-CH2-THF to 5-methylTHF by SAM will be abolished (Shane and 
Stokstad, 1983). Thus low levels of SAM will divert the folate pool to the forma-
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tion of 5-methylTHF. Since homocysteine can only be formed from SAH, the 
demethylated form of SAM, it is likely that an embryo deficient in methionine 
will have low homocysteine levels as well. However, methionine synthase, the 
only enzyme capable of demethylating 5-methylTHF, needs homocysteine as a 
substrate (Finkelstein, 1990) (Fig. 9.1). Methionine deficiency considered in this 
way, should therefore more appropriately be regarded as a deficiency in 
homocysteinyl moieties. Under these conditions not only reactions using SAM as 
a substrate will be hampered, but folate may be trapped as 5-methylTHF to 
some extent as well. Nevertheless, in our experiments a possible folate trapping 
effect of a homocysteinyl deficiency could not be counteracted upon by addition 
of 1 mM folinic acid. 
The observation that the addition of L-homocysteine prevents NTDs in the 
culture of gestational day 9.5 rat embryos, is not in favour of a previous hypoth-
esis that L-homocysteine may be the teratogen leading to this defect in women 
with mild hyperhomocysteinemia (Steegers-Theunissen, 1993; Steegers-
Theunissen et al., 1993). Blood homocysteine levels in these women were only 
marginally increased. Furthermore plasma homocysteine is mostly protein-
bound as a protein-homocysteine mixed-disulfide (Ueland et ai, 1992) and of 
the free homocysteine only one tenth is in its reduced form (Araki and Sako, 
1987). Blood homocysteine levels elevated to a greater degree as compared to 
healthy controls after an oral methionine load should therefore only be inter-
preted as a biochemical risk indicator, showing homocysteine-methionine me-
tabolism is not functioning optimally. 
High concentrations of L-homocysteine were embryotoxic to both gestational 
day 10 (1.8 mM and higher, VanAerts et al., 1993a) and gestational day 9.5 (4 
mM) rat embryos. The difference in sensitivity may have resulted from a higher 
rate of uptake in gestational day 10 rat embryos, as at this stage visceral yolk sac 
circulation is already present. Many dysmorphogenic features are observed in 
gestational day 10 rat conceptuses affecting many embryonic structures. This 
may be a reflection of reduced cell growth and increased cell death, since previ-
ous histological observations showed reduced mitotic indices of the neural 
epithelium, reduced cell densities of the mesenchyme adjacent to the neural 
tube and many apoptotic bodies (VanAerts et al., 1993a). A frequent dys-
morphogenic feature in gestational day 10 conceptuses, not related to L-homo-
cysteine exposure, was failure of fusion of the allantois to the chorion (Table 
9.2). This was not observed when gestational day 9.5 conceptuses were cul-
tured. It therefore seems to be related to the stage of development at the time of 
explantation of the concepruses. Failure of fusion of the allantois had no ad-
verse effect on the development of the embryo, except that in 50% of these 
embryos the caudal part of the embryo was positioned at the wrong side of the 
head. This indicates that if fusion fails at this stage of development positioning of 
the tail occurs randomly. 
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The embryotoxicity of L-homocysteine in gestational day 10 rat embryos could 
be attenuated by addition of 5-methylTHF or L-serine. 5-MethylTHF is the co-
substrate for methionine synthase, the enzyme remethylating homocysteine to 
methionine. L-serine in turn is a major one-carbon donor providing the methy­
lene moiety in the formation of N5,N10-CH2-THF. After reduction of this folate 
metabolite, 5-methylTHF is formed once again (Fig. 9.1). The attenuating effect 
of 5-methylTHF and L-serine on L-homocysteine embryotoxicity could therefore 
be explained by their stimulation of the remethylation of L-homocysteine to L-
methionine, which would result in a lowering of embryonic L-homocysteine 
levels to a less toxic level and an increase of L-methionine levels. 
The prevention of L-homocysteine embryotoxicity by vitamin Bl2 could theoreti­
cally be explained by stimulation of the activity of methionine synthase, which 
would increase the metabolism of L-homocysteine. However, the vitamin Bl2 
effect was abolished when the concentration of vitamin Bl2 was decreased to 
0.1 μΜ (data not shown). Physiological concentrations are in the picomolar 
range and cobalamines, like transition metal ions, in micromolar concentrations 
are known to catalyze thiol oxidation (Jacobsen et al., 1984; Cavallini et al., 
1969). However, the oxidation product of L-homocysteine, L-homocystine, is a 
less potent embryotoxicant (VanAerts et al, 1993a). It seemed therefore more 
likely that the vitamin Bl2 effect was mediated by an oxidative process. This 
conclusion is further substantiated by the observation that the transition metal 
ion Cu2 +, which also catalyses thiol oxidation, has the same attenuating effect. 
The observed effect of vitamin Bl2 also focussed our attention on a theory, 
which states that the toxicity of homocysteine to endothelial cells is mediated by 
a Cu2+-catalyzed, H2O2 producing oxidation of homocysteine (Starkebaum and 
Harlan, 1986). However catalase, a H2O2 scavenger, had no significant attenu­
ating effect on L-homocysteine embryotoxicity and Cu2 + abolishes L-homocyste­
ine embryotoxicity. This suggests that L-homocysteine embryotoxicity is not 
mediated by a Cuz+-catalyzed, H2O2 producing oxidation of homocysteine. On 
the contrary, the catalysis of the oxidation of L-homocysteine to the less toxic 
disulfide L-homocystine by vitamin Bl2 and Cu(II)S04 is the most probable 
explanation for the abolishment of the embryotoxicity of L-homocysteine. 
To investigate whether a disturbance of normal homocysteine metabolism by 
exposure to high concentrations of L-homocysteine could provide an explana­
tion for L-homocysteine embryotoxicity, we exposed gestational day 11 rat 
embryos to 3 mM L- and D-homocysteine and their thiolactones and measured 
embryonic homocysteine, methionine, SAM and SAH levels. Exposure to L-
homocysteine increased embryonic homocysteine concentrations dramatically, 
indicating that L-homocysteine was readily taken up. SAH concentrations were 
most probably increased by SAH hydrolase as it will convert part of the homo­
cysteine to SAH. Although under physiological conditions this enzyme hydroly­
ses SAH, it will synthesize SAH in the presence of high concentrations of homo-
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cysteine, since the reaction is reversible and synthesis is energetically even more 
favourable (Ueland, 1982). Because SAM levels did not change, the elevation of 
SAH resulted in a dramatic lowering of the SAM/SAH ratio. A SAM/SAH ratio 
lower than 4 will inhibit many transmethylation reactions up to 60% (Cantoni et 
al., 1979). Thus, when embryonic L-homocysteine levels are elevated too much 
this would lower the SAM/SAH ratio below a critical level and thereby inhibit 
crucial transmethylation reactions. Reduction of the SAM/SAH ratio as a mecha­
nism for L-homocysteine embryotoxicity may also provide an explanation for 
the attenuating effect of L-methionine on L-homocysteine embryotoxicity. When 
methionine concentrations are high SAM synthesis will be increased. Higher 
SAM levels will increase the SAM/SAH ratio and thereby counteract on the 
reduction of the SAM/SAH ratio by elevated SAH levels. Nevertheless, a low 
SAM/SAH ratio might not be the only possible way in which increased SAH 
formation could be toxic. Since adenosine is the co-substrate for SAH hydrolase, 
increased SAH formation by this enzyme may lead to reduction of cellular 
adenosine concentrations, which also may cause toxicity to the embryo. 
Exposure of gestational day 11 embryos to 3 mM D-homocysteine increased 
embryonic homocysteine levels to almost the same extent as L-homocysteine 
did. However, due to the high Km of SAH hydrolase for D-homocysteine, D-
homocysteine increased SAH levels to a much lesser extent than L-homocyste­
ine. This supports our hypothesis that increased SAH formation is the first step 
in the embryotoxic mechanism of L-homocysteine, since D-homocysteine was 
shown not to be embryotoxic at a concentration where L-homocysteine was very 
embryotoxic (VanAerts et al., 1993a). 
The homocysteinethiolactones were included in our experiments since they have 
been used as a test compound in other studies on the toxicity of homocysteine 
(Dudman and Wilcken, 1982; Ueland et al., 1992) and it has the advantage that 
it cannot oxidize to a disulfide form. However, the biological relevance may be 
low, since reports that homocysteinethiolactone is formed in the body could not 
be confirmed by others (Ueland et α/., 1992). Nevertheless, increase of both 
methionine and SAH after exposure to homocysteinethiolactone indicates that 
the thiolactone ring can be hydrolysed biologically. Since thiolactone esterase, 
the enzyme performing this reaction, is absent in human plasma (Dudman and 
Wilcken, 1982) this enzyme is apparently present in the conceptus. The large 
difference in embryonic homocysteine levels after D- or L-homocysteine-
thiolactone exposure probably reflects the stereospecific preference of this en­
zyme (Dudman and Wilcken, 1982). The lowering of the SAM/SAH ratio caused 
by the thiolactones was comparable with that observed after L-homocysteine 
exposure. Therefore our previous observation that both thiolactones are 
embryotoxic (VanAerts et al, 1993a) may also be explained by increased SAH 
formation, leading to reduced SAM/SAH ratios and consequently inhibition of 
transmethylation reactions. However, other effects, especially thiolactone-de-
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pendent acylation of proteins, may have attributed to the toxicity of the 
homocysteinethiolactones as well (Ueland et al., 1992). 
Based on the evidence presented in this paper, we propose that L-homocysteine 
embryotoxicity, as observed in our experiments, is not mediated by an oxidative 
process, but rather is initiated by increased SAH formation by SAH hydrolase 
leading to reduced SAM/SAH ratios and consequently inhibition of transmethyl-
ation reactions. The beneficial effect of L-homocysteine on the development of 
gestational day 9.5 embryos and the fact that only very high concentrations of L-
homocysteine caused embryotoxicity makes it very unlikely that L-homocysteine 
is the teratogen causing NTDs in children from mild hyperhomocysteinemic 
women. Our results suggest that methionine plays an important role in the 
neurulation process. Future research should therefore be directed to the elucida-
tion of the role of methionine in neurulation. 
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Abstract The developmental onset of three homocysteine metabolizing enzymes in the 
rat conceptus was investigated. Cystathionine-ß-synthase and methionine synthase were 
assayed from day 10 to day 20 of gestation in decidual and placental tissue, from day 10 
to day 12 of gestation in embryonic tissue, from day 14 to day 20 of gestation in fetal liver 
and from day 14 to day 20 of gestation in fetal tissue without liver. On each day, material 
was obtained from at least four conceptuses from two dams. S-adenosylhomocysteine 
hydrolase was assayed in neurulating conceptuses in decidual tissue, parietal yolksac 
plus ectoplacental cone, visceral yolksac plus amnion and embryo proper. Conceptuses 
were pooled from seven (day 9.5 of gestation) or three (days 10.5 and 11.5 of gestation) 
dams. In embryonic and fetal tissue cystathionine-ß-synthase first occurred in fetal liver 
During the organogenic phase it was present only in decidual tissue. Methionine synthase 
was present in all tissues from the first gestational day investigated and S-adenosyl-
homocysteine hydrolase was present in all tissues throughout the neurulating period. Our 
results indicate that the homocysteine-methionine cycle, which is crucial to trans-
methylation reactions, is functional during the neurulating period in embryonic tissue. 
Owing to the absence of cystathionine-fi-synthase at this stage of development in 
embryonic tissue, the homocysteinyl moiety is conserved in the homocysteine-methionine 
cycle. 
Introduction 
A disturbance of methionine-homocysteine metabolism may play a role in the 
aetiology of neural tube defects, and also in other obstetrical problems, such as 
recurrent spontaneous abortion and abruptio placentae (Schorah et al., 1993; 
Steegers-Theunissen, 1993; Steegers-Theunissen et al., 1991, 1992; Wouters et 
al., 1993). 
L-Homocysteine can be metabolised by several enzymes (Fig. 10.1). Methionine 
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Fig. 10.1 Homocysteine and methionine metabolism and its relation to folate metabo­
lism BHMT betaine-homocysteine methyltransferase, CS cystathionine-ß-
synthase, MAT methionine-adenosyl transferase, MS methionine synthase, MT. various 
methyltransferases, MTHFR melhylenetetrahydrofolate reductase, SAHH S-
adenosylhomocysteine hydrolase,SHMT sennehydroxymethyltransferase, SAM S-adenosvl-
methionine, SAH S-adenosylhomocysteine, THF tetrahydrofolate, CH2-THF A/ \N ' U -
methylenetetrahydrofolate, СНз-THF N'-methyltetrahydrofolate 
synthase (N5-methyltetrahydrofolate-L-glutamate:L-homocysteine S-methyltrans-
ferase, EC 2.1.1.13) remethylates L-homocysteine to L-methionine. In this way 
the homocysteinyl moiety is conserved in methionine-homocysteine metabo­
lism. At the same time methionine synthase is the only enzyme in mammals that 
can demethylate N5-methyltetrahydrofolate (5-methylTHF). Since 5-methylTHF 
is the major circulating form of folate, methionine synthase is the key enzyme to 
their active reduced folate supply, which is essential in one-carbon metabolism, 
and purine and pyrimidine synthesis. Therefore methionine synthase is consid­
ered to be ubiquitous in mammals (Shane and Stokstad, 1983). During gesta­
tional development methionine synthase activity seems to progressively decline 
in several species (Gaull et al., 1973; Stemowsky et al., 1976). However, a 
developmental study, including the organogenic phase, has never been pub­
lished. 
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Betaine L-homocysteine S-methyltransferase (EC 2 1 2 5) can also remethylate 
L-homocysteine to L-methionine Betaine L-homocysteme S-methyltransferase 
activity is found in liver tissue of all mammals investigated and also occurs in 
kidney tissue (Encson, 1960, Finkelstein et α/, 1971) In humans betaine L-
homocysteine S-methyltransferase activity is also present m both fetal and adult 
brain tissue, although activity is low (Gaull et α/, 1973) Since betaine L-homo­
cysteine S-methyltransferase is a typical liver enzyme, and the liver is not present 
at the time of neurulation, the penod under investigation, no attempt was made 
in this study to measure its activity in rat embryonic and fetal tissue 
Cystathionme-ß-synthase (EC 4 2 1 22) condenses L-senne with L-homocyste-
ine to L-cystathionine This is an irreversible step in the transsulfuration path-
way, the main pathway for methionine and homocysteine catabohsm Generally 
cystathionine-ß-synthase activity increases dunng fetal development, however, 
the developmental onset is unknown, and may differ between species (Volpe 
and Laster, 1970, 1972, Sturman et αϊ, 1976, Rassin et al, 1981, Gaull et ai 
1972) 
S-adenosylhomocysteine (SAH) hydrolase (EC 3 3 1 1 ) is the only source of L-
homocysteine in mammals as it hydrolyses SAH to L-homocysteme and adeno­
sine However, when L-homocysteine levels are high, SAH hydrolase will 
synthesize SAH, as the reaction is reversible and SAH synthesis is energetically 
more favourable (Ueland, 1982) Since SAH accumulation will inhibit crucial 
transmethylation reactions, in mammals, SAH hydrolase is assumed to be 
ubiquitous as well However, developmental studies have not been published 
The objective of this study was to investigate the gestational development of 
methionine synthase, cystathionine-ß-synthase and SAH hydrolase in the rat 
conceptus to provide a better understanding of the possible relationship between 
methionine-homocysteine metabolism and the aetiology of neural tube defects 
Materials and m e t h o d s 
Chemicals 
Bovine serum albumin (BSA), 5-methylTHF, complete o-phtaldialdehyde reagent 
solution, Coomassie Brilliant Blue G, dithiothreitol (DTT), L-homocysteinethiolactone, L-
senne, L-cystathionine, S-adenosylhomocysteine (SAH), S-adenosylmethionme (SAM), 
lubrol PX and pyndoxal phosphate were purchased from Sigma (St Louis, MO) Ascorbic 
acid and 2-mercaptoethanol were purchased from Merck (Darmstadt Germany) T61 
(containing 20% (w/v) embutramide, 5% (w/v) mebezomiumiodide and 0 5% (w/v) 
tetracaine hydrochloride in water) was obtained from Hoechst Vetennar GmbH (Munich, 
Germany), hydroxycobalamin (vitamin Bl2b) from Fluka Chemie (Buchs, Germany), [U 
14C]-L-senne (specific activity 166 mCi mmdl ) from DuPont de Nemours (Dreiech, 
Germany), erythro-9[2-hydroxy-3-nonyl]adenine (EHNA) from Burroughs Welcome 
(Research Triangle Park, NC), adenosine from USB (Cleveland, OH) and Triton X-100 
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from Serva Feinbiochemica (Heidelberg, Germany). All solutions were made in tap 
water, demineralised by a Milh-RO 10TS system from Millipore Corporation (Bedford, 
MA), except for the HPLC buffers, which were prepared with demineralised water 
additionally filtered by a Nanopure system from Sybron/Bamstaedt (De Bugue, IA). L-
Homocysteine was prepared from L-homocysteinethiolactone by alkaline hydrolysis (5 К 
NaOH, 5 min, 37 °C). The solution was neutralized with HCl and diluted with the 
appropriate assay buffer. 
Animals and dissection of tissues 
Random bred Cpb:WU (Wistar) rats were housed in pairs or groups of three in cages 
and allowed to eat (MRH-TM pellets, Hope Farms B.V., Woerden, The Netherlands) and 
drink (tap water) ad libitum. For animals from which material was obtained on days 1С. 
11, 12, 14, 16, 18 or 20 of gestation, lights were on from 12:00 h until 00:00 h. On day 
0, females (11-26 wk old, 200-300 g) were brought together with males (1:1) from 09:0C 
h until 12:00 h. Animals from which material was obtained on days 9 5, 10.5 or 11.5 o: 
gestation, were housed under the same conditions, except for the light regimen and the 
time of mating, which were shifted by 12 hr 
When the conceptuses had reached the gestational age desired, the dams were killed b\. 
an intracardial injection of 0.4 ml T61. The uterus was removed and the conceptuses 
were explanted and placed in Hank's balanced salt solution. Conceptuses at day 10, 11 
or 12 of gestation were dissected into (i) embryo proper and (ii) decidua. Extraembry­
onic membranes (amnion, visceral and panetal yolk sac and ectoplacental cone) were 
discarded. Conceptuses at day 14, 16, 18 or 20 of gestation were dissected into (i) fetai 
liver, (ii) rest of fetus and (iii) placenta plus extraembryonic membranes plus residual 
decidual tissue. Conceptuses at day 9.5 of gestation were dissected into (ι) embryo 
proper plus amnion plus visceral yolksac, (ii) parietal yolksac plus ectoplacental cone and 
(iii) decidua. Conceptuses at day 10.5 or 11.5 of gestation were dissected into (i) embryo 
proper, (ii) amnion plus visceral yolksac, (iii) parietal yolksac plus ectoplacental cone and 
(iv) decidua. For reference, maternal liver (day 10 of gestation) was used. After dissec­
tion, tissues were immediately frozen in liquid nitrogen and stored at -80 °C until further 
treatment. 
Enzyme assays 
Protein concentrations were assayed using Coomassie Brilliant Blue G according to 
Bradford (1965). BSA was used as a standard. All samples were analyzed in triplicate 
The methionine synthase and the cystathionine-ß-synthase assays were performed with 
all tissues obtained from dams on day 10, 11, 12, 14, 16, 18 or 20 of gestation. At each 
stage, material was obtained from two animals and at least two conceptuses from each 
animal were assayed in duplicate The methionine synthase assay and measurement of 
the o-phtaldialdehyde derived methionine by HPLC and fluorometric detection were 
performed according to Garras et al. (1991). 
The cystathionine-ß-synthase assay was performed according to Fowler et al. (1978), 
except that tissues were homogenized (1:10, w/v) in ice-cold 50 mM potassium phos-
phate buffer (pH 7.4) containing 0.1% (v/v) lubrol PX and the assay buffer (final volume 
100 μΐ) contained 50 μ\ homogenate, 25 mM potassium phosphate, 0.05% (v/v) lubrol 
PX, 108 mM TRIS-HC1 (pH 8.6), 8 mM L-serine (final specific activity 1563 дСі mmol _ 1 
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[U-MC]-L-serine), 1 M pyndoxal phosphate, 1 5 mM DTT and 15 mM L-homocysteine L-
Homocysteine stock solution (7 5 μΐ) was added to the incubation mixture after a 
preincubation of 5 min at 37 °C 
The S-adenosylhomocysteme hydrolase assay was performed with all tissues obtained 
on day 9 5 (7 rats, 75 conceptuses), 10 5 (3 rats, 32 conceptuses) or 11 5 (3 rats, 40 
conceptuses) of gestation Material from each rat was pooled separately, except for day 
9 5 of gestation when material from 2 or 3 rats was used for each pool Thus for each 
tissue and each gestational stage, tissues were assayed in triplicate Tissues were 
sonicated at a protein concentration of approximately 10 mg ml l in ice-cold 22 5 mM 
potassium phosphate buffer (pH 7 0) containing 1 mM Na2EDTA-2H20, 20 μΜ EHNA, 
1 64 ml Triton X-100 1 ' and 1 1 mM DTT The assay was performed at 37 °C for 20 
min in the same buffer (10 μΐ homogenate in a final volume of 200 μΐ) additionally 
containing 0 5 mM L-homocysteine and 0 5 mM adenosine After the incubation protein 
was precipitated with 12 μΙ 8 M perchloric 
acid After 10 min on ice, the mixture was 
centnfuged in a Eppendorf centrifuge for 5 
min (13,000 g, 4 °C) and 25 μΐ 4 M dipotas 
sium hydrogenphosphate was added to the 
supernatant After another 10 min on ice 
the precipitate was removed by centrifuga-
tion and the supernatant was frozen in liq­
uid nitrogen Samples were stored at -80 
°C until further analysis SAH was mea­
sured in duplicate by using HPLC and 
specrrophotometric detection according to 
DeAbreuera/ (1982) All enzyme activities 
were expressed in μϋ (pmol product 
formed mm ' mg ' protein) 
Statistical analysis 
Linear regression analysis was used to test 
whether methionine synthase activity or 
cystathionine-ß-synthase activity increased 
or decreased during gestation A decrease 
or increase was regarded as significant if 
P<0 05 for the null-hypothesis that the 
regression coefficient equalled zero Differ-
ences in enzyme activity between gesta-
tional days and differences in SAH hydro-
lase activity between tissues for each gesta-
activity tional day were tested using Student's t-test 
with Bonferroni correction With a nominal 
о of 0 05, differences were regarded as 
statistically significant at P < 0 05 fc ', where 
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section met the degree of statistical significance as mentioned above. 
Results 
125 
Γ3 
3 
100 
75 
Methionine synthase was present in all tissues investigated. The highest specific 
activity was found in embryonic tissue on day 12 of gestation. On days 10 and 
11 of gestation it was lower and from day 12 onward the activity decreased at 
an average rate of 33 μϋ day"1. Methionine synthase specific activity of mater­
nal liver was 180 μΐ), which was comparable to the average methionine syn­
thase specific activity of fetal liver. Methionine synthase activity of the fetal liver 
decreased during gestational development at a rate of 26 μϋ day"1. The lowest 
methionine synthase specific activity was found in decidual and placental tissue, 
and here it did not change significantly during gestation. (Fig. 10.2). 
During gestation, cystathionine-ß-syn-
thase activity was not present in embry-
onic tissue. In this organogenic phase of 
development, it was present only in the 
surrounding decidual or placental tissue. 
In the latter tissue, it decreased during 
gestation at a rate of 15 μο day"1 and 
was virtually absent at day 16 of gesta­
tion. In fetal tissue, activity first occurred 
in the liver, where it was present from 
the first day (day 14) that it was mea­
sured, although initially activity was low. 
Cystathionine-ß-synthase specific activ-
ity of fetal liver increased during the last 
trimester of gestation, at a rate of 235 
μΙ) day"1 and reached, on day 20 of 
gestation, 68% of cystathionine-ß-syn-
thase specific activity of maternal liver, 
which was 2100 μΌ. In fetal tissue with­
out liver, cystathionine-ß-synthase activ-
ity occurred only on days 18 and 20 of 
gestation (Fig. 10.2). 
SAH hydrolase was present in neu-
rulating rat conceptuses on all days in-
vestigated (days 9.5 to 11.5 of gesta-
tion), both in the embryos proper and in 
50 
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Fig. 10.3 S-adenosylhomocysteine hy­
drolase activity in neurulating 
rat conceptuses. Enzyme activity was mea­
sured in the direction of synthesis. Concep­
tuses were separated into embryo proper, 
visceral yolksac (+ amnion), parietal yolk-
sac (+ ectoplacental cone) and decidua, 
except for embryos from day 9.5 of gesta­
tion, in which embryos and visceral yolksac the surrounding tissues. However, spe-
were pooled together. Bars and error bars
 c i f i c a c t ivities differed markedly between 
represent the mean and SEM of three pools ^
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of conceptuses. э ' 3 э 
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tion, SAH hydrolase specific activity was greater in embryonic plus visceral yolk-
sac tissue than it was in decidual or parietal yolksac tissue. On day 10.5 of 
gestation, the investigated tissues could be ordered in sequence of increasing 
SAH hydrolase activity as follows: decidua <parietal yolksac < embryo <visceral 
yolksac. On day 11.5 of gestation, SAH hydrolase activity was greater in visceral 
yolksac tissue than it was in any other tissue. In addition, embryonic SAH 
hydrolase activity was greater than decidual SAH hydrolase activity. Interday 
differences in SAH hydrolase activity were limited. Only SAH hydrolase activity 
in parietal yolksac tissue on day 11.5 of gestation was lower as compared with 
that on day 10.5 of gestation. Maternal liver SAH hydrolase specific activity (on 
day 10 of gestation) was 262±48 (mean±SEM) /AJ. 
Discussion 
The data on the developmental onset of cystathionine-ß-synthase in rat fetuses 
extend those of Volpe and Laster (1972) and show that this enzyme first 
appears in the fetal liver and that, before this organ is formed, cystathionine-ß-
synthase activity is present only in the surrounding decidual and placental tissue. 
The presence of methionine synthase activity in rat embryos and fetal liver 
(Hansen and Billings, 1986; Baden et al., 1984; 1987) is confirmed; however, 
owing to the decrease of methionine synthase activity of fetal liver towards the 
end of gestation, it appears that the observation from Baden et al. (1984; 1987) 
that fetal liver activity is 50-65% of maternal liver activity is valid only for fetal 
liver at the end of gestation. The activity of methionine synthase in embryonic 
and fetal tissues from day 12 to day 18 of gestation was higher relative to 
maternal liver activity, which is in contrast to the results from Hansen and 
Billings (1985) that, at day 14 of gestation, activity in embryonic and fetal 
tissues was the same as the activity of maternal liver. The observations pre-
sented here extend those of Hansen and Billings (1985) and, for the first time, 
demonstrate that methionine synthase activity is present in neurulating rat 
embryos. In studies on the teratogenicity of nitrous oxide, a methionine synthase 
inhibitor, the presence of methionine synthase in neurulating embryos was only 
presumed (Baden et al., 1983; Baden and Fujinaga, 1991; Fujinaga and Baden, 
1994). 
This is also the first report to demonstrate SAH hydrolase activity in neurulating 
rat embryos. The higher activity of this enzyme in embryonic and visceral 
yolksac tissue relative to the activity in the surrounding parietal yolksac and 
decidua indicates that SAH metabolism occurs mainly in the embryonic and 
visceral yolksac compartments. The presence of SAH hydrolase and methionine 
synthase, and the absence of cystathionine-ß-synthase, in the embryo proper 
indicates that the homocysteine-methionine cycle is functional at this stage of 
development, but that there is no diversion into the transsulfuration pathway in 
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the embryo. It is calculated that in adult rat liver tissue about half of the homo-
cysteine is transsulfurated, whereas the other half is remethylated to methionine 
(Finkelstein, 1990; Finkelstein and Martin, 1986). The proportion of homocyste-
ine that will be remethylated can be increased or decreased depending on the 
need for SAM. The conservation of the homocysteinyl moiety in the 
homocysteine-methionine cycle as a result of the absence of cystathionine-ß-
synthase in the neurulating embryo emphasizes the importance of this cycle in 
embryonic development at this stage. The relevance of this notion is also 
supported by the work of Klein and coworkers (Coelho et ai, 1989; Coelho and 
Klein, 1990; Ferrari et ai., 1993), who show that methionine deficiency leads to 
neural tube defects in cultured rat embryos and that the teratogenicity of human 
sera in the whole embryo culture could be reversed by addition of methionine. 
Homocysteine-methionine metabolism has an unique function in metabolism of 
one-carbon compounds, namely by its metabolite SAM, which is an universal 
methyl group donor in transmethylation reactions. It has been suggested that 
decreased DNA methylation (Matsuda and Yasutomi, 1992; Li et al., 1992) and 
reduced protein methylation (Coelho and Klein, 1990) are teratogenic mecha-
nisms. The constant withdrawal of homocysteinyl moieties by incorporation of 
methionine into proteins and the use of SAM in polyamine synthesis dictate a 
need for constant replenishment of homocysteinyl moieties, preferably in the 
form of methionine. The embryo seems to economize in this respect by not 
expressing cystathionine-ß-synthase during this phase of gestation. 
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Summary and main conc lus ions 
Homocysteine hypothesis 
Folic acid-preventable NTDs are probably based on a genetic predisposition 
which is expressed as a folate related metabolic disorder. Due to the mild nature 
of this metabolic disorder it usually does not give rise to any clinical symptoms 
in the mother. However in combination with certain environmental factors it 
may affect the neurulation process of the embryo. Folic acid supplementation 
may overcome such a mild metabolic defect and in this way protect the embryo 
(Kirke et al, 1993; Yates et al, 1987; Scott et al, 1994). Besides a low folate 
status in combination with a folate related metabolic defect several studies 
suggest that a low vitamin Bl2 status or a disordered transport or metabolism of 
vitamin Bl2 are associated with an increased risk for NTDs as well (Schorah et 
ai, 1980; Gardiki-Kouidou and Seller, 1988; Magnus et ai, 1991; Economides 
et ai., 1992; Kirke et al, 1993; Mills et al, 1995). It has therefore been sug-
gested that a reduced substrate flux through methionine synthase is an impor-
tant mediator in the aetiology of NTDs. A reduced substrate flux through methi-
onine synthase will lead to an increase in homocysteine concentrations in blood 
and tissues, which are more pronounced after an oral methionine loading test. 
This has led to the hypothesis that these increased homocysteine levels, either 
maternal or in embryonic tissues, are responsible for the increased risk for a 
NTD-affected pregnancy. Investigation of the effects of increased homocysteine 
concentrations on the development of neurulating embryos was the main objec-
tive of this thesis. The culture of postimplantation rat embryos during the neur-
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ulating period was the tool by which most of these investigations were per-
formed. 
In chapter 8 we investigated the embryotoxicity of homocysteine in gestational 
day 10 rat embryos in the postimplantation rat embryo culture. It was found that 
homocysteine was embryotoxic in a stereospecific way. L-homocysteine induced 
many malformations, however no NTDs. Even at the highest concentration 
tested (2.7 mM) D-homocysteine did not produce any embryotoxicity. The most 
frequent malformations that were caused by L-homocysteine were enlarged and 
transparent rhombencephalon, no or delayed fore limb bud formation, irregular 
and reduced number of somites and blisters - sometimes filled with blood -
dorso-lateral of the place of fore limb bud formation. The lowest dose with an 
observable effect (reduced mitotic index of the neural epithelium and decreased 
mesenchymal cell density) was 0.9 mM and the lowest dose that induced mor-
phological defects was 1.8 mM, which is 100-fold higher than the blood homo-
cysteine levels observed in mild hyperhomocysteinemic women. In a subsequent 
study (chapter 9) in which gestational day 9.5 rat embryos were cultured in 
medium largely consisting of human serum and to which 1 or 2 mM L-homocys-
teine had been added, embryos developed normally, whereas embryos failed to 
close there neural tube when L-homocysteine was omitted. The high levels of 
homocysteine needed to induce embryotoxicity, the lack of induction of NTDs 
by L-homocysteine and even the prevention of NTDs by L-homocysteine in rat 
embryo culture make it highly unlikely that elevation of homocysteine concen-
trations either in the maternal serum or in the embryonic tissues is a causal 
factor in the aetiology of NTDs. Blood homocysteine levels elevated to a greater 
degree as compared to healthy controls after an oral methionine load should 
therefore only be interpreted as a biochemical risk indicator, showing homocys-
teine/methionine metabolism is not functioning optimally. 
The mechanism of the embryotoxicity observed in cultured rat embryos after 
exposure to high levels of L-homocysteine was further investigated in chapter 9. 
Gestational day 11 rat embryos were exposed to L- and D-homocysteine. To be 
able to measure homocysteine-related metabolites in the embryonic tissues, 
older embryos were used in this experiment. It was found that exposure to 3 mM 
L-homocysteine increased embryonic SAH concentrations to such an extent that 
the SAM/SAH ratio was reduced to a level were inhibition of transmethylation 
reactions should be expected. We therefore proposed that this decrease of the 
SAM/SAH ratio and the subsequent inhibition of transmethylation reactions are 
intermediary in the mechanism of L-homocysteine embryotoxicity in vitro. This 
proposition is furthermore supported by the following observations: (i) D-homo-
cysteine is much less embryotoxic (at the highest concentration tested (2.7 mM) 
no toxicity was observed), and (ii) the increase of embryonic SAH levels after D-
homocysteine exposure is much smaller as compared to the increase observed 
after L-homocysteine exposure. These observations correlate with the enzyme 
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kinetic properties of SAH hydrolase - the enzyme converting homocysteine and 
adenosine to SAH, when homocysteine concentrations are high - i.e. the Km for 
D-homocysteine was 79 times as high as the Km for its enantiomere. 
We also demonstrated homocysteine oxidizes to its disulfide homocystine - and 
probably also cysteine-homocysteine and protein-homocysteine mixed disulfides 
- when it is added to the embryo culture (chapter 8 and 9). Addition of transition 
metal ions enhances these oxidation reactions. The reduction of homocysteine 
embryotoxity by addition of transition metal ions and the absence of reduction 
of homocysteine embryotoxity when catalase is added make it unlikely homo-
cysteine embryotoxicity is based on a H2O2 producing transition metal ion 
catalyzed oxidation of homocysteine in the medium as it was proposed for 
endothelial toxicity of homocysteine (Starkebaum and Harlan, 1986). 
A study of the gestational development of homocysteine metabolizing enzymes 
in the rat (chapter 10) showed that cystathionine-ß-synthase activity first ap-
pears in the liver and therefore is not present in embryonic tissues before this 
organ is formed. Two enzymes of the methylation cycle that metabolize homo-
cysteine (methionine synthase and SAH hydrolase) are present during the neu-
rulation period indicating this cycle is 'active at this stage of development. Owing 
to the absence of cystathionine-ß-synthase activity in embryonic tissues during 
the neurulation period, the homocysteinyl moiety is conserved in the methyla-
tion cycle. The constant withdrawal of homocysteinyl moieties by incorporation 
of methionine into proteins and the use of SAM in polyamine synthesis dictates 
a need for continuous replenishment of homocysteinyl moieties, preferably in 
the form of methionine. The embryo seems to economize in this respect by not 
expressing cystathionine-ß-synthase during this stage of gestation. This feature 
of embryonic homocysteine metabolism constitutes another circumstantial 
evidence that slightly elevated homocysteine concentrations are more likely 
beneficial to embryonic development rather than the cause of deleterious effects. 
Methionine hypothesis 
Besides increased homocysteine levels due to decreased substrate flux through 
methionine synthase, decreased activity of methionine synthase will decrease 
the formation of methionine. In the experiment wherein homocysteine pre-
vented neural tube defects in cultured rat embryos, methionine showed the 
same preventive effect at even lower concentrations (chapter 9). This suggested 
that the preventive effect of homocysteine might be mediated by providing the 
embryo with more methionine. The same study showed that folinic acid (5-
formylTHF) could not attenuate the teratogenicity of the serum used. This 
suggests that prevention of NTDs in this model is much more linked with an 
adequate supply of methionine than with support of folate mediated purine and 
pyrimidine synthesis. Prevention of neural tube defects in cultured rat embryos 
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by methionine supplementation has been demonstrated before (Coelho et al., 
1989; Coelho and Klein, 1990; Flynn et al., 1987). Also studies on antilaminin 
antibodies showed methionine to be a limiting nutrient for normal development 
of cultured rat embryos (Chambers et al, 1995). Essien showed that methionine 
supplementation promoted the remediation of axial defects in Axd mutant mice 
(Essien, 1992; Essien and Wannberg, 1993a,b). Poor reproductive outcome in 
monkeys and humans could be improved by methionine supplementation (Klein 
et al., 1993; Ferrari et al., 1993). Although the latter studies are concerned with 
recurrent abortion and infertility, they still may be linked to NTDs since over 
90% of NTD-affected embryos are lost by the end of the embryonic period and 
the estimated total prenatal mortality rate of NTD-affected embryos is 98.4% 
(Shiota, 1993). 
Thus besides our own results presented in chapter 9, several other reports, 
especially those from Norman Klein and co-workers, provide evidence that 
methionine is the nutrient that is most limiting in the process of neural tube 
closure. The prevention of NTDs by folic acid supplementation may therefore be 
based on an increase of the methionine supply in embryonic tissues involved in 
neurulation. Folic acid supplementation will increase the availability of 5-
methylTHF and in this way increase the substrate flux through methionine 
synthase. Consequently the supply of methionine will be increased. This process 
may be of importance both in the maternal and in the embryonic tissues. In-
crease of methionine formation in the maternal tissues will reduce the need of 
these tissues to depend on the nutritional supply of methionine and therefore 
less methionine will have to be withdrawn from the circulation. Increased blood 
methionine levels will lead to a more sufficient provision of this crucial nutrient 
to the embryo. Additionally increased 5-methylTHF serum concentrations will 
increase the ability of the embryonic tissues to remethylate homocysteine to 
methionine and therefore make them less dependent on the maternal methio-
nine supply. 
Finally there may be some special circumstances in the tissues involved in neu-
rulation making them more prone to nutritional insufficiencies. These tissues 
divide rapidly and the nutritional demand will therefore be increased. Further-
more the blood supply, especially to the apical parts of the neural walls is lim-
ited. Nutrients might therefore easily become diluted while these tissues are 
increasing in biomass. Nutrient supply may therefore become critical in these 
tissues during neurulation and the one most limiting will be the one that first 
evokes a deleterious effect. When methionine is this most limiting nutrient, folic 
acid supplementation will prevent the developmental derailment by increasing 
both 5-methylTHF and methionine supply to the embryo. 
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Perspectives 
On the premise that an insufficient methionine supply plays a pivotal role in the 
aetiology of folic acid-preventable NTDs, one may speculate on several aspects 
of the aetiology of NTDs and the prevention of a large proportion of them by 
peri-conceptional folic acid supplementation. One question is 'What are possible 
causes leading to an insufficient methionine supply to the embryonic tissues 
involved in neurulation and may therefore be causal factors in the aetiology of 
NTDs?'. Another question is 'Why is methionine so important for the neurulation 
process?'. Finally one could ask 'What are the implications for the prevention of 
NTDs?' These questions will be addressed in the following sections. 
Environmental factors leading to an insufficient methionine supply 
When the question is asked what factors may cause an insufficient methionine 
supply to the embryonic tissues, the concept of a multifactorial aetiology of 
NTDs makes its entry once again. Although in some cases just a single causative 
factor may lead to insufficient methionine levels, it is more likely that an ensem-
ble of several factors will cause such an insufficiency. These factors may be of an 
environmental as well as of a genetic nature. 
One set of environmental factors that may contribute to an insufficient supply of 
methionine are nutritional deficiencies. The most obvious one is a low intake of 
methionine. This may occur when the diet is low in protein or when the proteins 
consumed are low in methionine. Little attention has been given to such a 
condition in relation to the aetiology of NTDs thus far. In early observational 
studies it was noted that protein intake was higher in mothers from social classes 
I and II than in mothers of lower social classes (Smithells et ai, 1977). Diets low 
in protein were classified as 'inadequate' and such diets were associated with an 
increased risk for an NTD-affected pregnancy (Laurence et ai, 1980). Although 
low methionine intake may have contributed to the increased risk for a NTD-
affected pregnancy, it will be difficult to isolate such a condition as a separate 
risk factor, since individuals that consume a poor diet that has a low protein 
content, have a lower intake of other dietary constituents, notably vitamins, as 
well (Smithells et ai, 1977). 
Another nutritional factor that may contribute to an insufficient methionine 
supply is a low intake of folates. Since the methylation of homocysteine to 
methionine is dependent on a sufficient supply of 5-methylTHF, an inadequate 
nutritional supply of folates may hamper the salvation of the homocysteinyl 
moiety and therefore induce a methionine deficiency. Inadequate intake of 
folates has been given the most attention during recent decades and it is now a 
well established risk factor for NTDs (Kirke et ai, 1993). 
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The other vitamin on which methionine synthase is dependent, is vitamin Bl2. 
Inadequate intake of vitamin Bl2 may therefore also contribute to an insufficient 
methionine supply to the embryonic tissues. A low vitamin Bl2 concentration in 
blood or amniotic fluid has been reported to be associated with NTD-pregnan-
cies (Schorah et al., 1980; Economides et al., 1992) and was identified as an 
independent risk factor for NTDs (Kirke et al., 1993). Recently Black et ai. 
(1994) reported that the folate status of women in a rural area of Mexico was 
normal, but a low vitamin Bl2 status (<74 pmol/1) was found in 15% of preg-
nant women. Knowing that the prevalence of NTDs in Mexico is 1 in every 300 
births (International Clearinghouse, 1991), these data may be a sign on the wall. 
Another set of environmental factors that may lead to an insufficient supply of 
methionine, is exposure to xenobiotics that either may enhance the catabolism 
or clearance of methionine or of vitamins necessary for its formation, or block 
the formation of methionine directly or indirectly. One group of such xenobiotics 
are the anticonvulsants. Several of them, notably phenytoin and phénobarbital, 
reduce the levels of folate (e.g. Dastur and Dave, 1987; Dansky et al., 1987; 
Hillesmaa et al., 1983) and therefore may reduce the degree in which homocys-
teine is remethylated to methionine. Interesting in this respect is the report by 
Nosel and Klein (1992) in which they demonstrated valproate teratogenicity in 
rats could be reduced by maternal methionine supplementation. In an in uitro 
study Lucock et al. (1994) showed that carbamazepine reduced the rate of 
conversion of folic acid to 5-methylTHF by rat liver homogenate, which shows 
that this drug has the potential of reducing the availability 5-methylTHF. 
Other drugs interfering with folate metabolism are folic acid antagonists (metho-
trexate, aminopterin, pyrimethamine, trimethoprim, sulphasalazine), As dis-
cussed in the introduction (chapter 7), due to the severity of the folate deficiency 
induced by folic acid antagonists, these drugs exert an abortifacient action when 
administered early in gestation rather than induce malformations. Cycloserine 
(used in tuberculosis treatment) and possibly oral contraceptives may have an 
anti-folate action as well (Lambie and Johnson, 1985). 
Chronic ethanol consumption is another way by which the folate stores will get 
depleted. The mechanism by which ethanol exerts its anti-folate action is un-
clear. Several mechanisms have been proposed, including reduced intestinal 
absorption, diminished liver storage and increased faecal and urinary loss 
(Lambie and Johnson, 1985). 
Another compound which would be expected to be very interesting with respect 
to the study of the necessity of methionine in the neurulation process is nitrous 
oxide (N2O). N2O inactivates methionine synthase by oxidation of the cobala-
min moiety over a prolonged period (days rather than minutes) (Nunn and 
Chanarin, 1985). In the light of the methionine hypothesis inactivation of this 
enzyme might therefore be expected to induce NTDs. However teratogenicity 
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studies with this anaesthetic gas have been somewhat disappointing in this 
respect. In humans N20 is strongly suspected of increasing the rate of spontane­
ous abortions among exposed operating room and dental suite personnel 
(Baden, 1985). In rodents it increases the rate of resorptions and induces both 
soft tissue and skeletal malformations. In postimplantation rat embryo culture 
N2O induced growth retardation and malformations, most notably disturbances 
of the normal development of the left/right body axis (Fujinaga et al., 1988; 
Baden and Fujinaga, 1991; Fujinaga, 1995). Thus there is a lack of a terato­
genic specificity of N2O with respect to NTDs which may be the result of the 
effects of N2O on both methionine synthesis and folate metabolism. Due to the 
prolonged inactivation of methionine synthase N2O may not only decrease 
methionine levels, but hamper folate metabolism as well for a period long e-
nough and in a degree grave enough that it compromises thymidine and purine 
synthesis. In this respect it may be comparable to the action of classical anti-
folates like aminopterin and methotrexate, which are also known for their aborti-
facient action and teratogenic aspecificity. In a recent report Fujinaga and 
Baden (1994) argued N2O teratogenicity was rather caused by a lack of methio­
nine than by a decreased folate metabolism, since methionine could prevent 
N2O induced teratogenicity and folinic acid could not. However their argument 
is not conclusive since the protective effect of methionine may at least partly be 
based on a regulatory mechanism. When methionine is administered, SAM 
levels will increase. High SAM levels will inhibit the activity of MTHFR. The 
lowering of 5-methylTHF levels, which would be the result of this feedback 
mechanism, would lead to a low flux through methionine synthase. Inactivation 
of methionine synthase by N2O is believed only to occur when the enzyme is in 
a metabolically active state (Christensen et ai, 1994). Methionine may therefore 
have protected methionine synthase from N2O induced oxidative damage 
instead of simply preventing a N2O induced methionine deficiency. 
Genetic factors leading to an insufficient methionine supply 
Mild metabolic defects that do not cause any problems in the mother may cause 
an inadequate methionine supply to or in the embryo when several of them 
occur together or when they occur in combination with one or more of the 
above mentioned environmental factors. These metabolic defects may be di­
vided into three groups: (i) Those affecting folate dependent enzymes, (ii) those 
that affect vitamin Bl2 metabolism, and (iii) those that affect methionine catabo-
lism. 
Yates et al. (1987) first proposed a disordered folate metabolism as a basis for 
genetic predisposition to neural tube defects. The hypothesis this could be due 
to a decreased activity of intestinal γ-carboxypeptidase - an enzyme that breaks 
down the polyglutamated folates to their absorbable monoglutamated forms -
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was investigated by Bower et al. (1993). Their results did not support this hy-
pothesis, but rather indicated that the distribution or metabolism of folic acid or 
its metabolites was impaired. Results of another study of limited scale (Lucock et 
al., 1994) also suggested that some NTD-mothers had a biochemical lesion 
somewhere in the multi-enzyme pathway leading from folic acid to 5-methyl-
THF. Very interesting in this respect are two independent observations. One is 
the finding that mild hyperhomocysteinemia occurs more frequently in NTD-
mothers (25%) than in a control population (Steegers-Theunissen et ai, 1991; 
1994). The other is the identification of a thermolabile variant of MTHFR which 
in its homozygous form leads to a reduced activity of this enzyme and causes 
mild hyperhomocysteinemia (Kang et al., 1988). Subsequent studies at our 
university showed that in NTD-children and their mothers and fathers homozy-
gosity for the thermolabile variant of MTHFR occurred in 14,16, and 10% of the 
cases, respectively (VanderPut et al., 1995). Thus homozygosity for this mild 
enzymatic defect may be one of the forms of genetic predisposition for folic acid-
preventable NTDs. Curiously it was found that in a control population the prev-
alence of homozygosity for thermolabile MTHFR was 5% (Kang et al, 1991). 
This means that the gene frequency for this trait is very high in the general 
population. Such high gene frequencies usually occur only if there is some 
evolutionary advantage. Just like the high frequency for a genetic defect causing 
sickle cell anaemia in some African populations is explained by the increased 
resistance of affected individuals for malaria. It might be interesting to speculate 
on the rationale behind the high frequency of the thermolabile MTHFR trait. 
Reduced activity of MTHFR will result in a shift of the one-carbon flow from 
methionine synthesis to purine and thymidine synthesis. When our predecessors 
descended from the trees they changed their diet to staple foods containing less 
folic acid. In periods of food scarcity nutritional folate deficiency must therefore 
have occurred frequently. Severe folate deficiency will impair purine and thymi-
dine synthesis and therefore decrease reproductive fitness of folate deficient 
individuals. Individuals inflicted with homozygosity for the thermolabile variant 
of MTHFR will however be protected from such an impairment to a certain 
degree, since their one-carbon flow is directed to purine and thymidine synthesis 
to a greater degree than in normal individuals. In other words their reproductive 
fitness will be greater under the conditions of a general folate deficiency. Surely 
such individuals would have an increased risk for an NTD-affected pregnancy, 
however this disadvantage might not counterbalance the advantage of a more 
efficient nucleotide synthesis. Thus increased purine and thymidine synthesis in 
individuals homozygous for thermolabile MTHFR may have resulted in a greater 
reproductive fitness in these individuals under conditions of general folate defi-
ciency and this may have resulted in selection of the thermolabile MTHFR trait. 
Another enzyme which is a likely candidate for a folate related mild enzymic 
defect leading an to insufficient methionine supply is methionine synthase. 
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Interesting results have been obtained by a group of Irish researchers (Kirke et 
al, 1993, Mills et al, 1995) They showed that in a group of NTD-mothers in 
which vitamin Bl2 plasma concentrations were in the lower range total homo-
cysteine concentrations were higher than in healthy controls This effect was 
independent of the folate status of these women They suggested cases pos-
sessed an abnormal methionine synthase that has a reduced metabolic capacity 
when vitamin Bl2 levels are low, however in a range where the normal enzyme 
is fully functional and active This may be a plausible explanation for the results 
they obtained, however their results may be interpreted in other ways as well 
Firstly the defect may also be caused by a defect in vitamin Bl2 metabolism 
Mills et al (1995) showed there was no difference in methylmalonic acid values 
between controls and cases, indicating Bl2 metabolism is normal up to the level 
of the Co2+ form of cobalamin However, vitamin Bl2 still has to be processed a 
little further before it is a functional component of methionine synthase Thus 
defects in the cobalamin binding capacity of methionine synthase, the reduction 
of Co2+ to Co+, or the methylation of the cobalamin moiety to its active methyl-
cobalamin form are alternative explanations for the findings of Mills et al 
(1995) Several enzymes and cofactors are involved in these processes and the 
marked heterogeneity in the more severe forms of defective cobalamin metabo-
lism at this level (cblG and cblE, Qureshi et al, 1994) indicates that the observa-
tions by Mills et al (1995) may also represent a heterogeneous population of 
mild enzymatic defects Secondly the results obtained by Mills et at (1995) and 
Kirke et al (1993) may just as well reflect the effects of mild enzymic defects in 
folate metabolism leading to reduced availability of 5-methylTHF This is be-
cause the crucial point seems to be the substrate flux through methionine syn-
thase When 5-methylTHF availability is low the substrate flux through methio-
nine synthase may still be sufficient when vitamin Bl2 levels are in the upper 
range and the amount of methionine synthase holo-enzyme therefore is large 
enough to compensate for the lower 5-methylTHF concentrations However 
when vitamin Bl2 levels are in the lower range the amount of methionine syn-
thase holo-enzyme may be insufficient to compensate for the reduced 5-methyl-
THF availability Thirdly defects in the catabolic route of methionine may result 
in increased blood homocysteine and decreased blood methionine levels as well 
(see below) 
A study by Schorah et al (1993) showed that incorporation of the methyl group 
of 5-methylTHF into DNA by trophoblasts denved from NTD-affected pregnan-
cies was smaller than by trophoblasts denved from normal pregnancies They 
too suggested that the reduced activity of methionine synthase was the most 
likely explanation for this difference However they measured the incorporation 
of the carbon atom in thymidine For this the methyl group of 5-methylTHF first 
has to be oxidized to methylene This involves a multi-enzyme pathway of four 
enzymes consisting of both cytoplasmic and mitochondnal enzymes (Fig 7 4) 
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Thus far metabolic defects that lead to a reduced formation of methionine have 
been discussed. However an insufficient methionine supply may also be caused 
by increased catabolism of methionine. Methionine is catabolized through the 
transsulfuration pathway. The first three enzymes are enzymes of the methyla-
tion cycle. These are methionine adenosyltransferase (MAT), a specific methyl-
transferase used for catabolism of SAM: sarcosine synthase (or N-glycine methyl-
transferase, GNMT) and SAH hydrolase. 
MAT is present in different isoforms. The predominant adult hepatic isoforms 
are MAT I and MAT III, which are probably coded by the same gene, but con­
tain two and four α subunits, respectively (Kotb and Geller, 1993). MAT I has an 
intermediary Km for methionine (3-14 μΜ) and MAT III has a high Km for methi­
onine (200 μΜ). The principal function of MAT III probably is catabolism of 
methionine when methionine levels are high. Reducing agents like dithiothreitol 
and glutathione (Pajares et al., 1992a,b; Kotb and Geller, 1993) convert the 
MAT I isoform to the MAT III isoform. In extrahepatic tissues and in the fetal 
hepatic tissue the predominant form of MAT is MAT II. It consists of α-, ß- and 
α-like (a') subunits. It has a low Km for methionine (6 μΜ). A less active MAT II-
like isoform has also been demonstrated in human lymphocytes, which was 
designated as the λ-form. On mitogenic activation the λ-form is either converted 
to the more active MAT II isoform or is replaced by it. A number of studies 
indicate that the MAT II isozyme is the predominant or only active MAT in 
rapidly dividing tissues (Kotb and Geller, 1993). MAT III deficiency leads to 
hypermethioninemia. MAT II deficiency has not been described, probably be­
cause it is fatal. However changes in the regulation of the interconversions of 
different polymeric isoforms if existent may lead to pathological conditions (Kotb 
and Geller, 1993). Although possible changes in MAT activity in maternal and 
embryonic tissues are probably not related to a hyperhomocysteinemic condi­
tion, the relevance of such changes for the aetiology of NTDs may still exist, 
since SAM is the universal methyl group donor and the postulated pivotal role of 
methionine in neurulation may be through this metabolite. 
When methionine levels are high the maternal liver will catabolize it with MAT 
III. The product of this reaction - SAM - is then further metabolized by GNMT. 
This enzyme is allosterically inhibited by 5-methylTHF. Hypothetically speaking 
a mutation leading to increased inherent activity of GNMT or decreased binding 
of 5-methylTHF to GNMT will lead to increased catabolism of SAM. Since SAM 
coordinates its own synthesis by its regulatory effects on cystathionine-ß-syn-
thase and MTHFR, increased remethylation and decreased transsulfuration of 
homocysteine will replenish the loss of SAM (Selhub and Miller, 1992). However 
when folate or vitamin Bl2 levels are low, the remethylating capacity of methio-
nine synthase may be inferior to the metabolic demand. This would lead to mild 
hyperhomocysteinemia and hypomethioninemia. Therefore a derangement in 
GNMT activity might yet provide another alternative explanation to the observa-
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tions made by Mills et al. (1995), who showed the blood homocysteine concen-
trations in NTD-mothers were elevated to a greater extent when their vitamin 
Bl2 levels were low, in comparison to the Bl2 and folate-matched controls. 
Given the fact that 5-methylTHF inhibits GNMT, aggravation of increased SAM 
catabolism under the condition of a folate deficiency may be anticipated. No 
reports are available on the activity of GNMT in NTD-mothers. The importance 
of this enzyme in the regulation of the steady state levels of SAM and the preser-
vation of the homocysteinyl moiety in the methylation cycle make this enzyme 
another interesting candidate to look at when a folate-related genetic predisposi-
tion to NTDs is investigated. 
Other factors affecting methionine supply to the embryo 
Increased activity of GNMT may also be related to yet another subgroup of 
NTDs, that is the subgroup of diabetes-related NTDs. Diabetic mothers have a 
three times greater risk to have a NTD-affected child than healthy controls have 
(Campbell et al., 1986). GNMT is under hormonal and nutritional control. Its 
activity will be increased after glucagon stimulation and under conditions of 
starvation. It is abundant in the periportal region of the liver and in the proximal 
convoluted tubules of the kidney, tissues both involved in gluconeogenesis (Yeo 
and Wagner, 1994). It may therefore be anticipated that in diabetic mothers an 
increased amount of methionine is metabolized to pyruvate through this path-
way, which may lead to an insufficient methionine supply to the embryo. 
Finally moderate auto-immune reactions of maternal antibodies to the embry-
onic yolk sac may affect the efficiency of the yolk sac to convey nutrients from 
the maternal circulation to the embryo. Carey and Klein (1989) have shown that 
antibodies to a basement membrane protein - laminin - were responsible for the 
embryotoxicity of sera from monkeys with a poor reproductive outcome. Immu-
nization of monkeys with good reproductive histories with laminin resulted in 
embryotoxicity of their sera in rat whole embryo culture and failure of the mon-
keys to reproduce (Weeks et ai, 1989). Further analysis of the sera of immu-
nized monkeys showed that the antibodies caused a reduction in the number of 
microvilli on the yolk sac cells and a reduction of cell size (Chambers et al., 
1995). Reduced nutrient uptake by the embryos was associated with increased 
binding of the antibodies to the yolk sac. Extensive binding of autoantibodies to 
the yolk sac and the subsequent reduction in the nutrient flow to the embryo will 
inevitably lead to embryonic loss. However moderate binding will only affect 
those nutrients which are most limiting. In such cases supplementation with 
these nutrients or their precursors may overcome such a mild nutrient block. 
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Methylation hypothesis 
Concerning the mechanism by which methionine exerts its preventive effect with 
respect to NTDs, it has been suggested methionine might increase the activity of 
the methylation cycle, i.e. the constant interconversion of methionine and ho-
mocysteine with intermittent donation of a methyl group by SAM. Coelho and 
Klein (1990) showed that methionine deprived cultured rat embryos had re-
duced ratios of methylated amino acids to unmethylated amino acids in proteins 
of the neural tube. However, the ratio of monomethylarginine to arginine in 
proteins of the heart was lower in methionine supplemented embryos as com-
pared to unsupplemented embryos. Matsuda and Yasutomi (1992) argued that 
5-azacytidine induced NTDs in cultured rat embryos were caused by reduced 
DNA methylation. However, their conclusion was based on measurement of 
DNA methylation by immunohistochemical methods, which can only be a semi-
quantative approach. Furthermore studies in our laboratory showed that high 
levels of homocysteine decreased the SAM to SAH ratio to such an extent that 
methylrransferase reactions must have been impaired. However no NTDs were 
observed (chapter 8 and 9). 
These first approaches do not disqualify the hypothesis reduced methylation is 
involved in the aetiology of NTDs, but rather demonstrate that until now little 
effort has been made to investigate this hypothesis. Nevertheless other mecha-
nisms by which methionine can prevent NTDs should be investigated as well. 
Besides acting as a methyl group donor through SAM, methionine is used in 
protein synthesis and SAM is a precursor in polyamine synthesis. Both reduced 
protein synthesis and perturbed polyamine synthesis could have a deleterious 
effect on embryonic development as well. 
Implications for the primary preuention of neural tube defects 
If a lack of methionine is the cause of failure of the process of neurulation, one 
might suggest the easiest way to prevent NTDs is supplementation with methio-
nine. Although from the work discussed in this thesis it seems evident sufficient 
methionine is essential to the neurulation process, there are several reasons that 
argue against such a strategy. The most important reason is that from animal 
experiments it is clear that overconsumption of methionine is harmful to both 
the mother and the conceptus. Young rats achieved optimal growth when they 
were fed a diet containing 0.3% L-methionine. However diets containing 2% or 
more methionine resulted in a reduced growth rate compared to the 0.3% 
methionine supplemented rats (Benevenga and Harper, 1967; Cohen et al., 
1958). Pregnant rats fed a diet containing 1.6% L-methionine from gestational 
day 10 till gestational day 20 resulted in a threefold increase of resorptions and 
4% of the fetuses had skeletal malformations (Kaemmerer and Zinat, 1975). 
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There is also a possibility that increasing the methionine content of the diet will 
result in an increased risk for premature vascular diseases, since higher levels of 
dietary methionine will increase plasma homocysteine concentrations as well 
(Guttormsen et al., 1994). Although there is no proof that slightly elevated 
homocysteine concentrations are the cause for the vascular defects, at this time 
it is still generally believed that the increased homocysteine concentrations in 
mild hyperhomocysteinemic individuals are responsible for these defects (Green 
and Jacobsen, 1995). 
Nevertheless it makes sense to ensure an adequate methionine intake by con­
suming a diet with sufficient methionine containing proteins. It has been esti­
mated that the daily requirement for methyl groups in humans is 0.35 mmole/kg 
every 24 hours (Mudd et al., 1975; 1980) 0 3 mmole is derived from methio­
nine, which is provided nutritionally or by remethylation of homocysteine. It was 
also estimated that the homocysteinyl moiety cycles approximately twice in the 
methylation cycle before it is transsulfurated to cystathionine, when methionine 
intake is normal. The daily requirement for methionine may therefore be esti­
mated to be approximately 1.5 g/day for an adult. However a lower intake can 
be compensated by increased homocysteine remethylation and decreased 
transsulfuration under the condition folate metabolism is functioning normally. 
Supplementation with methionine bears the risk of overconsumption and should 
therefore only be considered under clinically controlled conditions. 
Peri-conceptional supplementation with folic acid has been proven to be effi­
cient in the prevention of NTDs and should therefore be part of a strategy for 
the primary prevention of NTDs. 
A low vitamin Bl2 status has been shown to be an independent risk factor for 
NTDs (Kirke et al., 1993). Subsequently Mills et al. (1995) showed that NTD-
mothers who had a plasma Bl2 concentration in the lower range (<243 ng/1), 
had higher plasma homocysteine concentrations than controls that were mat­
ched for the Bl2 status, and this effect was found to be independent of the plas­
ma folate concentration. Furthermore plasma and amniotic fluid vitamin Bl2 
concentrations were lower in NTD-mothers as compared to controls 
(Economides et al, 1992; Schorah et α/., 1980). These data suggest that an 
adequate Bl2 status may be as important as an adequate folate status for the 
prevention of NTDs. It makes therefore sense to ensure an adequate vitamin Bl2 
status by vitamin Bl2 supplementation as well. Furthermore vitamin Bl2 supple­
mentation may be especially relevant when folate supplementation is considered 
by the means of food fortification. With respect to the fortification of staple foods 
with folic acid in order to achieve an increased folic acid intake in the general 
population there has arisen considerable debate on the increased risk for the 
elderly to have neurologic disorders that are related to vitamin Bl2 deficiency 
(Wald and Bower, 1994) Vitamin Bl2 deficiency often presents first as perni­
cious anaemia. An increased intake of folic acid will prevent this pathologic 
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condition. However the neurologic disorders won't be prevented by increased 
folic acid intake. Thus there may be an increased risk that patients with an 
acquired myelopathy due to vitamin Bl2 deficiency first seek medical care when 
already irreversible neurologic damage has occurred. Adding extra vitamin Bl2 
to the staple foods in conjunction with folic acid fortification will prevent such 
unwanted side effects and may in fact prevent acquired neurologic disorders and 
pernicious anaemia that are related to vitamin Bl2 deficiency. 
Based on the present knowledge it can be concluded that the best strategy for 
the primary prevention of NTDs is consumption of a diet containing an ade-
quate amount of methionine-rich proteins, supplemented with folic acid and 
vitamin Bl2. 
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Samenvatting voor niet-vakgenoten 
Dit proefschrift, getiteld Embryotoxiciteitsstudies betreffende cyclofosfa-
mide en homocysteine bestaat uit twee delen. Deel I gaat over de verdere 
ontwikkeling van het ratte-embryo kweekmodel waarbij ten behoeve van de 
omzetting van lichaamsvreemde stoffen levercellen van volwassen ratten aan het 
embryo kweekmodel werden toegevoegd. In deel II wordt verslag gedaan van 
onderzoek naar de mogelijke rol van homocysteine in het ontstaan van neurale 
buisdefecten. 
Deel I. Om de teratogeniteit - het vermogen om aangeboren afwijkingen te 
doen ontstaan - van stoffen te onderzoeken kunnen deze in het ratte-embryo 
kweekmodel getest worden. In dit model kunnen ratte-embryo's gedurende de 
periode van de orgaanaanleg buiten het moederdier in leven gehouden worden 
en gebruikt worden voor experimenten. Sommige stoffen zijn echter niet 
teratogeen van zichzelf, maar moeten eerst omgezet worden in een andere 
verbinding die wel teratogeen is. Een bekend voorbeeld van een stof die eerst 
omgezet moet worden, voordat deze teratogene effecten kan veroorzaken, is 
cyclofosfamide. Deze stof werd dan ook in onze experimenten gebruikt als een 
modelstof. De omzetting van lichaamsvreemde stoffen vindt hoofdzakelijk in de 
lever plaats. Het gekweekte ratte-embryo heeft echter nog geen lever ontwikkeld 
en de enzymen die nodig zijn voor de omzetting van de lichaamsvreemde stof 
zijn niet of slechts in zeer beperkte mate aanwezig in andere embryonale 
weefsels. Om toch de rol van dit soort omzettingen in het ratte-embryomodel te 
kunnen onderzoeken werd dit model gecombineerd met de kweek van levercel-
len afkomstig van volwassen ratten. Twee benaderingen werden hierbij onder-
zocht. In de eerste werden de levercellen rechtstreeks aan het serum waarin het 
ratte-embryo werd gekweekt, toegevoegd. In de tweede benadering werden de 
levercellen eerst gekweekt in een kunstmatig medium, waaraan de te onderzoe-
ken stof werd toegevoegd. Vervolgens werden monsters van dit medium 
toegevoegd aan het serum waarin de embryo's werden gekweekt. Beide bena-
deringen bleken te voldoen, maar hebben ieder hun eigen voor- en nadelen, 
waardoor de precieze vraagstelling van een onderzoek zal bepalen welke van de 
twee benaderingen de meest geëigende is. Wanneer onze resultaten vergeleken 
werden met die van andere onderzoekers, bleek dat de gevoeligheid van ons 
model een stuk lager was dan die die zij rapporteerden. Nader onderzoek wees 
uit dat de combinatie van het gebruik van mannelijke levercellen - wij gebruik-
ten levercellen van drachtige vrouwtjes - en een voorbehandeling van deze 
ratten met een PCB-mengsel - een methode om de omzetting van lichaams-
vreemde stoffen te versterken - door de andere onderzoekers de oorzaak was 
van de gevonden discrepantie. Een opmerkelijk resultaat uit het vervolgonder-
zoek was dat de voorbehandeling van drachtige ratten met het PCB-mengsel 
nauwelijks een versterkend effect op de omzetting van cyclophosphamide had. 
Een goede verklaring hiervoor kon op grond van onze resultaten niet worden 
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gegeven. Onze onderzoekingen toonden in elk geval wel duidelijk aan dat 
wanneer levercellen van volwassen dieren met het ratte-embryomodel gecombi-
neerd worden ten einde de omzetting van lichaamsvreemde stoffen in het 
onderzoek te betrekken, het van het allergrootste belang is wat de oorsprong 
van deze levercellen is. Dit geldt niet alleen voor het geslacht van de leverceldo-
noren, maar ook voor het soort voorbehandeling die de ratten hebben onder-
gaan. 
Deel II. Spina bifida (open ruggetje) en anencephalie (kattekopje) zijn 
ernstige aangeboren afwijkingen welke veroorzaakt worden doordat vroeg in 
zwangerschap (4e post-conceptionele week) de neurale buis niet sluit. Zij worden 
dan ook neurale buisdefecten (NBD) genoemd. Het is gebleken dat ongeveer 
70% van deze afwijkingen voorkomen kan worden door al voor de conceptie te 
starten met het innemen van extra foliumzuur, een vitamine uit de B-reeks. Het 
mechanisme van de beschermende werking van foliumzuur is echter onbekend. 
In deel II werd onderzoek gedaan naar dit mechanisme. De uitgangshypothese 
daarbij was de volgende. Wanneer er een tekort aan foliumzuur is, of wanneer 
er een stoornis is in de stofwisseling van dit vitamine dan zullen de homocystein-
econcentraties in het lichaam stijgen. Homocysteine is een aminozuur in de 
stofwisseling van methionine. Constante omzetting van methionine in homocys-
teine en uice versa is van belang bij de overdracht van methylgroepen naar tal 
van belangrijke moleculen in het lichaam. Er werd verondersteld dat een 
verhoogde homocysteineconcentratie de sluiting van de neurale buis verstoort. 
Om deze hypothese te onderzoeken werden ratte-embryo's gedurende de fase 
van de sluiting van de neurale buis blootgesteld aan verhoogde homocystein-
econcentraties. Het bleek dat sterk verhoogde homocysteineconcentraties 
weliswaar toxisch zijn voor het embryo, maar pas bij een concentratie die wel 
honderd maal hoger ligt dan die die bij vrouwen wordt gevonden die een kind 
met een NBD hebben gehad. Bovendien veroorzaakte de hoge homocystein-
econcentratie geen NBD in het ratte-embryomodel. Het bleek zelfs dat wanneer 
ratte-embryo's werden blootgesteld aan hoge homocysteineconcentraties aan 
het begin van het proces van de sluiting van de neurale buis, dit het ontstaan 
van NBD's kon voorkomen, wanneer de embryo's in menselijk serum werden 
gekweekt. Methionine had hetzelfde preventieve effect bij een concentratie die 
een factor tien lager lag. Folinezuur (leucovorine, een derivaat van foliumzuur 
dat zonder voorafgaande reductie in de foliumzuurstofwisseling kan deelnemen) 
kon de NBD's echter niet voorkomen. Hieruit werd geconcludeerd dat het 
beschermende effect van homocysteine in het ratte-embryomodel en foliumzuur 
bij de preventie van NBD's verklaard moet worden doordat ze de beschikbaar-
heid van methionine vergroten. Een belangrijke consequentie van deze conclu-
sie ten aanzien van de preventie van NBD's is, dat niet alleen een voldoende 
foliumzuurinname van belang is in het voorkómen van NBD's, maar dat ook 
een adequate vitamine Bl2 spiegel van groot belang is. Tevens dient het dieet 
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voldoende rijk te zijn aan eiwitten waarin het aminozuur methionine zit. 
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De schrijver van dit proefschrift werd geboren op 4 september 1957 te Roer­
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Nawoord 
Een proefschrift komt tot stand door de samenwerking van velen. Ik wil dan ook 
allen die aan dit werk hebben bijgedragen van harte daarvoor bedanken. Een 
aantal van hen wil ik met name noemen. 
Mijn promotor Prof. dr. Jan Noordhoek wil ik vooral danken dat ik de gelegen-
heid had dit werk in alle rust te voltooien. Tevens dank ik hem voor de tijd die 
hij besteed heeft aan het kritisch doornemen van de manuscripten. 
Mijn promotor Prof. dr. T.K.A.B Eskes dank ik voor de loyale steun die hij ten 
allen tijde aan het onderzoek heeft geboden en voor de onvoorwaardelijkheid 
welke zo essentieel is voor het verrichten van wetenschappelijk onderzoek. 
Mijn co-promotor dr. Jenny Copius Peereboom-Stegeman. Je was erbij vanaf 
het concipiëren van het onderzoek tot aan de voltooiing ervan. De stimulans die 
van jou uitging is zeer gewaardeerd. Met plezier kijk terug op de afgelopen 
periode. 
Het verrichten van wetenschappelijk onderzoek is vaak een kwestie van lange 
adem. Ik heb hierbij de steun gehad van vele medewerkers van de vakgroep 
Toxicologie. Hun inzet en expertise waren voor het onderzoek onmisbaar. Ik 
dank jullie allen voor jullie hulp en collegialiteit. In dit verband wil ik met nadruk 
Jeanne Pertijs noemen. Zonder jou doorzettingsvermogen en hulp was dit werk 
nooit voltooid. 
Gedurende de afgelopen jaren hebben heel wat studenten en stagiaires geparti-
cipeerd in het onderzoek. Het onderzoek dat in dit proefschrift is weergegeven is 
dan ook voor een deel hun werk. Simone, Marian, Henk, Baps, Socorro, Nancy, 
Bart, Monique, Marinka, Gerard, Peggy en Carla mijn hartelijke dank voor jullie 
inzet. 
Prof. dr. Paul Peters en dr. Aldert Piersma van het RIVM wil ik danken voor de 
gastvrijheid die zij mij hebben geboden gedurende de initialisatiefase van het 
onderzoek. Aart Verhoef wil ik in het bijzonder bedanken voor de introductie in 
de techniek van het embryokweken. Het was een plezier om met jullie samen te 
werken. 
Prof. dr. Frans Trijbels, dr. Henk Blom en dr. Ron DeAbreu van het Laboratori-
um voor Kindergeneeskunde ben ik zeer erkentelijk voor de goede samenwer-
king. Addy de Graaf, Maria Te Poele-Pothoff en Bertie van Raaij-Selten dank ik 
voor de analyses welke ze voor mij verricht hebben. 
Jan Koedam en alle medewerkers van afdeling IV van het Centraal DierenLabo-
ratorium dank ik van harte voor de goede zorgen voor de proefdieren welke 
onder hun hoede waren. Met name wil ik hier Monique Derks noemen. Jou 
hulp bij het embryokweekwerk was van onschatbare waarde. 
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Chris Poirot, je hebt niet alleen in praktische zin bijgedragen aan dit proefschrift. 
Ik heb genoten van de vele discussies die wij over het onderzoek samen hebben 
gevoerd. Je hebt me daarbij geïnspireerd en jou ideeën zijn mede bepalend 
geweest voor het verloop van het onderzoek. 
Tenslotte dank ik alle vrienden en familie voor de steun die ze hebben gegeven 
en de belangstelling die ze hebben getoond. In het bijzonder dank ik jou, 
Socorro, dat je mijn beste kameraad was gedurende de afgelopen jaren. 
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Stellingen behorende bij het proefschrift 
Embryotoxicity studies on cyclophosphamide and homocysteine, 
L.A.G.JM uanAerts, 1995 
1. Embryotoxiciteit van L-homocysteine, zoals deze in vitro werd waargeno-
men, is van geen betekenis voor de marginaal verhoogde homocysteine-
concentraties, zoals deze werden waargenomen bij een deel van de 
vrouwen die een kind met een neuraalbuisdefect hebben gehad. 
Dit proefschrift 
2. Ten aanzien van neuraalbuisdefecten is milde hyperhomocysteinaemie 
niet een mediator, maar een risico-indicator. 
Dit proefschrift 
3. Een homocysteinyldeficientie kan leiden tot open neuraalbuisdefecten. 
Dit proefschrift 
4. Door geen homocysteine te transsulfureren, behoudt het neurulerende 
ratte-embryo alle homocysteinyleenheden voor de transmethyleringscy-
clus. 
Dit proefschrift 
5. Het beschermende effect van foliumzuur ten aanzien van het 
voorkómen van neuraalbuisdefecten berust waarschijnlijk op een 
vergroting van de beschikbaarheid van methionine. 
Dit proefschrift 
6. Wanneer het preventieve effect van foliumzuursuppletie berust op het 
opheffen van een beperkte transmethyleringscapaciteit, dan kan deze 
laatste bestreden worden met foliumzuursuppletie of met het realiseren 
van een dieet rijk aan methionine bevattend eiwit. 
Coelho and Klein, Teratology 1990;42:437-451 
7. De wijde verspreidheid van het thermolabiele MTHFR gen bij mensen 
(25% is drager) duidt erop dat er een evolutionair voordeel mee behaald 
kon worden. Verschuiving van de one-carbon-flow van methioninesyn-
these naar nucleotidensynthese kan gedurende periodes van beperkte 
foliumzuurinname zo'n voordeel bieden. 
Kansetal., Am. J. Hum. Genet. 1991;48:536-545 
8. Indien softwareproducenten voor de ontwikkeling van hun produkten 
minder zwaar zouden leunen op post-marketing surveillance, dan 
zouden er aanzienlijk minder 'buggy programs' op de markt verschijnen. 
9. De tijdwinst die verkregen werd door de introductie van eenvoudige 
tekstverwerkers wordt volledig teniet gedaan door de tijd die er besteed 
wordt aan de uitgebreide mogelijkheden van hedendaagse tekstverwer-
kers. 
10. Daar het stopsignaal bij spoorwegovergangen er in veel verdergaande 
mate toe leidt dat fietsers daadwerkelijk stoppen dan het geval is bij 
overige verkeerslichten, verdient het aanbeveling de overige verkeers-
lichten te laten knipperen en van bellen te voorzien. 



